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Bronchiectasis is a chronic airway condition with permanently dilated airways, 
dysfunctional cilia and overproduction of mucus as main clinical symptoms, and in 
bronchiectasis there is a continuous cycle involving bacterial infection, host immune 
response and airway damage (Cole, 1986). More than 70% of bronchiectasis patients 
are chronically colonised with potential pathogens (Angrill et al., 2002). The 
Haemophilus species is the most commonly found bacteria in bronchiectasis 
(Chalmers et al., 2012), with Haemophilus influenzae (H. influenzae) being considered 
a pathogen and Haemophilus parainfluenzae (H. parainfluenzae) a commensal 
bacteria. However, H. parainfluenzae have been found more and more frequently 
associated with lower airway diseases, with further data suggesting it can also play a 
pathogenic role. Up to date, there is limited research about the role of H. 
parainfluenzae in bronchiectasis. This study will investigate the potential 
pathogenicity of H. parainfluenzae in bronchiectasis on its own and when combined 
with Pseudomonas aeruginosa (P. aeruginosa), the second most frequent organism 
isolated in bronchiectasis. We hypothesised that: H. parainfluenzae are common in 
bronchiectasis, and in high bacterial loads, it can play a similar pathogenic role as H. 
influenzae; H. parainfluenzae can induce a stronger inflammatory response when 
combined with P. aeruginosa. 
Main results 
1. H. parainfluenzae are commonly found in bronchiectasis patient’s lower 
airways, but it is seldom reported  
Of the 140 patient sputum samples that were previously found to be infected with 
Haemophilus species, 40% of the patients presented H. parainfluenzae and 47% H. 
influenzae. Another 51 were unselected bronchiectasis patients’ sputum samples were 
processed both in our laboratory and an NHS microbiology laboratory. 18% of these 
patients presented H. parainfluenzae in their samples according to our laboratory, but 
none according to the NHS laboratory.  
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2. H. parainfluenzae have similar clinical relevance as H. influenzae in patients 
with clinically stable bronchiectasis    
From those previously mentioned 140 bronchiectasis patients, 63 had their serum and 
sputum inflammatory markers compared. 24 of them had H. parainfluenzae and 39 H. 
influenzae. There was a similar bronchiectasis disease severity index (BSI) score 
between these two groups. There was similar systemic inflammation, with no 
significant differences in white cell counts (WCC), erythrocyte sedimentation rate 
(ESR), C-reactive protein (CRP), intercellular adhesion molecule 1 (ICAM-1) or 
Myeloperoxidase (MPO). These results suggest that H. parainfluenzae and H. 
influenzae have similar clinical relevance in bronchiectasis. 
3. H. parainfluenzae in high bacterial loads can stimulate significant 
inflammatory responses from epithelial cells  
H. parainfluenzae (at a concentration of 107 cfu/mL) can stimulate a range of 
inflammatory responses comparable to those of H. influenzae (107 cfu/mL) and P. 
aeruginosa (107 cfu/mL) on 16HBE cells, NHBE cells and bronchiectasis patients' 
nasal epithelial cells.  
3.1 Inflammatory responses from human bronchial epithelial cell line (16HBE) 
H. parainfluenzae (107 cfu/mL) can trigger significant interleukin 8 (CXCL8, p=0.001); 
chemokine ligand 1 (CXCL1, p=0.004); ICAM-1(p=0.004) and lipocalin 2 (LCN2, 
p=0.04) production from 16HBE cells compared to the control group after 8 hours. 
There was no significantly difference between 107 cfu/ml H. parainfluenzae, H. 
influenzae and P. aeruginosa. 
3.2 Inflammatory responses from normal human bronchial epithelial (NHBE) cells and 
bronchiectasis patients’ nasal epithelial cells 
H. parainfluenzae (107 cfu/mL) can trigger significantly more CXCL8, CXCL1 and 
ICAM-1 production in NHBE cells (p-values are 0.02, 0.033 and 0.02 respectively) 
and patients’ nasal epithelial cells (p-values are 0.038, 0.0005 and 0.0001 respectively) 
compared to the control group. 
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4. Poly-bacterial infection reduces 16HBE cells’ inflammatory response 
compared to single bacterial infection 
When 16HBE cells were co-cultured with H. parainfluenzae (105 cfu/mL) and P. 
aeruginosa (105 cfu/mL) for 8 hours, there was a significant decrease in CXCL8, 
CXCL1 and LCN2 production by 16HBE cells compared to cells that were cultured 
with only P. aeruginosa (105 cfu/mL), p-values are 0.0007, 0.0032 and 0.04 
respectively. 
5. Indirect interaction between H. parainfluenzae and P. aeruginosa may lead to 
the change observed in inflammatory response from previous result 
When 16HBE cells were co-cultured with heat-treated H. parainfluenzae (105 cfu/mL) 
and P. aeruginosa (105 cfu/mL) for 8 hours, there was no significant decrease in the 
co-infection group (CXCL8 p=0.16, CXCL1 p=0.2), which suggests that the 
previously observed reductive effect requires living bacteria. Therefore, this reduction 
is likely to be due to bacterial interaction between H. parainfluenzae and P. aeruginosa.  
When 16HBE cells and H. parainfluenzae (105 cfu/mL) (n=6) were cultured in filtered 
media that had cultured P. aeruginosa (n=6) for 8 hours, there was a significant 
decrease of CXCL8 and CXCL1 levels compared to cells cultured with H. 
parainfluenzae in media that had not cultured P. aeruginosa (CXCL8 p=0.002, 
CXCL1 p=0.027. This suggests that P. aeruginosa induced media conditions may play 
a role in this observed inhibition effect. Later experiments revealed that P. aeruginosa 
can promote the growth of H. parainfluenzae. 
Conclusion 
H. parainfluenzae are commonly found in bronchiectasis patient’s lower airways, and 
it is under-reported in bronchiectasis. Patients with H. parainfluenzae in their lower 
airways have similar sputum and serum inflammation compared to patients with H. 
influenzae. H. parainfluenzae can stimulate significant inflammatory responses from 
epithelial cells.  
Poly-microbial (H. parainfluenzae with P. aeruginosa) infection reduces 16HBE cell 
inflammatory response (CXCL8, CXCL1 and LCN2) compared to single bacterial 
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infection. The media cultured with P. aeruginosa can reduce cellular inflammatory 
response when co-cultured with H. parainfluenzae. The underlying mechanism 
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Chapter 1: Introduction 
 
1.1 What is bronchiectasis? 
Bronchiectasis is a chronic condition in which the lower airways become abnormally 
dilated; patients suffer from persistent bacterial infection and recurrent exacerbations. 
Common symptoms in bronchiectasis include daily cough, excessive sputum 
production and breathlessness. Microbiological results show more than 70% of 
patients are chronically colonized with a wide range of bacteria and present an 
excessive neutrophilic inflammation (Angrill et al., 2001).  
1.2 Epidemiology 
Bronchiectasis was first described in 1819 as a rather rare phenomenon and for a long 
period of time it was called an ‘orphan disease’. Since the beginning of the 21st century, 
with the more common use of high resolution computed tomography in the diagnosis 
of bronchiectasis (Chalmers and Hill, 2013), more and more data suggests that 
bronchiectasis is much more common than previously reported, and prevalence is 
quickly increasing since recent years (Jennifer K. Quint, et, 2016). In the UK, in 2013, 
the prevalence of bronchiectasis in women was reported at 566.1 per 100, 000, 
compared to the 350.5 per 100, 000 in 2004. In men, in 2013, there were 485.5 per 
100, 000 reported, compared to the 301.2 per 100, 000 in 2004 (Jennifer K. Quint, et, 
2016). Bronchiectasis is more common in people older than 40 years old, with more 
than 50% being over 65 years old (Jennifer K. Quint, et, 2016).  
Bronchiectasis is associated with a markedly increased mortality compared to general 
population. In England and Wales, the mortality rate in women and men with 
bronchiectasis (n=11862) has been researched. In women, the age-adjusted mortality 
rate for bronchiectasis population was 1437.7 per 100,000, and for general population 
635.9 per 100,000. In men, the age-adjusted mortality rate for the bronchiectasis 
population was 1914.6 per 100, 000 and for the general population 895.2 per 100,000 






A considerable number of disorders are associated to bronchiectasis, with different 
possible aetiologies contributing to the progression of the disease. Post-infection, 
chronic obstructive pulmonary disease (COPD), connective tissue disorder (CTD), 
ciliary dysfunction and allergic bronchopulmonary aspergillosis (ABPA) are the most 
common known aetiologies (McDonnell et al., 2016). In nearly half of the cases the 
underlying cause can not be identified. Identifying a specific aetiology may benefit 
patients with more specific treatments (Gao et al., 2016).    
1.4 Pathophysiology 
It has been 200 hundred years since bronchiectasis was first described, but our 
understanding about it is still poor (Goeminne and Soyza, 2016). As previously 
mentioned, a lot of bronchiectasis cases occur post-infection. Bacterial infection 
contributes to lung damage directly by releasing toxins that can impair airway function, 
and indirectly by over stimulating the host’s immune response. The immune response 
is a protective response from the body to harmful stimuli such as pathogens, and it can 
include the release of neutrophils, lymphocytes and macrophages into the bronchial 
lumen (Simpson et al., 2007). These immune cells all work towards the elimination of 
pathogens. However, in bronchiectasis there is excessive neutrophilic inflammation, 
which means either an overproduction of neutrophils or an inefficient neutrophil 
clearance by the airway after phagocytosis (Boyton and Altmann, 2016)(Bedi et al., 
2018). Neutrophilic products can also reduce epithelial cilia beat frequency and cause 
mucous gland hypersecretion, which negatively affects mucociliary clearance 
(Amitani et al., 1991). Neutrophils release chemicals such as elastase, which facilitates 
bacteria-killing, but can also damage bronchial elastin and other supporting lung 
structures, which leads to permanent dilatation of the bronchi (Amitani et al., 1991; 
Margaroli et al., 2019). Damaged bronchi contribute to pooling of mucus, which 
supports continued bacterial infection. In 1984, Cole described a ‘vicious circle’ in 




response and airway damage (Cole, 1986). A lot of research in bronchiectasis has 
aimed at breaking this cycle (Figure 1). 
Figure 1. The ‘vicious circle’ in bronchiectasis described by Cole (Cole, 1986) 
1.5 Bacterial infection in bronchiectasis 
The lung is continuously exposed to a large number of bacteria; excessive airway 
neutrophilic inflammation leads to damage to the bronchial wall and, paradoxically, 
promotes more airway inflammation and bacterial infection, creating a vicious cycle 
(Cole, 1986). The bacterial infection is a crucial part of this circle.  
In healthy lungs, infection is usually caused by microbial immigration (micro 
aspiration, inhalation of bacteria and direct mucosal dispersion) and clearance by 
microbial elimination (cough, mucociliary clearance and innate and adaptive host 
defences). In diseased lungs, bronchial infection is usually driven by regional bacterial 
growth and condition changes such as: pH value, temperature, oxygen tension, nutrient 
availability, local microbial competition, epithelial cell interactions, activation of 
inflammatory cells and concentration of inflammatory cells (Dickson, Martinez, & 
Huffnagle, 2014) (Dickson et al., 2014). In bronchiectasis, patients usually have 
permanently damaged and dilated airways with fewer cilia and more mucus 
(Rademacher & Welte, n.d.); mucus production results in decrease of oxygen tension 
(Worlitzsch et al., 2002) and an increase of temperature (Schmidt et al., 2014), which 




creates a selection pressure across the bacterial community. This pressure results in a 
disordered microbiome, which provokes further airway inflammation. If the host fails 
to clear the bacteria and the bacterial infection persists, the inflammatory response 
becomes chronic. 
The conventional view about bronchiectasis’ bacterial infection has long been limited 
to a few specific pathogens (B.Rogers, 2018). However, more recent studies have 
pointed out that bronchiectasis airways are colonised with complex microbial 
communities. A large percentage of bacteria in this community are upper airway 
opportunistic pathogens, which migrate to colonise the lower airways (Dickson and 
Huffnagle, 2015). The development of technology has changed our understanding of 
bacteria; previously under-reported bacteria have been found in bronchiectasis airways 
nowadays, and the widespread use of vaccination and antibiotics are changing the 
prevalence of bacteria (King et al., 2007). It is important to look outside the currently 
known pathogen model and explore more factors that may not have been included in 
the past. 
1.6 Microbiology 
Knowledge of lower airway microbiology is a very important in bronchiectasis 
treatment, in particular for future chest infections. Antibiotic selection is based on 
results from sputum microbiology tests and antibiotic sensitive tests. There is a defined 
group of bacteria that can be potentially pathogenic in bronchiectasis; a diagnostic is 
usually made based on this group. These species have been proven to be commonly 
found in bronchiectasis patients’ lower airways and also clinically relevant for 
infection and colonisation. Haemophilus influenzae (H. influenzae) and Pseudomonas 
aeruginosa (P. aeruginosa) are the two most commonly found species, with 




Streptococcus pneumoniae (S. pneumoniae) also being widespread (Chalmers et al., 
2012) (Figure 2).  
Figure 2. The main pathogens found in Bronchiectasis (Chalmers et al., 2012) 
1.7 H. influenzae 
H. influenzae are aerobic Gram-negative bacteria, although it can also grow as a 
facultative anaerobe. H. influenzae are cultured on chocolate blood agar plates. The 
growth of H. influenzae requires X (hemin) and V (nicotinamide adenine dinucleotide) 
factors. They grow at 37°C in a CO2 enriched environment. The colonies of H. 
influenzae on chocolate agar plates are convex, smooth, pale, grey or transparent in 
colour (Levine et al., 1996).  
There are capsulated H. influenzae and non-capsulated H. influenzae. Capsulated H. 
influenzae can be typed into type a, b, c, d, e and f, depending on their polysaccharide 
capsule (Brlrur and -Jourbml, 1952). Non-encapsulated H. influenzae can not be typed 
due to the lack of a capsule, and so they are also called as non-type-able H. influenzae 
(NTHi)(Davis et al., 2011).  
H. influenzae are important pathogen in other respiratory diseases such as otitis media, 
tonsillitis, COPD and cystic fibrosis (CF)(Erwin and Smith, 2007). Type b H. 
influenzae used to be the most common pathogenic one; however since the widespread 
use of Haemophilus influenzae type b (Hib) vaccination, the number of type b H. 
influenzae infection has significantly reduced, and NTHi prevalence has significantly 




While H. influenzae b is being neutralized by vaccination schemes, another 
Haemophilus species historically treated as a commensal bacterium in bronchiectasis 
is attracting more attention: Haemophilus parainfluenzae (H. parainfluenzae). While 
it used to be less common in the lower airways, H. parainfluenzae are now almost 
twice as frequent as H. influenzae (Ebbing and Robertson, 2015). It has also been 
found to have similar clinical relevance as H. influenzae in lower airway infection 
(Rhind et al., 1985). Furthermore, H. parainfluenzae presents a higher multidrug 
resistance than H. influenzae (Scheifele and Fussel L, 1981; Ebbing and Robertson, 
2015).      
1.8 H. parainfluenzae 
H. parainfluenzae are gram-negative coccobacillus, and it is a part of the normal 
human oropharyngeal and genitourinary microbiota. H. parainfluenzae and H. 
influenzae both belong to Haemophilus species. Haemophilus species are commonly 
isolated from all kinds of human specimen samples. They can be divided into three 
groups based on their nutritious needs: 1) H. influenzae group, X and V factor-
dependent, i.e. H. influenzae and Haemophilus haemolyticus (H. haemolyticus); 2) H. 
parainfluenzae group, V factor-dependent, i.e. H. parainfluenzae; and 3) Haemophilus 
ducreyi, X factor-dependent. 
H. parainfluenzae can be differentiated into eight subtypes depending on their 
production of three metabolic products: indole from tryptophan, urease and ornithine 
decarboxylase. Subtype I and II constitute most of the isolates of H. parainfluenzae 
from the oropharynx in controls (75%) and chronic bronchitis (90%). Subtype VI, VII 
and VIII are the least common ones (Taylor et al., 1992).  
H. parainfluenzae have historically been considered commensal bacteria in 
bronchiectasis. A paper published in 1976 indicated H. parainfluenzae as a commensal 
bacteria in lower airway disease, reporting that H. parainfluenzae were not as 
frequently isolated as H. influenzae from lower airways; it also suggested that H. 
parainfluenzae did not stimulate a significant immune response from the host (Smith 
et al., 1976). However, with the development of technology, H. parainfluenzae have 




and more recent research suggest that H. parainfluenzae can trigger a significant innate 
and adaptive immune response from the host (Mitchell and Hill, 2009; Goleva et al., 
2013). The difficulty in identifying H. parainfluenzae could have led to misdiagnosis 
and an underestimated pathogenicity in the past. 
1.9 Why H. parainfluenzae are important now 
1.9.1 H. parainfluenzae are common in lower airways 
H. parainfluenzae are ubiquitous on the human upper airways, representing more than 
60% of the Haemophilus found in the human upper airways (Andrzejczuk et al., 2017). 
It has been isolated from the sputum of 70% of COPD patients(Simpson, Baines, et al., 
2016), and it has also been found in corticosteroid-resistant asthma airways (Goleva et 
al., 2013).  
A 15-year study about CF showed a significant increase in the prevalence of H. 
parainfluenzae in CF patients. Especially after 2010, the number of H. parainfluenzae 
was more than twice that of H. influenzae; while in 1998, the number of H. 
parainfluenzae was around half of H. influenzae (Figure 3). The significant increase 
of H. parainfluenzae in COPD was proposed to be because of the development of 
techniques to identify H. parainfluenzae and a higher awareness of H. parainfluenzae 
as a pathogen (Ebbing and Robertson, 2015).  
Figure 3. The prevalence of H. influenzae and H. parainfluenzae in CF from 1998 to 2012. 






H. influenzae are considered one of the most common bacteria in bronchiectasis. 
However, there is contradictory data about the prevalence of H. parainfluenzae in 
bronchiectasis. A study of 144 patients showed that 10.4% had H. parainfluenzae and 
9.7% H. influenzae (Guan et al., 2015). Another study reported only 1 out of 70 
patients with H. parainfluenzae, and 20% with H. influenzae (Purcell et al., 2014). 
Another report followed 5 children that developed bronchiectasis after liver or kidney 
transplantation, in which 2 of them had H. parainfluenzae in the lower airways 
(Pijnenburg et al., 2004).  
1.9.2 H. parainfluenzae are associated with a variety of diseases 
H. parainfluenzae have been related to a spectrum of diseases. It has been implicated 
in pneumonia, where the patient presented high concentrations of H. parainfluenzae 
in sputum, a high titre of H. parainfluenzae specific immunoglobulin M, as well as 
high serum erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) (Pillai 
et al., 2000). It has also been associated with acute otitis media (Cardines et al., 2009), 
secondary bacteraemia (Kaushik et al., 2015), endocarditis (Duzenli, Dwyer and Carey, 
2017), urethritis (Hsu et al., 2015), biliary tract infections (Frankard et al., 2004), 
hepatic abscesses (Athreya, Hrastar and Khan, 2017) and meningitis (Cardines et al., 
2009).  
1.9.3 H. parainfluenzae can be multidrug-resistant 
Haemophilus species can be multidrug-resistant (Tristram, Jacobs and Appelbaum, 
2007; Magiorakos et al., 2012). H. parainfluenzae isolates producing TEM-1/ROB-1 
beta-lactamases and with altered PBP3 (beta-lactamase negative ampicillin-resistant 
[BLNAR]) are being reported increasingly in recent years (Tinguely et al., 2013). In 
2011, a multidrug-resistant clinical isolate presenting resistance to quinolones, 
tetracycline and co-trimoxazole was reported in a prostatitis patient in Spain 
(Rodríguez-Martínez, López-Hernández and Pascual, 2011). Two cases of extensively 
drug-resistant H. parainfluenzae were found in Switzerland in 2013 (Tinguely et al., 
2013). These two H. parainfluenzae strains were non-susceptible to ampicillin, 
amoxicillin-clavulanate, cefotaxime, cefepime, meropenem, cefuroxime, 




A study looked into Haemophilus species in sputum before and after 7 days of 
ampicillin treatment. They found that at day 0, 4 out of 5 patients only presented H. 
influenzae; after treatment, those H. influenzae were all replaced by H. parainfluenzae 
(Foweraker, Cooke and Hawkey, 1993).  
In CF, H. parainfluenzae have been found more frequently associated with multidrug 
resistance than H. influenzae. With a higher resistance to ampicillin, amoxicillin and 
clavulanic acid, co-trimoxazole, rifampicin and cefotaxime than H. influenzae (Ebbing 
and Robertson, 2015).  
In a throat culture survey, β-lactamase-producing H. parainfluenzae was detected in 
192 out of 266 ambulatory children. Colonisation with β-lactamase-producing H. 
parainfluenzae was 26 times more frequent than with H. influenzae (Fussell, 2019). 
The study also proposed that H. parainfluenzae could be a vector for the spread of 
resistance genes to H. influenzae. 
1.9.4 H. parainfluenzae can be pathogenic 
One of the main reasons that H. parainfluenzae have been considered commensal 
bacteria is that, in the past, H. parainfluenzae was proven to be not virulent and could 
not stimulate host immune response (Smith et al., 1976). However, modern studies 
highlight H. parainfluenzae as a potentially pathogenic organism. In the year of 2000, 
a group of researchers demonstrated the presence of a species-specific systemic 
immune response to H. parainfluenzae in colonised patients (Mitchell and Hill, 2000). 
In this study, they investigated serum and sputum immunoglobulin G from 10 
bronchiectasis and 3 chronic bronchitis patients. These patients had H. parainfluenzae 
regularly isolated from their sputum. Using enzyme-linked immunosorbent assay 
(ELISA) and sodium dodecyl sulphate–polyacrylamide gel electrophoresis (SDS-
PAGE), they confirmed that those patients had significantly higher H. parainfluenzae 
specific immunoglobulin G (IgG) compared to healthy controls. There are also studies 
focused on immunoglobulin A nephropathy (IgAN) suggesting H. parainfluenzae 
antigens stimulate IgA antibodies, as well as tonsillar T and B lymphocytes in patients 
with IgAN (Suzuki at al, 1994; Suzuki et al., 2000). This all suggests H. 




Another study indicated H. parainfluenzae can stimulate a significant pro-
inflammatory response in asthma. H. parainfluenzae significantly activated 
macrophage p38 mitogen-activated protein kinase, which led to the production of 
interleukin 8 (CXCL8) as well as mitogen-activated kinase phosphatase 1 (MKP-1) 
mRNA. As a comparison, macrophages were co-cultured with Prevotella 
melaninogenia, which did not induce the same effect as H. parainfluenzae (Goleva et 
al., 2013). H. parainfluenzae also stimulated CXCL8 production in A549 cells 
(Middleton, Dowling, et al., 2003). 
A small scale research (n=2) reported H. parainfluenzae could cause immediate 
slowing of nasal epithelial ciliary beat frequency, significantly more mucosal damage 
and significantly less ciliated and unciliated cells (Middleton, Dowling, et al., 2003). 
In the same study, they found H. parainfluenzae had a tendency to adhere to the 
damaged epithelial area, which suggests that H. parainfluenzae may be more 
pathogenic in impaired airways rather than healthy ones. H. parainfluenzae adhered to 
a bronchial epithelial cell line to the same degree as NTHi (Pollard et al., 2008).  
1.10 What makes H. parainfluenzae virulent 
1.10.1 Endotoxin of H. parainfluenzae 
Lipopolysaccharides (LPS) are their main virulence factor. LPS located on the outer 
layer of the outer membrane; it is gram-negative bacteria’s major cell surface 
component. It forms a chemical and physical barrier for bacteria. There is a low 
molecular weight form of LPS which is called lipooligosaccharide (LOS). H. 





The structure of LOS can determine bacterial interactions with host cells. H. 
parainfluenzae and H. influenzae have similar LOS; they have identical lipid A and 
inner core (Young and Hood, 2013), however, there are some differences between 
these two close relatives. H. parainfluenzae have a reduced capacity for synthesis of 
outer core structures, including phosphocholine, sialic acid, digalactoside and Oacetyl 
groups; these are expressed in a phase variable manner, which suggest that there is a 
lack of phase variability in H. parainfluenzae LOS (Young and Hood, 2013). Those 
outer core peptides are involved in H. influenzae pathogenesis. It was found that the 
lack of outer core LOS in a mutant H. parainfluenzae led to reduced ability to adhere 
to the epithelial cell, which indicates that outer core LOS also play an important role 
in H. parainfluenzae colonisation. On the other hand, H. parainfluenzae LOS contains 
O-antigen, which is not found in H. influenzae LOS. O-antigen can contribute 
significantly to H. parainfluenzae resistance to the killing effect of human serum in 
vitro (Young et al., 2013)(Vitiazeva et al., 2011).  
H. influenzae LOS has been proven to induce significant interleukin 6 (IL6), CXCL8, 
tumour necrosis factor alpha (TNFα) and intercellular adhesion molecule 1 (ICAM-1) 
production in human bronchial epithelial cells (Khair et al., 1994). There is no research 
about the inflammatory response caused by H. parainfluenzae LOS yet. Those 
differences in LOS structure suggest that the two Haemophilus may play pathogenic 
roles in different ways. 
Figure 4. Model of LPS of gram-negative bacteria. Figure made based on Steimle 





1.10.2 H. parainfluenzae polysaccharide capsule 
Although the capsule has not yet been very well described in H. parainfluenzae, it is 
one of the most important virulence factors in H. influenzae. To date, six different 
capsular serotypes have been described for H. influenzae (a to f) (Satola, Schirmer and 
Farley, 2003). Recently, a study described for the first time a capsular operon in H. 
parainfluenzae, a major determinant of pathogenicity that may contribute to increased 
virulence in extensively drug-resistant (XDR) clinical isolates (González-Díaz et al., 
2019). Polysaccharide capsules contribute to bacterial resistance to antimicrobial 
peptides, enhance bacterial adherence to the cell surface, and also facilitate bacterial 
biofilm formation.  
1.11 How H. parainfluenzae colonises in the respiratory tract 
The first interaction between bacteria and epithelial cells happens through mucus. The 
Haemophilus species has a high affinity with mucus in vitro. The affinity of H. 
influenzae for mucus and the fact they are not efficient at adhering to healthy 
epithelium may explain why they do not infect healthy airways (Read et al., 1992). In 
abnormal airways, such as in bronchiectasis airways (Currie, Pavia and Lopez-
Vidriero, 1987), mucociliary clearance is delayed and bacteria that have already 
adhered to the mucus will have more time to establish infection and cause further 
damage. Leucocytes will be attracted to the airways because of the infection and then 
generate DNA which makes secretions more viscous and difficult to clear (Currie, 
Pavia and Lopez-Vidriero, 1987). Sputum of bronchiectasis patients is poorly 
transported by cilia compared to healthy mucus, which will further accelerate this 
process.   
Piliated bacteria can be more easily trapped by cilia, and the fact most H. 
parainfluenzae don not have cilia helps them penetrate epithelium (Middleton, 
Chadwick, et al., 2003). H. parainfluenzae and H. influenzae, as previously mentioned, 
can slow down the ciliary beating frequency. This contributes to slower mucus 
clearance. Cilia need to beat in the same direction and coordinate to push out mucus 
efficiently. In the bacteria-infected area, cilia beat direction is uncoordinated 




As previously described, H. parainfluenzae and H. influenzae can adhere to bronchial 
epithelial cells similarly. Several adhesins are known to be present in H. influenzae, 
but not much has been investigated in H. parainfluenzae. Pili mediate adherence to all 
cell types in respiratory cells; it is important for the early stage of colonisation. Most 
H. parainfluenzae contain pili; however, like NTHi, not all of them do (Kahn and 
Gromkova, 1981). More commonly, H. parainfluenzae produces mannose resistant 
hemagglutinin that can agglutinate animal erythrocytes. H. parainfluenzae contains 
outer membrane protein adhesins which mediate binding to oral streptococci, salivary 
pellicle, and neuraminidase-treated erythrocytes. H. parainfluenzae LOS plays a role 
in adherence (Liljemark, Bloomquist and Lai, 1991). 
H. parainfluenzae and H. influenzae can form a biofilm that helps resistance against 
opsonophagocytic killing by neutrophils. H. influenzae can also be found between 
epithelial cells and inside macrophage-like cells in chronic bronchitis patients 
(Pickering et al., 2016). More recent studies show that H. influenzae can persist 
intracellularly in the respiratory tract (Clementi and Murphy, 2011; Murphy et al., 









1.12 How H. parainfluenzae can cause inflammatory responses and damage in 
bronchiectasis 
H. parainfluenzae LOS interacts with toll-like receptor 4 (TLR4) and activates 
transforming growth factor beta associated kinase-1 (TAK1) through myeloid 
differentiation primary response 88 (MyD88) pathway, leading to p38 mitogen-
activated protein kinase phosphorylation and nuclear factor-κB (NF-κB) activation, 
which positively regulates transcription of pro-inflammatory cytokines like CXCL8 
(Miller, Ernst and Bader, 2005) (Figure 5). CXCL8 is a chemoattractant, which attracts 
neutrophils to the airways; neutrophils can release proteinase such as elastase to kill 
bacteria (Miller, Ernst and Bader, 2005). In bronchiectasis, there is already a high level 
of neutrophil and elastase persistence; elastase can damage the epithelium and 
stimulate mucus production; this can support bacterial infection by impairing 
mucociliary clearance. Thus, a vicious cycle may develop.  
 
 
Figure 5. The simplified signal pathway stimulated by H. parainfluenzae. H. 
parainfluenzae interact with TLR4, then actives P38 and NFκB through MyD88 pathway. 
This leads to the production of pro-inflammatory cytokines such as CXCL8 which can 




1.13 Current treatment for H. parainfluenzae in bronchiectasis 
Although the pathogenesis of H. parainfluenzae is under debate, in bronchiectasis, H. 
parainfluenzae are still rarely reported. According to the protocol in Royal Infirmary’s 
bronchiectasis clinic in Edinburgh, H. parainfluenzae are considered commensal 
bacteria, which means patients’ sputum samples with H. parainfluenzae would be 
reported as containing mixed normal flora. Therefore, no H. parainfluenzae specific 
antibiotic sensitivity test would be done. 
The technique used to process the patient’s sputum sample is key for an accurate 
diagnosis, especially for Haemophilus species, which is nutrient fastidious. In the 
Royal Infirmary of Edinburgh microbiology laboratory, sputum processing is as 
follows. The sample is hydrolysed using an equal volume of Sputolysin (Calbiochem), 
then a loop (around 10 µL) of the hydrolysed sample will be diluted with 5 mL of 
saline. 100 µL of the diluted sample will be plated on blood agar (BA), and chocolate 
blood agar (CBA), and results read after 24 hours. Using this method, because of the 
small sample size used for culture (a loop of the sample) and lack of serial dilution, 
there is a high chance of under-identifying bacteria. There is also no routine 
quantification carried out. This may underestimate the number of Haemophilus species 
identified.    
1.14 Current research about H. parainfluenzae in bronchiectasis 
As previously mentioned, there has been limited research about H. parainfluenzae in 
airway infection and the debate about whether H. parainfluenzae are pathogen or not 
has remained. With modern techniques, more studies point to H. parainfluenzae 
playing a pathogenic role in different diseases, and more researchers are working on 
their pathogenicity. The high multidrug resistance associated to H. parainfluenzae is 
also attracting more attention to this area. There is a need to investigate the prevalence 
of H. parainfluenzae in bronchiectasis and, more importantly, whether it has a 
pathogenic role.    
To look into the potential pathogenicity of H. parainfluenzae, it is also important to 
investigate its role in the lung microbiome, and whether this pathogenicity may be 




Infirmary bronchiectasis clinic, patients sometimes are found to have more than one 
dominant pathogen present in their lower airway, but few of them have Haemophilus 
species and P. aeruginosa at the same time, even though Haemophilus species and P. 
aeruginosa are the two most common pathogens in bronchiectasis. H. influenzae and 
P. aeruginosa had been found together in CF patients; however, there is also a 
tendency to lower numbers of H. influenzae in patients chronically colonised by P. 
aeruginosa, and later in the CF, H. influenzae may be replaced by P. aeruginosa (Riley 
and  Hoffman, 1986). There is limited data about H. parainfluenzae as a co-pathogen 
in bronchiectasis, but there is research suggesting that H. parainfluenzae can promote 
the growth of two laboratory strains of P. aeruginosa (Liu A et al, 2017). It is still 
unclear what interaction there is between H. parainfluenzae and P. aeruginosa or how 
it could influence the virulence of H. parainfluenzae and affect the lung microbiome 
in bronchiectasis. In this study we looked into the interaction of H. parainfluenzae and 
P. aeruginosa as a stepping stone in the understanding of how bacterial interaction 
contributes to the change of the lung microbiome and, eventually, the host 
inflammatory responses in bronchiectasis. 
1.15 The lung microbiome: what is the microbiome in the lung and how is it 
associated with disease 
The human microbiome is the collection of microorganisms that live in and on the 
human body. Healthy lower airways have long been considered sterile. This concept 
has been challenged by robust studies focusing on airway microbiomes. The first study 
reporting the existence of significant microbiota in the lower airways was published in 
2010 (Hilty et al., 2010); after that, more and more studies proved the presence of 
microbiota in the lower airways. This study identified 16s sRNA bacterial sequences 
from 8 healthy subjects, as well as 11 asthma patients and 5 COPD patients. They 
found those three groups have similar kinds of bacteria in their nose, oropharynx and 
left upper lung. However, there is a significant difference in bacterial community 
composition in the three patients’ groups. This study suggests that not only is there a 
microbiome in the lung, but that it differs in healthy and diseased lungs.  
After that, more studies started to look at the composition of the microbiome in 




diseased lung, which contributes to a heavier bacterial burden. However, this process 
is not simply an enrichment of all bacteria community, but more likely a selection 
(Salami and Marsland, 2015). In COPD, pathogenic Proteobacteria, particularly the 
Haemophilus species, were much more frequently isolated compared to in healthy 
controls (Dickson, Martinez and Huffnagle, 2014). In children with asthma, there was 
also a highly significant increase in Haemophilus species, compared to healthy 
controls (Simpson, Daly, et al., 2016). In idiopathic pulmonary fibrosis, Haemophilus 
and Streptococcus were found to be more abundant than in healthy controls 
(Molyneaux et al., 2014).  
Change in the microbiome is also related to the severity of a disease. There is an 
increased bacterial burden and decreased bacterial diversity in exacerbated COPD 
compared to stable COPD  (Dickson, Martinez and Huffnagle, 2014). In adult 
neutrophilic asthma compared to non-neutrophilic asthma, there is significantly more 
Proteobacteria, and interestingly, significantly fewer Actinobacteria and Firmicutes. 
The colonisation of Haemophilus species was significantly associated with increased 
risk of viral infection in the lower airways (Simpson, Daly, et al., 2016). In 
bronchiectasis, patients who have P. aeruginosa or H. influenzae dominated 
communities have significantly higher serum CRP, sputum CXCL8 and interleukin 1 
beta (IL1β), worse lung function and more frequent exacerbations. These changes 
usually lead to a reduced richness and diversity of bacterial species in the community, 
as well as a shift in microbiome composition. In a case of early childhood asthma, the 
colonisation started from Staphylococcus and Corynebacterium; after one year, these 
had been replaced by Alloicoccus and Moraxella (Simpson, Daly, et al., 2016). The 
microbiome often shifts from healthy lung dominated bacteria species to a phylum that 
contains pathogenic bacteria such as Proteobacteria. It is still under debate, however, 
whether this shift is driven by antibiotic usage or disease development.  
Current knowledge about the microbiome in the lung does not clarify whether it is an 
altered lung microbiome that leads to disease development or viceversa. An altered 
airways’ microbiome should also be considered on top of the traditional single 
pathogen model, therapies targeting at changing microbiome may be a future solution 




1.16 The microbiome is the community 
To understand the microbiome, change in lung diseases, it is important to understand 
how the dominant pathogen wipes out the others. With this purpose, we should start to 
look at bacteria as social creatures in a community called the microbiome. Bacteria 
can communicate within their species or interspecies, and they can form ‘group 
activities’ (Stacy et al., 2016). The interactions between bacteria impact the 
microbiome composition, their biological activities and finally, change disease 
severity. For example, in a wound model, the interaction between P. aeruginosa- S. 
aureus leads to a more severe infection, and a higher resistance to antibiotic treatment 
compared to P. aeruginosa infections on their own  (DeLeon et al., 2014). Oppositely, 
Bifidobacteria can inhibit the translocation of Escherichia coli (E. coli) Shiga toxin 
from the gut lumen to the blood through production of acetate, thereby protecting the 
host from E.coli infection (Fukuda et al., 2011). Bacterial interaction can be synergistic 
or antagonistic; this mainly depends on how bacteria communicate.  
1.17 How do bacteria communicate? 
Bacteria interact in many ways. Their interaction can be parasitic, mutualistic or 
commensal bacteria. They interact directly or indirectly (Waters and Bassler, 
2005)(Dworkin, 1999).  
Direct interaction, also called physical interaction, is commonly used and requires 
actual cell-to-cell contact. Bacteria establish a multi-bacterial structure by getting close 
to each other; this can contribute to further indirect interaction between cells or 
facilitate bacterial invasion to cells. Physical interactions are often mediated by pili. 
Bacteria usually exchange information (such as chemicals, proteins or genetic 
materials) through it from one bacteria to another (Dworkin, 1999). It can also be 
achieved by bacteria recognising each other through receptors and adhesins on the 
surface of bacteria (Jakubovics et al., 2006). These two processes all require a short 
distance between bacteria for physical contact.  
Indirect or chemical interaction facilitates bacterial information exchange through long 
distances using chemical molecules. Bacteria produce and release chemical molecules 




increases, the other bacteria can detect the signal when the concentration reaches the 
minimum threshold, then it can stimulate changes in bacterial gene expressions, and 
bacterial behaviour. This process is called quorum sensing (Waters and Bassler, 2005).  
There are four most common examples of bacterial interactions: co-aggregation 
(physical), biofilm remodelling (physical), local growth inhibition (chemical) and 
local growth promotion (chemical) (Stacy et al., 2016). 
Co-aggregation is a multi-species bacterial mixture which is mediated by recognition 
of specific surface molecules. Co-aggregation is a very common phenomenon for 
bacteria isolated from the dental plaque (Ganpshkumar, 2017), although it has also 
been found in the gut and urogenital tract (Reid et al., 1990). In co-aggregation, 
bacteria are attached to a specific group of bacteria. It is unusual for one bacterium to 
bind to a wide variety of bacteria. Bacteria that do not have competitive adhesins and 
receptors can use other bacteria as a bridge to co-aggregate. Sometimes they can 
develop into a co-aggregation net  (Jakubovics et al., 2006).   
Biofilm remodelling. A biofilm is a dynamic structure; it allows bacteria to reach an 
optimum position to get nutrients and oxygen. For example, when culturing P. 
aeruginosa and S. aureus together, P. aeruginosa can form a cap-like biofilm on top 
of S. aureus. P. aeruginosa dominates the upper layer while S. aureus is mainly 
persistent at the bottom. In this way, P. aeruginosa can obtain more nutrients and 
oxygen; at the same time, if the P. aeruginosa is an ampicillin resistant strain, this cap 
protects S. aureus from the antibiotic. (Kim et al., 2014) Polysaccharide synthesis 
locus (Psl), a major polysaccharide in P. aeruginosa, which is required in this process, 
is strongly selected in the lungs of patients with cystic fibrosis (Jackson et al., 2004; 
Hogardt and Heesemann, 2010).  
Local growth promotion. Bacterial growth can be promoted by receiving beneficial 
metabolites from distant bacteria. This bacterial communication is called metabolic 
cross-feeding (Ramsey, Rumbaugh and Whiteley, 2011).      
Production of a beneficial metabolite is an important bacterial communication tool. 
Bacteria can consume the by-product of another by metabolic cross-feeding. 




L-lactate provides Aggregatibacter actinomycetemcomitans with a preferred carbon 
source for growth and reduces the need to compete with S. gordonii for glucose during 
aerobic co-culture  (Ramsey, Rumbaugh and Whiteley, 2011). This metabolic synergy 
results in a mutualistic relationship between both species during an abscess 
co-infection in which both bacteria reach higher burdens when together rather than 
when apart.  
Local growth inhibition. Metabolic waste products can also act as broad-spectrum 
toxins, affecting bacterial growth near the producer bacteria. For example, 
Bifidobacteria can inhibit the translocation of E. coli Shiga toxin from the gut lumen 
to the blood through the production of acetate, thereby protecting the host from E.coli 
infection (Fukuda et al., 2011).  
1.18 How the microbiome and bacterial communication influence bronchiectasis 
Across many respiratory diseases, it has been shown that disease is associated with a 
loss of bacterial diversity and richness, or the dominance of a single kind of bacteria 
or a small group of bacteria, which leads to a loss of evenness in the microbiota. The 
richness and diversity of bacterial composite show a positive correlation with lung 
function in bronchiectasis  (Woo et al., 2019), although it cannot be stated whether 
this result is causal or due to frequent antibiotic exposure. Proteobacteria, which 
include Pseudomonas and Haemophilus, usually dominate the diseased airway in 





Interactions between species could influence their virulence and pathogenicity, 
contribute to changes in the microbiome, and eventually influence the severity of the 
disease. There are a few different ways in which the microbiome or bacterial 
interactions can contribute to airway damage: interspecies interaction may encourage 
the production and release of virulent traits or metabolic interactions may change 
bacterial growth and alter the environment. Genetic material exchange may develop 
higher antibiotic resistance, and mixed biofilm formation increase microbiota 
resilience (B.Rogers, 2018) (Figure 6).  
Figure 6. The influence from the microbiome to bronchiectasis (B.Rogers, 2018) 
There is still much to learn about the changes in the microbiota that may be relevant 
to the development of bronchiectasis and its progression. There is also much to know 
about bacterial interactions in the airways and bronchiectasis.  
Most of the research on bacterial communication has used laboratory strains of bacteria, 
and mainly focused on acute infections. Research on bacterial interactions in 
bronchiectasis will help understand the microbiome found in chronic lung disease and 






1.20.1 H. parainfluenzae are common in bronchiectasis, and in high bacterial loads, it 
can play a similar pathogenic role as NTHi.  
 H. parainfluenzae can be isolated from lower airways in bronchiectasis patients. 
 H. parainfluenzae isolates from lower airways and upper airways may be 
gnomically different. 
 The clinical symptoms found in bronchiectasis patients with H. parainfluenzae 
and NTHi are similar. 
 H. parainfluenzae can stimulate an inflammatory response from epithelial cells. 
1.20.2 H. parainfluenzae can induce a stronger inflammatory response when combined 
with P. aeruginosa. 
1.21 Aims 
 Classify the Haemophilus species found in stable bronchiectasis patients. 
 Compare H. parainfluenzae isolates from bronchiectasis patients’ upper airways 
and lower airways. 
 Compare clinical features of H. parainfluenzae and NTHi in bronchiectasis 
patients. 
 Assess the impact of H. parainfluenzae on epithelial cells. 
 Assess the impact of coinfection of H. parainfluenzae with P. aeruginosa and H. 
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Chapter 2: Material and Methods 
 
The proposed studies only commenced after ethics and R+D approvals. All patients 
and healthy volunteers filled in a consent form before participating. 
2.1 Study designs    
2.1.1 Classify the Haemophilus species found in bronchiectasis patients 
To understand Haemophilus species in bronchiectasis, a total of 140 stable patients 
were recruited. Patients’ sputum samples were collected and processed for microbial 
culture. Multiple techniques (described later in this chapter) were performed to classify 
the Haemophilus species.  
Sputum samples from another 51 unselected patients were also sent to NHS 
microbiology laboratory to compare the outcomes from our proposed method.  
2.1.2 Compare H. parainfluenzae isolates from bronchiectasis patients’ upper and 
lower airways  
From 30 stable bronchiectasis patients recruited, sputum and throat swab samples were 
collected and processed for microbial culture. Haemophilus species were isolated from 
the samples and stored at -80C. Their genomic profile was analysed.  
The inflammatory effect of H. parainfluenzae cultured from same patient’s upper and 
lower airways was tested on human bronchial epithelial cell line (16HBE). Cell 
cytokine production CXCL8 was measured. 
2.1.3 Compare clinical features of H. parainfluenzae and NTHi in bronchiectasis 
patients 
Blood and sputum samples were collected from 63 stable bronchiectasis patients that 
had either NTHi or H. parainfluenzae isolated from their sputum culture. Their clinical 
features, sputum and serum inflammatory markers were compared. Serum White cell 
counts (WCC), ESR, CRP and ICAM-1 were measured as well as sputum sol phase 
myeloperoxidase (MPO). 
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2.1.4. Assess the impact of H. parainfluenzae on epithelial cells 
In order to understand the pathogenicity of H. parainfluenzae, the inflammatory effect 
of H. parainfluenzae, NTHi and P. aeruginosa on 16HBE cells, human primary 
bronchial epithelial cells (NHBE) and bronchiectasis patient primary nasal epithelial 
cells was tested. Cytokine production was measured using multiple methods. 
2.1.5 Assess the impact of coinfection of H. parainfluenzae with P. aeruginosa and 
H. parainfluenzae with NTHi 
To understand the interaction between bacteria and the changes to the microbiome in 
bronchiectasis, 16HBE cells were co-infected by H. parainfluenzae and P. aeruginosa, 
the two most common pathogens in bronchiectasis. To further unveil the mechanics, 
16HBE cells were challenged by H. parainfluenzae in multiple conditions: with broth 
that had previously cultured P. aeruginosa, with cell media that had previously 
cultured P. aeruginosa and with cell media that had co-cultured cells and P. 
aeruginosa. Cellular inflammatory response and bacterial loads were measured after 
cellular co-culture.  
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2.2 Study Methods 
2.2.1 Classify Haemophilus species in bronchiectasis patients 
2.2.1.1 Patient recruitment and sample collection 
A. Inclusion criteria of bronchiectasis patients 
Patients were chosen from the bronchiectasis clinic in the Royal Infirmary of 
Edinburgh. Inclusion criteria for stable patients included: patients with clinically 
significant bronchiectasis; 18 years old and older; no clinical exacerbations for at least 
4 weeks; not on long term oral or inhaled antibiotics; H. influenzae found in the last 
sputum culture within the past year according to NHS microbiology reports. 
B. Patient information  
Information on patient’s age, sex, smoking status, body-mass index (BMI), spirometry, 
bronchiectasis severity index and medical history were collected.  
Bronchiectasis severity index (BSI): BSI uses specific criteria (Table 1) and is 
calculated with the assistance of an online calculation tool 
(http://www.bronchiectasisseverity.com/15-2/). BSI scores of 1-4 are considered mild 
bronchiectasis, 5-8 are moderate bronchiectasis, and 9 or more is considered severe 
bronchiectasis. 




C. Patients sample collection 
Spontaneous sputum was collected from patients.  
2.2.1.2 Sputum processing  
The proposed method was based on our laboratory methodology (Figure 7). The 
standard methods used in the NHS microbiology laboratories is shown for comparison. 
Table 1. Bronchiectasis severity index 




Figure 8. Sputum processing protocol. Methods from NHS microbiology laboratory 
method and our proposed method 
Materials and equipment  
 Sputolysin (Calbiochem®) 
 0.85% sterile saline 
 BA (Columbia blood agar base + 5% defibrinated horse blood – Oxoid®) 
 CBA (heated Columbia blood agar base + 5% defibrinated horse blood – 
Oxoid®) 
 Pseudomonas isolation agar (PIA)(Difco®) 
 Sterile tubes 
 37 ˚C incubator 
 37 ˚C carbon dioxide incubator  
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 Ultracentrifuge maximum speed up to 50,000×g (Sorvall Discovery 100AC) 
 -80 ˚C freezer  
Methods  
In accordance with the proposed method (Figure 6), sputum sample was hydrolysed 
using Sputolysin and then serially diluted to 1 in 10,000 times with sterile saline. 100 
µL of diluted sputum was plated onto BA plate, CBA plate and PIA plate. Plates were 
cultured in 37 ˚C for 48 hours, CBA plates were incubated in an aerobic atmosphere 
enriched with 5-10 % carbon dioxide.  
After 48 hours of culture, colony numbers on plates were counted. Bacterial load was 
calculated according to the dilutions.  Three colonies were collected for future research. 
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2.2.1.3 Bacterial identification for S. aureus, S. pneumoniae, P. aeruginosa and 
other Gram-negative bacteria  
After the growth of bacteria, different techniques were used for bacterial identification.  
Materials and equipment 
 Staphaurex Plus kit (Bronidox®) 
 Optochin discs (Mast Group Ltd®) 
 API 20E and API 20NE kits ((bioMerieux UK Limited, Basingstoke, 
Hampshire)  
 BA (Columbia blood agar base + 5% defibrinated horse blood – Oxoid®) 
 CBA (heated Columbia blood agar base + 5% defibrinated horse blood – 
Oxoid®) 
 Pseudomonas isolation agar (PIA)(Difco®) 
 MacConkey agar 
Methods 
A. S. aureus  
S. aureus grows on CBA plates, form large, round and yellow colonies. They are 
Gram-positive cocci, usually found in grape-like (staphylo-) clusters. 
Staphaurex Plus kit from Bronidox® was used to confirm S. aureus. The reagent 
contains yellow latex particles, those particles were coated by S. aureus specific 
fibrinogen and rabbit IgG. During the test, mix a drop of this reagent with S. aureus 
organisms, strong agglutination happens in 30 seconds between S. aureus clumping 
factor and fibrinogen, S. aureus protein A and the fragment crystallizable of IgG, or S. 
aureus cell surface antigens and specific IgG (Figure 8). 




Figure 9. S. aureus colony appearance and Staphaurex assay results a) S. aureus 
colonies on blood agar plate. b) Staphaurex assay results for negative control and S. 
aureus. In the positive test, there is clumping of particles formed by S. aureus and 
fibrinogen.    
a) 
b) 
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B. S. pneumoniae  
S. pneumoniae grow on CBA plates, form small (1-2mm in diameter), round and white 
colonies. S. pneumoniae are alpha-haemolytic. They are Gram-positive cocci, often 
found in pairs, chains or clusters. 
S. pneumoniae were confirmed by optochin text (optochin discs - Mast Group Ltd.). 
Different from other streptococci, S. pneumoniae is sensitive to ethylhydrocuprein 
hydrochloride (optochin). Optochin discs are paper discs that already impregnated 
with optochin. For the test, one S. pneumoniae colony was streaked all over blood agar, 
then place one optochin disc in the centre of the plate. Incubate the plate at 37 ˚C for 
24 hours. S. pneumoniae culture shows a zone of inhibition around the impregnated 
disc (Figure 9). 
 
Figure 10. S. pneumoniae test results. A positive result for S. pneumoniae test, showing 
growth inhibition around the optochin disc.   
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C. P. aeruginosa 
P. aeruginosa grows on PIA plates, their colony appearance varies. The most common 
ones are 2-3mm diameter and round shape. Colony colour changes depending on the 
production of PCN (blue-green), pyoverdine (yellow-green, fluorescent), or pyorubin 
(red-brown, produced by a small proportion of strains). Some strains do not produce 
PCN. P. aeruginosa have a characteristic smell of aminoacetophenone. There are both 
mucoid and non-mucoid P. aeruginosa. P. aeruginosa are gram-negative bacteria.  
Figure 11. P. aeruginosa colony appearance. P. aeruginosa colonies on PIA plates. This 
non-mucoid P. aeruginosa shows brown staining on the PIA plate.  
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D. Other Gram-negative bacteria 
Other Gram-negative bacteria identified using API 20E and API 20NE kits from 
BIOMERIEUX®. They were plated on MacConkey agar plates, MacConkey agar can 
prevent the growth of gram-positive bacteria, and differentiate bacteria that can 
ferment the sugar lactose or not.  
Bacteria that cannot ferment the sugar lactose were further tested using API20NE test. 
According to the manufacturer’s directions, around one to four colonies were 
suspended in 2 mL of 0.85% sterile saline. There are twenty micro-tubes containing 
dehydrated substances in API 20NE test strip. These micro-tubes were inoculated with 
the bacterial suspension for 24 hours or 48 hours at 30°C with the addition of reagents 
and interpretation of reactions carried out according to the manufacturer’s directions. 
The biochemical reactions were converted accordingly into an octal profile number 
and decoded using the Analytical Profile Index (API Database Vn6.0, APILAB 
Software Vn3.3.3, Apilab Plus; bioMerieux) 
Bacteria that can ferment sugar lactose were further tested using API 20E test 
according to the instructions, similar to API 20NE test.  
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2.2.1.4 Bacterial identification for Haemophilus species to differentiate NTHi, H. 
parainfluenzae and H. haemolyticus 
Haemophilus species grow on CBA plates. They are small, grey or transparent round 
colonies (Figure 11). They are gram-negative coccobacillus.   
Figure 12. Haemophilus species. a) NTHi; b) H. parainfluenzae and c) H. haemolyticus on 
CBA plates 
A. Identify H. parainfluenzae  
For identification of H. parainfluenzae, the XV test was used.  
Different from H. influenzae and H. haemolyticus, the growth of H. parainfluenzae 
only requires V factor rather than both X and V factor. XV test based on this theory is 
commonly used to differentiate H. parainfluenzae from H. influenzae (Hinz et al. 
2015).  
Materials and equipment 
 X+V factor discs (Mast Group Ltd.) 
 Nutrient agar (Columbia Blood Agar Base, Oxoid®)  
 37 ˚C incubator with 5% CO2 
Methods 
One colony was streaked all over the nutrient agar, then placed the paper discs that 
containing X factor, V factor and X+V factor on the surface of the agar in the 
configuration of an equilateral triangle with a minimum of 3.5 cm distance between 
discs. Then incubated at 37 ˚C with 5% CO2 for 24 hours. H. parainfluenzae grew 
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around both V factor disc and X+V factor disc, while H. influenzae and H. 
haemolyticus only grew around X+V factor disc (table 2). This experiment was 
repeated for three separate colonies.  
Table 2 Growth factors for Haemophilus species  
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B. Identify H. haemolyticus 
qPCR assay was performed to identify H. haemolyticus. H. influenzae are positive for 
Fuculose Kinase (fucK) and H. influenzae specific protein D genes (Hi hpd), H. 
haemolyticus is positive for [Cu, Zn]-superoxide dismutase C (sodC) and H. 
haemolyticus specific hpd genes (Hh hpd) (Table 3) (Roger Latham, 2015).  Figure 12 
shows the qPCR result of a clinical strain of H. influenzae, a laboratory strain of H. 
influenzae and a laboratory strain of H. haemolyticus.  
Table 3 Genes used to differentiate H. influenzae and H. haemolyticus   
 
Figure 13. qPCR result for genes Fuculose kinase, Hi hpd, SodC and Hh hpd. Red dots 
stand for the patient strain. Green dots represent a laboratory strain H. influenzae; blue 
dots are a laboratory strain H. haemolyticus. The Y axis shows the fluorescence rate of the 
tested genes. The X axis stands for the qPCR cycle number. 
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Preparation for qPCR: DNA abstraction:  
Bacterial genomic DNA was abstracted using Wizard® Genomic DNA Purification 
Kit.  
Materials and equipment 
 Brain heart infusion broth (BHI broth) 
 Wizard® Genomic DNA Purification Kit contains: Nuclei Lysis Solution, 
RNase Solution, Protein Precipitation Solution and DNA Rehydration Solution 
(Wizard®) 
 Isopropanol, room temperature 
 70% ethanol, room temperature 
 Water bath, 80 °C 
 Water bath, 37 °C 
 1.5 mL micro centrifuge tubes 
 Nanodrop spectrophotometer (Thermo Scientific) 
 Centrifuge make and model of centrifuge 
 H. haemolyticus laboratory strain: NCTC10659 (NHS microbiology laboratory 
collection) 
 H. influenzae type c laboratory strain: ATCC9007 (NHS microbiology 
laboratory collection) 
Methods 
Bacteria were cultured in BHI broth overnight. The next day, 1mL of the overnight 
culture was collected and centrifuged at 13,000–16,000×g for 2 minutes to pellet the 
cells. Removed the supernatant and added 600 µL of Nuclei Lysis Solution, incubated 
in 80 °C for 5 minutes to lyse the cells. After cooled down to room temperature, added 
3 µL of RNase Solution to the cell lysate and incubated at 37 °C for 15–60 minutes. 
Cooled the sample to room temperature. Then added 200 µL of Protein Precipitation 
Solution to the RNase-treated cell lysate. Vortexed vigorously at high speed for 20 
seconds to mix the Protein Precipitation Solution with the cell lysate. Incubated the 
sample on ice for 5 minutes. Then centrifuged at 13,000–16,000×g for 3 minutes. 
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Transferred the supernatant containing the DNA to a clean 1.5 mL micro centrifuge 
tube containing 600 µL of room temperature isopropanol, and gently mixed by 
inversion until the thread-like strands of DNA form a visible mass. Then centrifuged 
at 13,000–16,000×g for 2 minutes. Carefully poured off the supernatant and drained 
the tube on clean absorbent paper. Added 600 µL of room temperature 70% ethanol 
and gently inverted the tube several times to wash the DNA pellet. Centrifuged at 
13,000–16,000×g for 2 minutes again and carefully aspirated the ethanol. Drained the 
tube on clean absorbent paper and allow the pellet to air-dry for 10–15 minutes. After 
the pellet dried added 100 µL of DNA Rehydration Solution to the tube and rehydrated 
the DNA by incubating at 65 °C for 1 hour. Periodically mix the solution by gently 
tapping the tube. Final DNA product was stored at 2–8 °C. 
Copy number of DNA product was performed using Nanodrop spectrophotometer. 
qPCR set up 
Material and equipment 
 SensiFAST SYBR (Bioline, BIO-98005) 
 Primer (Eurofins genomics) 
 Distilled water 
 0.1 mL tubes 
 Thermal cycler (Rotor-Gene Q, Qiagen) 
Methods  
Primers were referenced from Latham’s study (Latham, Zhang, & Tristram) (Table 4). 
The reaction volumes for the qPCR assays were 15 μL in 0.1 mL tubes and contained 
100 pg of template, 333 nM each primer, and 7.5 μL SensiFAST SYBR. Thermo 
cycling consisted of an initial melt at 95 °C for 3 minutes followed by 30 cycles of 
95 °C for 10 seconds, 60 °C for 10 seconds and 72 °C for 10 seconds. Data were 
acquired at 72 °C, and a melt curve was collected between 60 °C and 95 °C. All qPCR 
amplification delivered a single melt peak with cycle threshold between 13 and 18.   
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Table 4. Primers information for qPCR 
 
  
Material and Methods 
59 
 
C. Identify NTHi and type-able H. influenzae 
PCR technique was used to identify NTHi. Capsular export gene bexA and bexB were 
found exclusively on the cap locus of the bacteria, which encodes the polysaccharide 
capsule, and therefore were not present in NTHi strains. Gene pepN, which is 
necessary for the glutathione metabolism of all H. influenzae, was chosen as a positive 
control (Table 5) (Davis, G. S. et al. 2011). Figure 13 shows the results for 2 clinical 
strains of NTHi (P1 and P2).  
Table 5. Genes used to differentiate NTHi and Capsule H. influenzae 
 
Figure 14. Electrophoresis result of H. influenzae strains from patients P1 and P2. Two 
pairs of primers for bexB gene were used. Previously described bexA-specific primers produce 
a 343-bp amplicon, bexB primers used in this study amplify 567-bp and 760-bp products, pepN 
primers amplify 918-bp products. – stands for negative control. + is strain ATCC9007, which 
is type c capsule H. influenzae. P1 and P2 are the NTHi colonies isolated from patient sputum 
samples.  
Preparation for PCR: DNA cell lysate  
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Materials and equipment 
 Distilled water 
 95 °C heat block incubator 
 Ice 
 Centrifuge  
 -20 °C freezer 
 H. influenzae type c laboratory strain: ATCC9007 (NHS microbiology 
laboratory collection) 
Methods 
Two to three colonies were picked up from chocolate blood agar and suspended in 
100µL sterile distilled water. The suspension was heated at 95 °C for 10 minutes, then 
chilled on ice immediately for 5 minutes. The tubes were then centrifuged at 12,000×g 
for 3 minutes and the supernatant stored at -20 °C for PCR. (Davis, G. S. et al. 2011) 
PCR set up 
Materials and equipment 
 Mytag reaction buffer (Bioline®) 
 Primers (Eurofins genomics®) 
 tagDNA polymerase (Bioline®) 
 Distilled water  
 Agarose (Sigma®) 
 TBE buffer 
 0.1 mL tubes 
 Thermal cycler  
Methods  
Primers of bexA, bexB and pepN were referenced from Davis et al, and two pairs of 
bexB primers were used (Table 6). Capsulated H. influenzae ATCC9007 from NHS 
laboratory is a capsulated type C H. influenzae was used as the positive control.  
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For each reaction, 5 μL Mytag reaction buffer, 2 μL template (the cell lysate made 
from the last step), 1.5 μL primers, 0.25 μL tagDNA polymerase and distilled water 
made up to in total to 25 μL in 0.1 mL tubes. Thermo cycling consisted of an initial 
denaturation at 95 °C for 1 minute, then followed by 30 cycles of 95 °C for 15 seconds, 
55 °C for 15 s and 72 °C for 10 seconds. The final extension was 72 °C for 2 minutes. 
PCR products were confirmed by running on 10% agarose gel.   
Table 6. Primer information for PCR 
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D. Identify H. parainfluenzae subgroups 
H. parainfluenzae were bio typed by their production of indole, urease and ornithine 
decarboxylase (Table 7). 
Materials and equipment 
 API NH kits (bioMerieux UK Limited, Basingstoke, Hampshire) 
 Incubator 
Methods 
The production of indole, urease and ornithine decarboxylase were tested using API 
NH kits (bioMerieux UK Limited, Basingstoke, Hampshire) according to the 
instructions, similar to the previously described API20NE test. 
Table 7. Chemicals produced from H. parainfluenzae subtype I to VIII 
 
2.2.1.5 Bacteria storage 
To preserve bacteria, bacteria were stored in a freezer at -80 °C in 1mL 10% skimmed 
milk (Oxoid®). 
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2.2.2 Compare H. parainfluenzae isolates from bronchiectasis patients’ upper 
airways and lower airways 
2.2.2.1 Inclusion criterial of bronchiectasis patients 
Thirty patients were chosen from the bronchiectasis clinic in the Royal Infirmary of 
Edinburgh. Inclusion criteria for the stable patients included: patients with clinically 
significant bronchiectasis; 18 years old and older; have not had an exacerbation for at 
least 4 weeks; were not on long term oral or inhaled antibiotics; have grown H. 
influenzae in the last sputum culture within the past one year according to NHS 
microbiology reports. 
2.2.2.2 Patients sample collection 
Spontaneous sputum and throat swabs were collected from patients.  
2.2.2.3 Sputum processing  
In accordance with the previously described method, sputum sample was hydrolysed 
using Sputolysin and then serially diluted to 1 in 10,000 times with sterile saline. 100 
µL of diluted sputum was plated onto BA plate, CBA plate and PIA plate. Plates were 
cultured in 37 ˚C for 48 hours, chocolate blood agar was incubated in an aerobic 
atmosphere enriched with 5-10 % carbon dioxide (Figure 7).  
After 48 hours of culture, colony numbers on plates were counted. Three colonies were 
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2.2.2.4 Throat swabs processing 
Swabs were plated on CBA plate, BA plate and PIA plate and then streak using a loop 
to zone 1, 2, 3 and 4, the loop was sterilised between each zone. Then incubated for 48 
hours. After 48 hours, growth was measured as follows:  zone 1- light growth; zone 1 
and zone 2 - medium growth; zone1, zone 2, zone 3 or even to zone 4 - heavy growth 
(Figure 14). 
Figure 15. The growth zones for throat swab on CBA plates. Growth was measured as: 
zone 1- light growth; zone 1 and zone 2 - medium growth; zone1, zone 2, zone 3 or 
even to zone 4 - heavy growth.   
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2.2.2.5 Bacteria identification 
H. parainfluenzae and NTHi were differentiated by XV test.  
2.2.2.6 Bacteria collection 
NTHi and H. parainfluenzae from both sputum and throat swabs were collected and 
stored in 10% skimmed milk in -80 °C. 
2.2.2.7 H. parainfluenzae genomic profile 
Genomic profile of H. parainfluenzae from same patient’s sputum and throat swab 
were compared using Pulsed-field gel electrophoresis (PFGE). 
Materials and equipment 
 Low melt agarose (Bio-Rad Laboratories) 
 SE Buffer (75 mM NaCl, 25 mM EDTA, pH 7.5) 
 Lysis Buffer (1% N-lauroylsarosine, 0.5mM EDTA, pH 9.5) 
 Triton X-100 (Sigma®) 
 TE Buffer (10mM Tris, 10 mM EDTA, pH 7.5) 
 Distilled water 
 Reaction buffer (10× React buffer 2, Invitrogen™) 
 Bovine serum albumin (BSA 1 mg/mL, New England BioLabs® Inc.) 
 Restriction enzyme (XbaI, Invitrogen™) 
 Dithiothreitol (DTT 1.5 mg/100 µL in distilled water) 
 TBE Buffer (Severn Biotech Ltd.) 
 Pulsed-field agarose (Bio-Rad Laboratories) 
 Gel red (7.5 μL in 250 mL of 0.1M NaCl) 
 CHEF-DRII PFGE system  (Bio-Rad Laboratories) 
Methods 
 Plug preparation 
Fresh H. parainfluenzae bacterial cells grown for 24 hours at 37 °C on CBA plates 
were suspended in 1 mL SE buffer, in Eppendorf tubes and centrifuged for 2 minutes 
Material and Methods 
66 
 
at 13,000 rpm. The pellets were re-suspended in 500 µL of SE buffer but the volume 
was adjusted depending on the size of the pellet to give a uniform cell density for each 
isolate. The bacterial cells were encased in an agarose matrix made up of 1.5% low 
melt agarose in SE buffer (0.15 g of low melt agarose in 10 mL of SE buffer), 
previously microwaved for 15 seconds and then 4 times 5 seconds, gently mixing 
between every heating. An equal volume of 1.5% low melt agarose solution was added 
to the bacterial suspension in SE buffer and subsequently pipetted into the plug mould. 
Plugs were left at 4 °C for 15 minutes to solidify. Plugs were then transferred into 
small bijoux containing 2 mL of lysis buffer and 10 µL Triton X-100 and incubated 
overnight in a water bath at 55 °C. Plugs were then washed by removing the lysis 
buffer and replacing it with 2 mL of TE buffer for 30 minutes at 4 °C and repeating 
this step carefully another two times to ensure removal of any potential cellular debris 
that would prevent proper digestion in later steps. 
 Restriction enzyme digestion 
A small portion of each plug of approximately 2 mm was cut and placed in an 
Eppendorf tube filled with 90 µL of distilled water and 10 µL of reaction buffer and 
placed in a fridge at 4 °C for 30 minutes. The buffer was carefully removed using a 
fine pasteur pipette and replaced by a solution containing 90 µL of distilled water, 10 
µL of reaction buffer, 2 µL of BSA, 2 µL of dithiothreitol and 2 µL of restriction 
enzyme in which the plugs were incubated overnight at 37 °C in a water bath. 
 Loading of plug slices and running of the gel 
2 L of 0.5% TBE buffer was made and 150 mL of it was used for making the gel, to 
which 1.5 g of pulsed-field agarose was added and the mix was microwaved for 1 
minute, then mixed and again microwave for 1-minute and10 seconds. Once cooled, 
the agarose was poured into the gel mould previously cleaned with ethanol, and 
allowed to solidify for 30 minutes. Finally, the plugs were placed in the wells and the 
gel was placed in the CHEF-DRII gel tank and the remainder of the 2 L of TBE buffer 
was added. The chiller was set at 14 °C and parameters were set as follows: initial time 
0.5 seconds, final time 20 seconds, voltage 6 volts/cm, run time 16 hours. 
 Image analysis 
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The gel was stained with gel red for visualization under UV trans-illumination using 
the Molecular Imager® GelDoc™ XR+ system with Image Lab™ software (Bio-Rad 
Laboratories). The exposure time and saturation were adjusted to obtain optimal 
pictures with distinct bands. 
2.2.2.8 16HBE cells co-culture with H. parainfluenzae from upper airways and 
lower airways 
Inflammatory effect of H. parainfluenzae from same patient’s sputum and throat swab 
sample on 16HBE cell line were tested. 107 cfu/mL H. parainfluenzae from patient 
sputum and 107 cfu/mL H. parainfluenzae from same patient throat swab were co-
cultured with 16HBE cells for 8 hours. Control group was the same volume of 
phosphate buffered saline (PBS) co-cultured with 16HBE cells for 8 hours. After 8 
hours, spin plates at 300×g for 5 minutes, then abstracted supernatant. Supernatant 
were stored in -20 °C.   
2.2.2.9 Cell pro-inflammatory response measurement  
Supernatant CXCL8 and CXCL1 were measured using ELISA in accordance with the 
manufacture instruction. 
CXCL8 ELISA assay 
Materials and equipment 
 PBS (Gibco®) 
 Human CXCL8 Duoset ELISA kit® contains standards, detection antibody and 
streptavidin-HRP.  (R&D System®)  
 Wash Buffer: 0.05% Tween® 20 in PBS, pH 7.2-7.4  
 Block Buffer: 1% BSA (Sigma®) in PBS 
 Reagent Diluent: 0.1% BSA, 0.05% Tween 20 in Tris-buffered Saline 
 Substrate Solution: 1:1 mixture of 0.75mM H2O2 (Sigma®) 
 Tetramethylbenzidine (TMB) (Sigma®) 
 Stop solution: 2 mM H2SO4 
 96 well microplates 
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 Plate reader 
Methods 
CXCL8 ELISA was performed according to manufactures instructions, the main steps 
were: 96-well microplate was coated with capture antibody and left overnight at room 
temperature. The next day, each well was aspirated and washed with Wash Buffer 
three times. After the final wash, all the wash buffer was removed and the plate dried, 
300 μL of Block Buffer was added to each well for more than 1 hour. At the same time, 
serum samples were defrosted at room temperature, then vortexed and diluted 20 times 
with reagent diluent. Standards were serially diluted with reagent diluent. The plate 
was washed three times after 1 hour and then it was ready for sample culturing. For 
sample culturing, 100 μL of diluted sample or standards were added to plate in 
duplicate, appropriate diluent was added, plate covered and cultured at room 
temperature for 2 hours. After 2 hours, plate was washed, then 100 μL of the working 
dilution of Detection Antibody was added to each well, plate covered and incubated at 
room temperature for 2 hours. The plate was washed and 100 μL of the working 
dilution of Streptavidin-HRP was added and incubated in the dark for 20 minutes. 
Repeated washing, 100 μL of Substrate Solution was added to each well and incubated 
in the dark for 20 minutes, then 50 μL of stop solution was added to each well, and the 
plate was read at 450 nm and 570 nm wavelengths using plate reader. 
2.2.2.10 Validation of ELISA 
All ELISA assays were validated. Three parameters were assessed in validating assays: 
Reliability, recovery of spiked mediators and the effect of sample dilution.  
Reliability: The reliability of each ELISA assay was determined by assessing their 
intra-assay co-efficient and inter-assay coefficient of variation. Individual samples 
were assayed 5 times on a single plate to obtain the intra-assay coefficient of variation. 
Each sample was also assayed 5 times on different plates to obtain the inter-assay 
coefficient of variation.  
Spike and recovery: a known quantity of each mediator was spiked into the 3 samples. 
These “spiked” samples were then assayed and compared to the values obtained for 
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the original sample. The obtained value was divided by the predicted value to calculate 
the recovery percentage. 
Linearity-of dilution effect: The three samples were assayed at dilutions ranging from 
1 in 1, to 1 in 5. Observed values were assessed relative to the assay standard curve.  
A linearity-of-dilution experiment provides information about the precision of results 
for samples tested at different levels of dilution in a chosen sample diluent. If the 
linearity is good over a wide range of dilutions, then the assay method provides 
flexibility to assay samples with different levels of dilutions. 
An assay was deemed to be valid if it had a reliable standard curve, an intra-assay and 
inter-assay coefficient of variation <10%, recovery of spiked samples in the range 80-
120% of predicted and a linear dilution effect (Stockley and Bayley 2000). All ELISA 
assay passed each validation step and was used in the study. Each assay gave a linear, 
reliable standard curve and representative standard curves are shown below. 
Table 8 shows the validation data for all ELISA assays tested. The figure below shows 
the validation data for CXCL-8. Figure 15 shows the linearity of the dilution effect. 
Figure 16 shows the representative standard curve for measurement of interleukin 8.  
Table 8 Validation of ELISA assays used in the study 





















































Figure 16. Validation of  ELISA assays for CXCL8 measurements: a) linearity of 
dilution effects interleukin-8. Samples were diluted to 1 in 1, 1 in 2, 1 in 4 and 1in 8. Then 
CXCL8 level was measured and calculated according to the dilutions. b) representative 
standard curve for sputum measurement of interleukin-8. R² =0.9924 
b)  
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2.2.3 Compare clinical features of H. parainfluenzae and NTHi in bronchiectasis 
patients 
2.2.3.1 Sputum sol preparation  
Sputum was centrifuged at 50,000×g for 90 minutes to get sputum sol phase for the 
measuring of airways inflammation. It was stored at -80 ˚C. 
2.2.3.2 Sputum inflammation  
For sputum inflammation, sputum sol MPO was measured.  
MPO test 
Materials and equipment 
 MPO (Sigma®) 
 PBS (Gibco®) 
 0.75 mM H2O2 
 TMB (Sigma®) 
 2 mM H2SO4 
 96 well plates 
 Plate reader with a wavelength of 450 nm 
Methods 
Sputum sol samples were diluted 50 times in PBS, 10 μL diluted sample and standard 
were reacted with 80 μL 0.75 mM H2O2 and 110 μL TMB in 96 well plates for 5 
minutes at 37 ˚C. The reaction was stopped by addition of 50 μL 2 M H2SO4. The plate 
was read in a plate reader at a wavelength of 450 nm. Serial dilutions of MPO (33 
μg/mL) were used as standards. Samples and standards were all tested in duplicate.  
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2.2.3.3 Blood processing  
Blood samples were taken from patients in the hospital and then centrifuge for 15 
minutes at 1000×g.  Serum was pipetted off and stored at -80 °C before further tests.  
Blood samples were sent to the NHS microbiology laboratory for WCC, ESR and CRP 
tests. 
2.2.3.4 Serum inflammation  
Serum WCC, ESR, CRP results were from NHS trust laboratory, serum ICAM-1 was 
measured by ELISA. 
Serum ICAM-1 test 
Materials and equipment 
 PBS (Gibco) 
 Human ICAM-1 Duoset ELISA kit® contains standards, detection antibody 
and streptavidin-HRP.  (R&D System®)  
 Wash Buffer: 0.05% Tween® 20 in PBS, pH 7.2-7.4 
 Reagent Diluent: 1% BSA (Sigma®) in PBS 
 Substrate Solution: 1:1 mixture of 0.75 mM H2O2 (Sigma®) 
 TMB (Sigma®) 
 Stop solution: 2 mM H2SO4 
 96 well microplates 
 Plate reader 
Methods 
ICAM-1 ELISA was performed according to manufactures instructions, the main steps 
were: 96 well microplate was coated with capture antibody and left overnight at room 
temperature. The next day, each well was aspirated and washed with Wash Buffer 
three times. After the final wash, all the wash buffer was removed and the plate dried, 
300 μL of Reagent Diluent was added to each well for more than 1 hour. At the same 
time, serum samples were defrosted at room temperature, then vortexed and diluted 20 
times with reagent diluent. Standards were serially diluted with reagent diluent. The 
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plate was washed three times after 1 hour and then it was ready for sample culturing. 
For sample culturing, 100 μL of diluted sample or standards were added to plate in 
duplicate, appropriate diluent was added, plate covered and cultured at room 
temperature for 2 hours. After 2 hours, plate was washed, then 100 μL of the working 
dilution of Detection Antibody was added to each well, plate covered and incubated at 
room temperature for 2 hours. The plate was washed and 100 μL of the working 
dilution of Streptavidin-HRP was added and incubated in the dark for 20 minutes. 
Repeated washing, 100 μL of Substrate Solution was added to each well and incubated 
in the dark for 20 minutes, then 50 μL of Stop Solution was added to each well, and 
the plate was read at 450 nm and 570 nm wavelengths using plate reader. 
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2.2.4 Assess impact of H. parainfluenzae on epithelial cells 
Inflammatory effect of H. parainfluenzae, NTHi and P. aeruginosa on 16HBE cell 
lines, human primary bronchial epithelial cells and bronchiectasis patient primary 
nasal epithelial cells were tested. 
2.2.4.1 16HBE cell culture 
Materials and equipment 
 Dulbecco’s Modified Eagle Medium (DMEM) (Gibco®) 
 10% fetal bovine serum (Gibco®) 
 1% penicillin and streptomycin (Gibco®) 
 1% L-glutamine (Gibco®) 
 37 ˚C, 5% CO2 incubator 
Methods 
16HBE cells are human bronchial epithelial cell line, 16HBE cells were cultured in 
DMEM, containing 10% fetal bovine serum, 1% penicillin and streptomycin, 1% L-
glutamine. Cells were kept in 37 ˚C, 5% CO2 incubator. For cell infection experiment, 
cells were seeded into 12 wells plate with each well containing 5×106 cells. Plates were 
incubated at 37 ˚C for 48 hours, then medium extracted, and wells washed with PBS 
twice. Penicillin and streptomycin free medium were added and cells were ready for 
infection experiments. 
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2.2.4.2 Human Bronchial Epithelial Cells (NHBE) culture 
Material and equipment 
 NHBE (LonzaTM) 
 BEBMTM Bronchial Epithelial Cell Growth Basal Medium (LonzaTM) 
 BEGMTM SingleQuotsTM Supplement Pack (LonzaTM) 
 Trypsin/EDTA (LonzaTM) 
 Trypsin neutralising solution (LonzaTM) 
 Hepes solution (LonzaTM) 
 12 wells plates 
 37 ˚C, 5% CO2 incubator 
Methods 
NHBE from LonzaTM was isolated from the epithelial lining of the airways above 
bifurcation of the lungs of normal donors, cells cultured in BEBMTM Bronchial 
Epithelial Cell Growth Basal Medium with BEGMTM SingleQuotsTM Supplement Pack 
including: 0.4% Orange Cap Vial with BPE, 0.1% Lilac Cap Vial with Insulin, 0.1% 
Natural Cap Vial with Hydrocortisone, 0.1% Red Cap Vial with GA-1000, 0.1% 
Amber Vial with Retinoic Acid, 0.1% Natural Cap Vial with Transferrin, 0.1% Amber 
Vial with Triiodothyronine, 0.1% Amber Vial with Epinephrine and 0.1% Green Cap 
Vial with hEGF. Cells were kept in 37 ˚C, 5% CO2 incubator. Media was changed 
every two days. For cell infection experiment, cells were seeded into 12 wells plate, 
with each well containing 5×105 cells. Cells remained at 37˚C until fully confluent. 
Then cells were ready for infection.  
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2.2.4.3 Human primary nasal epithelial cells culture 
Nasal cells were isolated from bronchiectasis patients.  
A. Inclusion criteria of bronchiectasis patients 
Patients were selected from the bronchiectasis clinic in the Royal Infirmary of 
Edinburgh. Inclusion criteria for the stable patients included: patients with clinically 
significant bronchiectasis and don not have severe asthma; 18 years old and older; 
have not had an exacerbation for at least 4 weeks; were not on long term oral or inhaled 
antibiotics; were not rhinitis on nasal steroids; were not on anticoagulants; not current 
smokers or ex-smoker less than 1 year; not currently enrolled in a clinical trial of an 
investigation medical product within the or 28 days prior.  
B. Preparation before sample collecting (Collagen coating of 6 well plates) 
Materials and equipment 
 PureCol® Collagen (5409, Nutacon, Netherlands) 
 Tissue culture grade water 
 PBS (Gibco®) 
 6 wells plates 
 4 °C fridge 
Methods 
Added 670 µL of PureCol Collagen to 50 mL tissue culture grade water and mixed 
well. Used this collagen within 24 hours and stored at 4 °C. For coating the plates, 
3750 µL/well of prepared collagen solution was added and plates were left in the hood 
with the plate lids off to evaporate. Removed remaining collagen and washed wells 
once in PBS before cell culture.  
C. Cell collection and culture 
Materials and equipment 
 Sterile endocervical brushes 
 BEBMTM Bronchial Epithelial Cell Growth Basal Medium (LonzaTM) 
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 BEGMTM SingleQuotsTM Supplement Pack (LonzaTM) 
 Trypsin/EDTA (LonzaTM)  
 Trypsin neutralising solution (LonzaTM) 
 Hepes solution (LonzaTM)   
 Collagen coated plates 
 12 well plates 
 37 ˚C, 5% CO2 incubator 
Methods 
Cells were collected from brushing patient nasal cavity with a sterile brush. Then 
twirled brush in 1mL warm BEGM media. The media need to be kept warm. As soon 
as cells were collected, they were divided into 2 wells in collagen-coated plates. This 
process needed to be done as quickly as possible, ideally in 5 minutes. Cells were 
cultured in 37 ˚C, 5% CO2 incubator. 
After two days, the cells were checked to ensure they had stuck to the bottom of the 
well before feeding fresh media. If not, only half the media was removed and replaced 
with fresh media. The removed media was seeded into a second collagen-coated plate 
to encourage further attachment and growth. 
After another 48 hours, if there was evidence of cell attachment, the supernatant and 
unattached cells were removed and replaced with fresh BEGM, cells were fed every 
2-3 days. When cells were confluent they were split into a new uncoated plate for 
experiments. For cell infection experiment, cells were seeded into 12 wells plate, with 
each well containing 5×105 cells. Cells were kept at 37 ˚C until fully confluent.  
2.2.4.4 Bacterial preparation 
Six different strains of unselected H. parainfluenzae, NTHi and P. aeruginosa from 
previously-stored bronchiectasis patient colonies collection. 
Materials and equipment 
 CBA plates 
 Nutrient agar plates 
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 5% CO2 incubator 
 37 ˚C incubator 
Methods 
NTHi and H. parainfluenzae were grown on CBA plates, incubated at 37 ˚C in 5% 
CO2 overnight. P. aeruginosa were grown on nutrient agar, at 37 ˚C overnight. 
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2.2.4.5 Equation of bacterial optical density and bacterial load (cfu/mL)  
The experiments below are key so that an accurate bacterial load can be derived for 
the different pathogens. Correlation of H. influenzae and H. parainfluenzae OD value 
and colony forming unite have been tested to get an accurate bacterial load (Figure 16).  
Materials and equipment 
 CBA plates 
 Nutrient agar 
 PBS 
 Spectrophotometer 
 5% CO2 incubator 
 37 ˚C incubator 
Methods 
Bacteria (H. parainfluenzae, NTHi and P. aeruginosa) were cultured on agar plates 
overnight. Next day, colonies were picked from the plate and then suspended in PBS. 
The suspensions were diluted with PBS: 1 in 1, 1 in 2, 1 in 3, 1 in 4, 1 in 10, 1 in 20 
and 1 in 100. OD value was measured for each dilution, and each dilution was also 
plated on an agar plate and cultured for colony number counting next day. The 
equations were used to calculate bacterial load when cells were co-cultured with 
bacteria. The correlations have been proved significant before each test. Figure 17 
show the equation of H. parainfluenzae, NTHi and P. aeruginosa OD value and 
bacterial load (cfu/mL). 
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Figure 17. Equation of bacterial optical density and bacterial load (cfu/mL). a) is the 
correlation between the H. parainfluenzae cfu and OD value. The equation between H. 
parainfluenzae OD value and cfu is cfu =2×109×OD value +1×109. b) is the correlation 
between the NTHi cfu and OD value. The equation between NTHi OD value and cfu is cfu 
=3×107×OD value -7×108. c) is the correlation between the P. aeruginosa cfu and OD 
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3.2.4.6 Heat killed bacterial preparation 
Materials and equipment 
 80 ˚C water bath 
 CBA plates 
 Nutrient agar plates 
Methods 
Bacterial suspensions, in sterile PBS, of H. parainfluenzae (n=6), NTHi (n=6) and P. 
aeruginosa (n=6) were prepared, using colonies from agar plates. Then OD value of 
the bacterial suspension was measured at a wavelength of 600 nm. Then the bacterial 
load was calculated by using the previously calculated equation. Bacteria, at the 
required bacterial load, were heat-killed by placing them into an 80 ˚C water bath for 
an hour before co-cultured with cells. 100 µL of heat-treated bacteria were plated on 
an agar plate and cultured overnight to check the viability. All heat-treated bacteria 
showed no bacterial growth after the overnight incubation.   
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2.2.4.7 Epithelial cells co-cultured with H. parainfluenzae, NTHi and P. 
aeruginosa 
Materials and equipment 
 Sterile PBS 
 Spectrophotometer 
 Centrifuge  
Methods 
Bacterial suspensions, in sterile PBS, of H. parainfluenzae, NTHi and P. aeruginosa 
were prepared, using colonies from agar plates. OD600 value was then measured and 
the bacterial load was calculated based on the previously mentioned equation (Figure 
10).  Bacteria were then diluted to the required bacterial load. 100 µL bacteria were 
co-cultured with cells in duplicate for various experiments. The negative control 
contained 100 µL PBS co-cultured with cells. For time-course experiments, 107 
cfu/mL bacteria were co-cultured with cells for 1hour, 2 hours, 4 hours, 6 hours and 8 
hours. For bacterial dose-response experiments, 103-108 cfu/mL bacteria were co-
cultured with cells for 8 hours.  
After co-culture, cell culture media was pipetted off, centrifuged at 300×g for 5 
minutes, then the supernatant was removed and stored at -20˚C. 
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2.2.4.8 Cell lactate dehydrogenase release after co-culture  
Cell lactate dehydrogenase (LDH) release was measured in previously collected cell 
culture supernatant. LDH commonly exist in living cells. When cell membranes are 
damaged, LDH is released to the surrounding environment. Cytotoxicity Detection Kit 
was used. 
Materials and equipment 
 Cytotoxicity Detection Kit contains catalyst and dye solution (Sigma-
Aldrich)® 
 Plate reader with wavelength of 490 nm and 600 nm 
Methods 
LDH assay was performed according to the manufacturer’s instructions. To determine 
the LDH activity in media samples, samples were defrosted to room temperature. Fill 
the well with 100 µL sample, all samples were tested in duplicate. 100 µL freshly 
prepared Reaction mixture (for 100 tests, mix 250 µL Catalyst with 11.25 mL dye 
solution) added to each well and incubated for up to 30 minutes at 15 °C to 25 °C. 
During this incubation period, the plate should be protected from light. The absorbance 
of the samples was measured at 490 nm and 600 nm. 
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2.2.4.9 Epithelial cells pro-inflammatory response measurement  
Cytokines produced by cells after co-cultured with bacteria were tested. Cytokine 
profile (105 cytokines show in Table 7) was measured using Proteome Profiler Human 
XL Cytokine Array kit®. For quantitative CXCL8, IL1β, LCN2, CXCL1 and ICAM-
1 measurement, Duoset ELISA kit® was used. 
A. Epithelial cells cytokine profile measurement 
Materials and equipment 
 Distilled water 
 Proteome Profiler Human XL Cytokine Array Kit (R&D system) contains: 
 Human XL Cytokine Array  
 Array Buffer 4  
 Array Buffer 6  
 Wash Buffer Concentrate  
 Detection Antibody Cocktail, Human XL Cytokine Array  
 Streptavidin-HRP  
 Chemi Reagent 1  
 Chemi Reagent 2  
 4-Well Multi-dish  
 Transparency Overlay Template  
 Rocking platform shaker 
 Autoradiography cassette 
 Film developer 
 X-ray film (Kodak® BioMax™ Light-1)  
Methods 
 Sample preparation 
Cells were co-cultured with four groups of bacteria: 
 104 cfu/mL H. parainfluenzae (6 different clinical strains)  
 107 cfu/mL H. parainfluenzae (same strains as the first group) 
Material and Methods 
85 
 
 107 cfu/mL NTHi (6 different clinical strains)  
 107 cfu/mL P. aeruginosa (6 different clinical strains)   
After 8 hours, cell culture media was collected and stored as previously described. 
Before the array test, all samples were defrosted to room temperature. 100 µL were 
abstracted from each sample then pooled with the other five samples from the same 
group. These four pooled samples were used for further tests. 
 Proteome Profiler Human XL Cytokine Array kit 
Proteome Profiler Human XL Cytokine Array is a membrane-based antibody array for 
the parallel determination of the relative levels of selected human cytokines and 
chemokines. There are four membranes spotted with 105 different antibodies to human 
cytokines (Table 7). 
The method strictly followed the instruction from the Proteome Profiler Human XL 
Cytokine Array Kit. The main steps are: 
Placed each membrane in a separate well and block with 2 mL of Array Buffer 6. 
Incubated for one hour on a rocking platform shaker. While the arrays were blocking, 
prepared the pooled sample to a final volume of 1.5 mL with Array Buffer 6. Array 
Buffer 6 was aspirated from the wells of the 4Well Multi-dish and the prepared 
samples added. Incubated overnight at 2-8 °C on a rocking platform shaker. 
The next day, washed each membrane with 1×Wash Buffer for 10 minutes on a rocking 
platform shaker three times. Returned the array to the 4 Well Multi-dish containing 
the diluted Detection Antibody Cocktail (30 μL of Detection Antibody Cocktail to 1.5 
mL of 1× Array Buffer 4/6), and covered with the lid. Incubated for 1 hour on a rocking 
platform shaker. Repeated the washing step, then returned the membrane to the 4-Well 
Multi-dish containing 1.5mL 1× Streptavidin-HRP. Covered the wells with the lid. 
Incubated for 30 minutes at room temperature on a rocking platform shaker. Washed 
each array again, then pipetted 1.0 mL of the prepared Chemi Reagent Mix evenly 
onto each membrane. Carefully covered with the top sheet of the plastic sheet protector. 
Gently smoothed out any air bubbles and ensured Chemi Reagent Mix was spread 
evenly to all corners of each membrane. Incubated for 1 minute. Positioned paper 
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towels on the top and sides of the plastic sheet protector containing the membranes 
and carefully squeezed out excess Chemi Reagent Mix. Then covered the membranes 
with plastic wrap. Placed the membranes with the identification numbers facing up in 
an autoradiography film cassette. Exposed membranes to X-ray film for 30 seconds, 1 
minute, 3 minutes and 5 minutes. 
 DATA analysis 
X-ray films were scanned and the density of individual spot was calculated using 
software Image J®. A template was provided with the kit.  
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B. Epithelial cells quantitative CXCL8, IL1β, Lipocalin2, CXCL1 and ICAM-1 
measurement 
Duoset ELISA kit (R&D system) was used according to manufacture as described 
previously.     
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2.2.5 Assess the impact of coinfection of H. parainfluenzae with P. aeruginosa and 
H. parainfluenzae with NTHi 
3.2.5.1 H. parainfluenzae and P. aeruginosa co-cultured with 16HBE cells 
A. 16HBE cells were co-cultured with: 
 100 µL 1×105 cfu/mL H. parainfluenzae and 100 µL PBS 
 100 µL 2×105 cfu/mL H. parainfluenzae and 100 µL PBS 
 100 µL 1×105 cfu/mL P. aeruginosa and 100 µL PBS 
 100 µL 2×105 cfu/mL P. aeruginosa and 100 µL PBS 
 100 µL 1×105 cfu/mL H. parainfluenzae and 100 µL 1×105 cfu/mL P. aeruginosa  
 200 µL PBS 
After 8 hours, for cytokine measurement, plates were centrifuged at 300×g for 5 
minutes, then supernatant abstracted. The supernatant was stored at -20 °C for future 
CXCL1, CXCL8 and LCN2 measurement. 
For outer cellular and intercellular bacterial load measurement, media was abstracted 
and then serial dilutions were made, 100 µL of diluted media was plated on CBA plates 
and nutrient plates. Plates were incubated at 37 °C for 24 hours and colonies counted.  
B. 16HBE cells were also co-cultured with:  
 100 µL 1×106 cfu/mL H. parainfluenzae and 100 µL PBS 
 100 µL 2×106 cfu/mL H. parainfluenzae and 100 µL PBS 
 100 µL 1×106 cfu/mL P. aeruginosa and 100 µL PBS 
 100 µL 2×106 cfu/mL P. aeruginosa and 100 µL PBS 
 100 µL 1×106 cfu/mL H. parainfluenzae and 100 µL 1×106 cfu/mL P. aeruginosa  
 200 µL PBS 
After 8 hours, the supernatant was collected as above for CXCL1, CXCL8 and LCN2 
test.  
2.2.5.2 16HBE cells were co-cultured with: 
 100 µL 1×103 cfu/mL to 1×107 cfu/mL NTHi and 100 µL PBS 
Material and Methods 
90 
 
 100 µL 1×103 cfu/mL to 1×107 cfu/mL NTHi and 100 µL 1×105 cfu/mL H. 
parainfluenzae 
 200 µL PBS 
After 8 hours, the supernatant was collected as above for CXCL1 and CXCL8 test.  
2.2.5.3 H. parainfluenzae and non-PCN P. aeruginosa co-culture with 16HBE cell 
line in combination  
16HBE cells were co-cultured with:  
 100 µL 1×105cfu/mL H. parainfluenzae and 100 µL PBS 
 100 µL 1×105cfu/mL non-PCN P. aeruginosa and 100 µL PBS 
 100 µL 1×105cfu/mL H. parainfluenzae and 100 µL 1×105cfu/mL non-PCN P. 
aeruginosa  
 200 µL PBS 
After 8 hours, the supernatant was collected as above for CXCL1 and CXCL8 test.  
2.2.5.4 Heat-treated H. parainfluenzae and P. aeruginosa co-culture with 16HBE 
cell line in combination  
16HBE cells were co-cultured with:  
 100 µL 1×105 cfu/mL heat-treated H. parainfluenzae and 100 µL PBS 
 100 µL 1×105 cfu/mL heat-treated P. aeruginosa and 100 µL PBS 
 100 µL 1×105 cfu/mL heat-treated H. parainfluenzae and 100 µL 1×105 cfu/mL 
heat-treated P. aeruginosa  
 200 µL PBS 
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2.2.5.5 H. parainfluenzae co-culture with 16HBE cell line in the media that has 
cultured P. aeruginosa  
16HBE cells were co-cultured with 1×105 cfu/mL P. aeruginosa for 8 hours, the 
supernatants were collected and filtered through 0.22 µm2 filters to remove P. 
aeruginosa, then stored at -20 °C. Next day, 16HBE cells were co-cultured with 1×105 
cfu/mL H. parainfluenzae for 8 hours in 900 µL supernatant collected the previous 
day. Cytokine measurement and bacterial load counts were performed as described 
above.  
For the comparison group, 16HBE cells were co-cultured without bacteria for 8 hours, 
supernatants were collected, filtered and then stored in -20 °C. Next day, 16HBE cells 
were co-cultured with 105 cfu/mL H. parainfluenzae for 8 hours in 900 µL supernatant 
collected the previous day. 
A reverse experiment has also been done on 16 HBE cells. 16HBE cells were co-
cultured with 105 cfu/mL H. parainfluenzae for 8 hours, supernatants were collected, 
filtered and stored in -20 °C. Next day, 16HBE cells were co-cultured with 105 cfu/mL 
P. aeruginosa for 8 hours in 900 µL supernatant collected the previous day. 
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2.2.5.6 H. parainfluenzae co-culture with P. aeruginosa growth broth  
P. aeruginosa was cultured in nutrient broth and H. parainfluenzae were cultured in 
BHI broth (containing Fildes extract, Oxoid®) overnight. Next day, P. aeruginosa 
culture broth was collected and filtered with 0.22 µm2 filters to remove P. aeruginosa. 
H. parainfluenzae culture was diluted by PBS to 50 times, and then 100 µL of diluted 
H. parainfluenzae were cultured with 1 mL of the filtered P. aeruginosa broth and 
4mL BHI broth (containing Fildes extract). For comparison experiment, 100 µL of 
diluted H. parainfluenzae were cultured with 1 mL nutrient broth and 4mL BHI broth 
(containing Fildes extract). Incubated in 37°C with 5% CO2 shaker. OD values were 
measured after 1hour, 2hours, 4 hours, 6 hours, 8 hours and 24 hours.  
In vitro, 16HBE cells were co-cultured with 1×105 cfu/mL H. parainfluenzae, 200 µL 
filtered P. aeruginosa broth culture and 700 µL DMEM media for 8 hours. For 
comparison experiment, 16HBE cells were co-cultured with 1×105 cfu/mL H. 
parainfluenzae, 200 µL nutrient culture broth and 700 µL DMEM media for 8 hours. 
After 8 hours, abstract media and serial dilutions were done, then plated on CBA plates. 
Plates were incubated at 37 °C with 5% CO2 for 24 hours and colonies counted.  
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2.2.5.7 H. parainfluenzae co-culture with media that has cultured P. aeruginosa 
on CBA plates 
16HBE cells were co-cultured with 105 cfu/mL P. aeruginosa for 8 hours, supernatants 
were collected, filtered with 0.22 µm2 filters and stored in -20 °C. The next day, H. 
parainfluenzae colonies were streaked all over the nutrient agar. A heated loop was 
used to make a 0.5 cm diameter well in the centre of the plate (Figure 18). In the 
experimental group, 100 µL supernatant collected from the previous day was pipetted 
into this well, and for the positive control, 100 µL 15 ng/mL polymyxin B was added 
to the well. Plates were incubated at 37 °C with 5% CO2 for 24 hours, colonies were 
counted. Polymyxin B can lead to an inhibition of H. parainfluenzae growth. 
 
Figure 18. H. parainfluenzae co-culture with polymyxin B on CBA plates. A sample of 
the 0.5 cm diameter well in the centre of the plate and the zone of inhibition caused by 15 
ng/mL polymyxin B. 
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2.2.5.8 Minimum inhibitory concentration (MIC) of Polymyxin B to H. 
parainfluenzae  
Five different strains of H. parainfluenzae were cultured on CBA plates that contain 0 
µg/mL, 3 µg/mL, 5 µg/mL, 8 µg/mL, 10 µg/mL, 15 µg/mL and 30 µg/mL of 
polymyxin B for overnight. After 24 hours, plates were taken out and the growth of H. 
parainfluenzae was noted down. Table 10 shows the growth of H. parainfluenzae on 
polymyxin B CBA plates. + indicates the growth of H. parainfluenzae; - indicates the 
inhibition of H. parainfluenzae growth. The results suggested that at 15 µg/mL, the 
polymyxin B can lead to inhibition of all H. parainfluenzae.  
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2.3 Statistical analysis 
Data were present as median and interquartile range (IQR). The difference between 
two groups was analysed by un-paired Student’s t-test or paired t test (GraphPad Prism 
version 6; GraphPad Software). When three groups were involved, data were analysed 
by one-way ANOVA with a Bonferroni multiple comparison post-hoc test (GraphPad 
Prism version 6; GraphPad Software). P-values < 0.05 were considered as statistically 
significant. The heat map was generated using R®. 
Power calculations are carried out using GPower 3.1 Statistical package.  For 
comparing bacterial loads, a 1 log unit change in bacterial load is clinically important. 
For comparing sputum inflammation, a 33% reduction in sputum myeloperoxidase 
would represent a significant reduction. Same patients’ size was used for comparing 
serum inflammation. 
Bacterial load: With a common standard deviation 0.98 (log cfu/ml), using 5 groups, 
90% power and 1.25 % level of significance due to multiple comparisons, 28 per group 
are needed to detect a 1 log unit change in bacterial load (this represents a major change 
in bacterial load).  
Myeloperoxidase: With a common standard deviation of 0.7 (U/ml), using 5 groups, 
90% power and 1.25% level of significance due to multiple comparisons, 24 per group 



















Chapter 3: Results 
 
3.1 Results for aim 1. Classify Haemophilus species in bronchiectasis 
This part of the study was done to characterise H. parainfluenzae, as well as other 
common Haemophilus species isolated from 140 stable bronchiectasis patients’ 
sputum samples. The most commonly reported Haemophilus species in bronchiectasis 
were tested: NTHi, H. parainfluenzae and H. haemolyticus. H. parainfluenzae 
subtypes were also investigated.  
Sputum samples from another 51 stable bronchiectasis patients were sent to an NHS 
trusted laboratory to compare outcomes for the isolation of Haemophilus species, with 
special focus on H. parainfluenzae. 
3.1.1 Bronchiectasis patients recruited  
To classify Haemophilus species in bronchiectasis patients, 140 patients were recruited. 
They were chronically colonised but currently stable, with an average age of 69 years 
old (standard deviation of 11 years). 76 were female, 64 males. 43 were ex-smokers, 
and 97 non-smokers; there were no current smokers. None of them were on antibiotic 
treatment since at least four weeks before the study. They all had had H. influenzae on 





Table 11.   Patient’s information 
                       IBD: Inflammatory bowel disease                  





3.1.2 Identification of H. parainfluenzae, NTHi and H. haemolyticus 
Both H. parainfluenzae and H. influenzae grew on CBA plate. They all formed grey 
or cream coloured small round colonies. On nutrient agar, H. parainfluenzae grew 
around both V disks, and V+X disks. H. influenzae and H. haemolyticus grew only 
around V+X disks. From the Haemophilus species collected from those 140 patients, 
57 strains were confirmed to be H. parainfluenzae, and 66 were identified as either H. 
influenzae or H. haemolyticus. These strains were kept at -80 ºC for future experiments.  
Forty-five strains of H. influenzae (or H. haemolyticus) isolated from the last step were 
recovered from -80 ºC conditions and then tested using qPCR. qPCR results showed 
44 strains were H. influenzae, and one strain was H. haemolyticus.   
These 44 H. influenzae strains identified in the last step were then confirmed to be 
















3.1.3 H. parainfluenzae was isolated from more than a third of the patients’ 
sputum samples 
Among the 140 patients, using traditional microbiology techniques, 57 (40%) patients 
isolated H. parainfluenzae including one patient that had H. parainfluenzae and S. 
pneumoniae, and one had H. parainfluenzae and S. aureus.  H. influenzae was isolated 
from 66 (47%) patients including one patient that  had H. influenzae and  S. 
pneumoniae and two had H. influenzae and S. aureus. Two patients had H. 
parainfluenzae and H. influenzae. Furthermore, 1 patient presented P. aeruginosa, 2 
presented S. pneumoniae, and 4 presented S. aureus. Out of all patients, 9 (6%) had 
mixed normal flora (MNF) with no dominant pathogen identified. Using molecular 
methods, we found one patient presented H. haemolyticus and no patients had 
capsulated H. influenzae (Figure 19). 
 
  
Figure 19. Haemophilus species in 140 bronchiectasis patients. 53 (39%) patients had H. 
parainfluenzae. One patient (0.7%) had H. parainfluenzae and  S. pneumoniae, one (0.7%) 
had H. parainfluenzae and S. aureus. 61 (44%) patients had NTHi. One patient (0.7%) had 
H. influenzae and  S. pneumoniae, two (1.4%) had H. influenzae and S. aureus. Two patients 
(1.4%) had H. parainfluenzae and H. parainfluenzae. One patient (0.7%) had H. 
haemolyticus, two (1.4 %) had S. pneumoniae, one patient (0.7%) had P. aeruginosa and 
four (2.8%) had S. aureus. Nine (6%) patients had mixed normal flora (MNF) with no 




3.1.4 Subtypes of H. parainfluenzae isolated from patients  
Subtypes of H. parainfluenzae were identified. Forty-one strains of H. parainfluenzae 
were recovered from -80 ºC condition. Most of the H. parainfluenzae isolated from 
patients were subtype V (32%) and subtype I (27%); 15% were subtype II and another 
15% subtype III (Figure 20). 7% of the patients had subtype VII, 2% had subtype VIII, 
and 2% had subtype VIII. There was no patient with subtype VI H. parainfluenzae. 
  Table 12. Differentiation of subtypes of H. parainfluenzae 
Figure 20. H. parainfluenzae subtypes. Forty-one strains of H. parainfluenzae were 
recovered from -80 ºC. Results of indole, urease and ornithine decarboxylase test shows: 
11 (27%) strains were subtype I, 6 (15%) strains were subtype II, 6 (15%) strains were 
subtype III, 1 (2%) strain were subtype IV, 13 (31%) strains were subtype V, there was no 




3.1.5 NHS microbiology laboratory results compared to our laboratory results  
Fifty-one unselected patients’ sputum microbiology results were compared between 
the ones obtained in our own laboratory with our proposed method and the ones given 
by an NHS microbiology laboratory. These patients’ samples were collected from the 
Royal Infirmary bronchiectasis clinic. But they should be ≥ 18 years old, at a stable 
stage of bronchiectasis, and not on long term oral or inhaled antibiotics. Results from 
both laboratories showed a distinct difference in the number of pathogens. H. 
parainfluenzae was not reported by the NHS microbiology laboratory. However, our 
laboratory results showed that 9 patients (18%) had H. parainfluenzae. There was 
higher number of NTHi identified by our laboratory (33%) compared to the NHS 
microbiology results (20%). We also found less MNF (6%) compared to NHS results 







Figure 21. Microbiology results from NHS microbiology laboratory and our 
laboratory. From my lab results, 17 (33%) patients had NTHi, 9 (18%) patients had H. 
parainfluenzae. 11 (22%) patients had P. aeruginosa. One (2%) patient had Moraxella 
catarrhalis, one had S. aureus and one had S. pneumonia. There 8 (16%) patients had other 
pathogen such as: one Achromabacter xylosidans, one Chryseobacterium indologens, one 
Pasteurella mucocida, Four S. maltophilia and one E. coli. Three patients had mixed 
normal flora. From NHS microbiology results, 10 (23%) patients had NTHi, 0 (0%) 
patients had H. parainfluenzae. 8 (15%) patients had P. aeruginosa. Three (5%) patient 
had Moraxella catarrhalis, one (3%) had Staphylococcus aureus and three (5%) had S. 
pneumoniae. There were 8 (15%) patients had other pathogens such as: two Pasteurella 
multocida, one Klebsiella oxytoca, mycobacteria, three S. maltophilia, one Enterococcus 




3.2 Results for aim 2. Compare H. parainfluenzae isolates from bronchiectasis 
patients’ upper airways and lower airways 
Throat swabs have been collected from 30 unselected patients together with their 
sputum samples. Those patients were from the previously described 140 stable 
bronchiectasis patients. They were ≧18 years old; have not had any exacerbation for 
at least 4 weeks before the study; were not on long term oral or inhaled antibiotics; had 
grown H. influenzae in the last sputum culture within the past one year according to 
NHS microbiology reports. 
Eight patients had H. parainfluenzae in both throat swab and sputum samples. The H. 
parainfluenzae from same patient’s upper airways and low airways were compared for 





3.2.1 Genomic profile of H. parainfluenzae from the upper airways and lower 
airways 
Four pairs of H. parainfluenzae from four patients’ upper and lower airways were 
recovered from frozen stock and compared for their genomic profile. The genomic 
profile of the H. parainfluenzae from the same patient’s upper and lower airways was 
different but related (Figure 22). For patient 1, there were four bands different between 
H. parainfluenzae from sputum and throat swab; for patients 2, there were two bands 
different; for patients 3, there were eight bands different; for patients 4, there were five 
bands different. Because most pairs had less than 6 bands different, it suggests that H. 
parainfluenzae from upper airways and lower airways are different and possibly 
related. 
  
Figure 22. Genomic profile of H. parainfluenzae from patients’ upper airways and 
lower airways. Four pairs of H. parainfluenzae from four individual patients’ throat and 
sputum were compared for their genomic profile using PFGE. The red squares point out 
the different bands between H. parainfluenzae from throat or sputum. For PFGE, when 
different band number is less than 1, it indicates the genomic profiles are the same; when 
the number is 1 to 3 (including 3), it indicates that the genomic profiles are closely related; 
when the number is 4 to 6 (including 6), it indicates the genomic profiles are possible 





3.2.2 H. parainfluenzae isolated from upper airways stimulated different 
inflammatory responses compared to the H. parainfluenzae isolated from lower 
airways on 16HBE cells 
The four pairs of H. parainfluenzae from upper and lower airways (same strains as the 
last page) were then co-cultured with 16HBE cells for 8 hours at different bacterial 
load. CXCL8 produced from 16HBE cells were measured by ELISA. There was no 
significant difference in the level of CXCL8 produced from 16HBE cells when they 
were co-cultured with H. parainfluenzae from upper or lower airways at low bacterial 
load (103 cfu/mL to 106 cfu/mL). At high bacterial load (107 cfu/mL and 108 cfu/mL), 
H. parainfluenzae from upper airways induced significantly more CXCL8 production 
from 16HBE cells than the H. parainfluenzae from lower airways (p=0.017 and 
p=0.017 respectively; Figure 23). Median CXCL8 value for H. parainfluenzae from 
lower airways were: 644.7 pg/mL for 103 cfu/mL, 577.4 pg/mL for 104 cfu/mL, 647.9 
pg/mL for 105 cfu/mL, 702.9 pg/mL for 106 cfu/mL, 1264.4 pg/mL for 107 cfu/m and 
1917.0 pg/mL for 108 cfu/mL. Median CXCL8 value for H. parainfluenzae from upper 
airways were: 658 pg/mL for 103 cfu/mL, 611.4 pg/mL for 104 cfu/mL, 672.0 pg/mL 
for 105 cfu/mL, 802.5 pg/mL for 106 cfu/mL, 1805.2 pg/mL for 107 cfu/m and 2536.5 







   
H. parainfluenzae from sputum samples 

































































Figure 23. Inflammatory responses from 16HBE cells after co-cultured with H. 
parainfluenzae from patients’ upper airways and lower airways. Four pairs of H. 
parainfluenzae from four individual patients’ throat and sputum were co-cultured with 
16HBE cells at different bacterial loads: 103 cfu/mL, 104 cfu/mL, 105 cfu/mL, 106 cfu/mL, 
107 cfu/mL and 108 cfu/mL. Control group was same volume of PBS. After 8 hours, media 
was then collected. Media CXCL8 level was measured by ELISA. CXCL8 value was 
compared between H. parainfluenzae from sputum and throat swab. P-value was calculated 
by paired t-test. Y axis shows the actual value of CXCL8, data presented in box and whisker 




3.2.3 Conclusions for aim 1 and aim 2 
 Haemophilus species are under-reported from traditional NHS microbiological 
laboratory methods, particularly with patients that had H. parainfluenzae. 
 There were fewer patients that had found no dominant pathogen using our 
laboratory method which includes quantitative bacteriology and multiple 
molecular tests compared to the NHS microbiology laboratory results.   
 In a limited sample size, the H. parainfluenzae isolates from upper airways and 
lower airways had a different but related genomic profile. 
 Both H. parainfluenzae from lower and upper airways stimulated 
inflammatory responses at 107 cfu/mL and 108 cfu/mL.  In a small sample size, 
H. parainfluenzae from upper airways stimulated greater inflammatory 






3.3 Results for aim 3. Compare clinical features of H. parainfluenzae and NTHi 
in bronchiectasis patients 
Having found that a relatively significant percentage of patients had H. parainfluenzae, 
and H. parainfluenzae was not reported from the NHS clinic at all, to figure out what 
kind of role H. parainfluenzae play in bronchiectasis lower airways became very 
crucial. This part of the study was mainly to investigate the sputum and serum 
inflammation of patients who had H. parainfluenzae; we compared those patients to 
the patients that had NTHi since NTHi have been regarded as pathogen in 
bronchiectasis. 
Serum and sputum sol phase samples were collected from 63 patients that had either 
H. parainfluenzae or NTHi based on our laboratory method results. Those patients 
were all ≥18 years old, at a stable stage of bronchiectasis, and not on long term oral or 
inhaled antibiotics, no current smokers. Their Serum WCC, ESR, CRP and ICAM-1 
were measured. Sputum sol phase MPO and sputum bacterial load were accessed. 





3.3.1 Patients clinical information 
Patients were divided into two groups: 1) patients that had only H. parainfluenzae as 
the dominant potential pathogen in their sputum; 2) patients that had only NTHi as the 
dominant pathogen in their sputum. There were 24 patients had H. parainfluenzae, 39 
patients had NTHi. Their clinical information was collected from the NHS. No 
significant difference was observed between these two groups of patients in their sex, 
age, smoking spirometry, the number of infected lobes and exacerbation in the past 
year (Table 13). 
Table 13. Patient’s information
 
Median value (min- max) 
FEV1% pred: FEV1% predicted 





3.3.2 The NTHi bacterial load in patients' samples was significantly higher than 
that of H. parainfluenzae 
There was a significant difference between patients who had NTHi and H. 
parainfluenzae in their sputum bacterial load. The median bacterial load was 1.6×106 
cfu/mL in the patients that had H. parainfluenzae and 1.06×108 cfu/mL in the patients 
with NTHi, p˂0.0001 (Figure 24). Even though the bacterial load was lower in the 
patients that had H. parainfluenzae, there were 15 (60%) patients had more than 106 
cfu/mL H. parainfluenzae in their sputum samples, which is a significant bacterial 


























Figure 24. NTHi bacterial load and H. parainfluenzae load in patients. Patients sputum 
H. parainfluenzae (n=24) and NTHi (n=39) bacterial load was calculated and compared 
using unpaired t-test. Data are presented in min to max box and whisker plots. The box 




3.3.3 Patients had H. parainfluenzae and NTHi had similar serum WCC, ESR, 
CRP and ICAM-1 values 
Patients’ serum WCC, CRP, ESR and ICAM-1 values were measured. Patients that 
had H. parainfluenzae(n=24) had similar WCC, ESR, CRP and ICAM-1 as the patients 
that had NTHi (n=39). P-values are 0.06, 0.5, 0.62 and 0.52 (Figure 24). The median 
WCC, ESR, CRP and ICAM-1 were 6.9×109 /mL, 8.0 mm/h, 4.0 mg/L, 7903 pg/mL 
in patients that had H. parainfluenzae; 8.0×109 /mL, 8.0 mm/h, 4.0 mg/L, 7941 pg/mL 





Figure 25. Serum WCC, ESR, CRP and ICAM level for patients that had H. 
parainfluenzae or NTHi. Patient’s serum WCC, ESR, CRP and ICAM-1 were calculated 
and compared between patients that had H. parainfluenzae (n=24) and NTHi (n=39) in 
their sputum. Data are presented in Tukey box and whisker plots. The box shows +/- IQR. 
The line inside the box is median. The dots are outliers. P-values were calculated by 




3.3.4 Patients that had higher sputum H. parainfluenzae bacterial load had higher 
serum ICAM-1 and ESR levels compared to the patients that had lower sputum 
H. parainfluenzae bacterial load 
Those patients’ serum WCC, CRP, ESR and ICAM-1 value were then compared 
between those had high sputum H. parainfluenzae bacterial load and those had low 
sputum H. parainfluenzae load. There were six patients in each group; their sputum 
bacterial load was higher or lower than the interquartile range (1.16× 105 cfu/mL to 
2.34 ×107 cfu/mL). The median bacterial load for low bacterial load group was 9× 104 
cfu/mL, for high bacterial load group was 3.4× 107 cfu/mL. Serum ESR and ICAM-1 
were significantly higher in patients that had high bacterial load (ESR=18 mm/h, 
ICAM-1=10446.7 pg/mL) compare to patients that had a lower bacterial load 
(ESR=6.5mm/h, p=0.04, ICAM-1=6616.7 pg/mL, p=0.02). There was no difference 
in serum WCC and CRP. (Figure 26)  
Figure 26. Serum WCC, ESR, CRP and ICAM-1 level of patients that had high 
bacterial load and low bacterial load. Patient’s serum WCC, ESR, CRP and ICAM-1 
were calculated and compared between patients that had high bacterial load (n=6) and low 
bacterial load (n=6) of H. parainfluenzae in their sputum. Those patients sputum bacterial 
load were either higher or lower than the interquartile range (1.16×105 cfu/mL to 2.34×107 
cfu/mL). Data are presented in min to max box and whisker plots. The box shows +/- IQR. 




3.3.5 Patients that had NTHi or H. parainfluenzae had similar sputum MPO value 
Patients’ sputum MPO levels were measured. Similar to those serum inflammatory 
markers, there was no significant difference between patients who had NTHi (n=39) 
or H. parainfluenzae (n=24). The median MPO was 65.19 µg/mL in patients that had 
H. parainfluenzae (n=24), 116.4 µg/mL in patients that had NTHi (n=39), p=0.068 
between groups (Figure 27).  
 
  
Figure 27. Sputum MPO level of the patients that had H. parainfluenzae or NTHi. 
Sputum MPO value of patient that had H. parainfluenzae (n=24) and NTHi (n=39), data 
are presented in Tukey box and whisker plots. The box shows +/- IQR. The line inside the 
































3.3.6 Patients had higher sputum H. parainfluenzae load had higher sputum 
MPO level 
Sputum MPO values were compared between six patients who had high sputum H. 
parainfluenzae bacterial load (˃2.34×107 cfu/mL) and six patients who had low 
sputum H. parainfluenzae bacterial load (˂1.16×105 cfu/mL). The median bacterial 
load for low bacterial load group was 9×104 cfu/mL, for high bacterial load group was 
3.4×107 cfu/mL. Sputum MPO was significantly higher in the patients that had a high 
bacterial load. Median MPO value for high bacterial load group was 311.7 µg/mL, for 
low bacterial load group was 57.4 µg/mL, p=0.0087 (Figure 28). 
 
  
Figure 28. Sputum MPO of the patients that had high bacterial load and low bacterial 
load. Patient’s sputum MPO was calculated and compared between patients that had higher 
load (n=6) and lower load (n=6) of H. parainfluenzae in their sputum. Those patients 
sputum bacterial load were higher than 2.34×107cfu/mL or lower than 1.16×105 cfu/mL. 
Data are presented in min to max box and whisker plots. The box shows +/- IQR. The line 
inside the box is median. P-value were calculated using an unpaired t-test.    
MPO

















3.3.7 Patients had NTHi or H. parainfluenzae had similar BSI scores 
For their BSI score, there was no significant difference between patients who had 
NTHi (n=24) and H. parainfluenzae (n=39). The median BSI score was 7.0 in patients 
that had H. parainfluenzae, 7.0 in patients that had NTHi, p=0.9. (Figure 29a) 
Those patients’ BSI score was then compared between six patients who had high 
sputum H. parainfluenzae bacterial load (˃2.34×107 cfu/mL) and six patients who had 
low sputum H. parainfluenzae bacterial load (˂1.16×105 cfu/mL). The median 
bacterial load for low bacterial load group was 9×104 cfu/mL, for high bacterial load 
group was 3.4×107 cfu/mL. There was no significant difference in the BSI scores 
between these two groups. Median BSI score for high bacterial load group was 5.0, for 
low bacterial load group was 6.0, p=1.0. (Figure 29b) 
  
Figure 29. Patients BSI scores. a) BSI score for patients that had H. parainfluenzae (n=25) 
and NTHi (n=39). b) Patient’s BSI score were calculated and compared between patients 
that had higher bacterial load (n=6) and lower bacterial load (n=6) of H. parainfluenzae in 
their sputum. Those patients sputum bacterial load were either higher or lower than the 
interquartile range (1.16×105 cfu/mL to 2.34×107 cfu/mL). Data are presented in min to 
max box and whisker plots. The box shows +/- IQR. The line inside the box is median. P-






































3.3.8 Conclusions for aim 3 
 The bacterial load was lower in the patients that had H. parainfluenzae 
compared to the patients that had NTHi. 
 Patients that had H. parainfluenzae or NTHi had similar sputum and serum 
inflammatory results. 
 Patients that had H. parainfluenzae or NTHi had similar bronchiectasis severity, 
according to BSI scores. 
 In a small sample size, in comparison of H. parainfluenzae in high bacterial 
load and low bacterial load, patients that had high H. parainfluenzae bacterial 
load had higher serum inflammation with raised ESR and ICAM-1, although 






3.4 Results for aim 4. Assess the impact of H. parainfluenzae on epithelial cells 
From previously results, we have established that patients had H. parainfluenzae and 
NTHi were similar in their clinical features with similar serum inflammation and 
sputum inflammation. In addition, high bacterial load of H. parainfluenzae led to more 
inflammation in bronchiectasis. We wanted to establish further if H. parainfluenzae 
would trigger an inflammatory response as NTHi did in vitro, and if so, we wanted to 
see if the inflammatory responses were bacterial load related, subtype related, or 
culture time related. Hence, 12 unselected strains of H. parainfluenzae, NTHi and P. 
aeruginosa that were isolated from bronchiectasis patients were co-cultured with three 
different types of epithelial cells: human bronchial epithelial cell line (16HBE), normal 
human bronchial epithelial cells (NHBE) and bronchiectasis patients’ primary nasal 
epithelial cells. We mainly looked into the cytokine production of cells after being co-




3.4.1 16HBE CXCL8 production induced by H. parainfluenzae was culture time-
dependent 
After co-cultured with 16HBE cells for 2 hours, 107 cfu/mL H. parainfluenzae (n=6) 
induced significantly more CXCL8 production compared to the first hour, p=0.0001. 
p-value was calculated by paired t-test. There was a significant increase in CXCL8 
level over 24 hours’ co-culture time, p=0.0001. P-value was calculated by 1-way 
ANOVA. The production of CXCL8 reached to peak after 8 hours. There was no 
significant difference between 8 hours and 24 hours. The median CXCL8 fold change 
compared to negative control was 0.9 for 1 hour, 1.9 for 2 hours, 4.1 for 4 hours, 3.9 
for 6 hours, 6.9 for 8 hours and 5.1 for 24 hours (Figure 30).  
Figure 30. CXCL8 production after 16HBE cells co-cultured with H. parainfluenzae. 
16HBE cells were co-cultured with 107 cfu/mL H. parainfluenzae (n=6) for 1 hour, 2 hours, 
4 hours, 6 hours, 8 hours and 24 hours, control was same volume of PBS. 100 μL of cell 
culture supernatant was run on each ELISA. Data are presented in min to max box and 
whisker plots. The box shows +/- IQR. The line inside the box is median. Y axis shows 
fold change of CXCL8 compare to average negative control. P-values between individual 
time points were calculated by paired t-test.  P-value for overall comparison was 1 way 
ANOVA.   
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3.4.2 16HBE CXCL8 production induced by NTHi was culture time related 
After co-cultured with 16HBE cells for 2 hours, 107 cfu/mL NTHi (n=6) induced 
significantly more CXCL8 production compared to the first hour, p=0.0001. P-value 
was calculated by paired t-test. There was no significant difference between 8 hours 
and 24 hours. There was a significant increase in CXCL8 level over the 24 hours’ co-
culture time, p=0.0001. P-value was calculated by 1-way ANOVA. The median 
CXCL8 fold change compared to negative control was 1.2 for 1 hour, 2.4 for 2 hours, 




Figure 31. CXCL8 production after 16HBE cells co-cultured with NTHi. 16HBE cells 
were co-cultured with 107 cfu/mL NTHi (n=6) for 1 hour, 2 hours, 4 hours, 6 hours, 8 hours 
and 24 hours, control was same volume of PBS. 100μL of cell culture supernatant was run 
on each ELISA. Data are presented in min to max box and whisker plots. The box shows 
+/- IQR. The line inside the box is median. Y axis shows fold change of CXCL8 compare 
to negative control. P-values between individual time points were calculated by paired t-




3.4.3 16HBE CXCL8 production induced by P. aeruginosa was culture time-
dependent 
After co-cultured with 16HBE cells, 107 cfu/mL P. aeruginosa (n=6) induced 
significantly more CXCL8 production after 2 hours, p=0.007. Different from H. 
parainfluenzae and NTHi, there was significant higher CXCL8 level at 24 hours 
compared to 8 hours. The production of CXCL8 was positively correlated with culture 
time, p=0.0001. P-value was calculated by 1-way ANOVA. The median CXCL8 fold 
change compared to negative control was 0.9 for 1 hour, 1.8 for 2 hours, 6.8 for 4 
hours, 6.6 for 6 hours, 6.8 for 8 hours and 8.7 for 24 hours (Figure 32). 
 
  
Figure 32. CXCL8 production after 16HBE cells co-cultured with P. aeruginosa. 
16HBE cells were co-cultured with 107 cfu/mL P. aeruginosa (n=6) for 1 hour, 2 hours, 4 
hours, 6 hours, 8 hours and 24 hours, control was same volume of PBS. 100 μL of cell 
culture supernatant was run on each ELISA. Data are presented in min to max box and 
whisker plots. The box shows +/- IQR. The line inside the box is median. Y axis shows 
fold change of CXCL8 compare to negative control. P-values between individual time 




3.4.4 P. aeruginosa stimulated significantly more CXCL8 production than H. 
parainfluenzae and NTHi at 24 hours  
After co-cultured with 16HBE cells for 8 hours, the CXCL8 level from both 107 
cfu/mL H. parainfluenzae (n=6) and 107 cfu/mL NTHi (n=6) groups reached to peak. 
The 16HBE cells that were co-cultured with 107 cfu/mL P. aeruginosa (n=6), however, 
produced more CXCL8 at 24 hours than at 8 hours. 
At 24 hours, P. aeruginosa triggered significantly more CXCL8 production than H. 
parainfluenzae and NTHi ( p=0.02 and p=0.006 respectively). P-value was calculated 
by unpaired t-test.  The median CXCL8 value for H. parainfluenzae was 1571 pg/mL, 
for NTHi was 1082 pg/mL and for P. aeruginosa was 3048 pg/mL (Figure 33). 
  
Figure 33. CXCL8 production after 16HBE cells co-cultured with H. parainfluenzae, 
NTHi and P. aeruginosa for 24 hours. 16HBE cells were co-cultured with 107 cfu/mL H. 
parainfluenzae (n=6), 107 cfu/mL NTHi (n=6) or 107 cfu/mL P. aeruginosa (n=6) for 24 
hours, control was same volume of PBS. 100 μL of cell culture supernatant was run on 
each ELISA. Data is presented in min to max box and whisker plots. The box shows +/- 
IRQ. The line inside the box is median. Y axis shows CXCL8 value. P-values were 




3.4.5 H. parainfluenzae significantly stimulated cells LDH releasement after 24 
hours of culture time 
After 8 hours, the production of CXCL8 from 16HBE cells caused by H. 
parainfluenzae reached to the peak. We further checked the cells LDH releasement at 
8 hours and 24 hours. 
After 16HBE cell has been co-cultured with H. parainfluenzae, NTHi and P. 
aeruginosa (107 cfu/mL, n=6) for 8 hours, there was no significant LDH release 
compared to the control group. The median LDH release for the control group was 6%, 
for H. parainfluenzae was 9%, for NTHi was 8% and for P. aeruginosa was 10%. 
After 24 hours, 16HBE cells that were co-cultured with bacteria had significantly 
higher LDH level compared to the control group (H. parainfluenzae p=0.016, NTHI 
p=0.02, P. aeruginosa p=0.016). There was no significant difference between H. 
parainfluenzae, NTHi and P. aeruginosa groups at both 8 hours and 24 hours. The 
median LDH release at 24 hours for control was 6.5%, for H. parainfluenzae was 29%, 
for NTHi was 24% and for P. aeruginosa was 43%.  Because of the low rate of LDH 
release at 8 hours, 8 hours was chosen to be the time point for further cell-bacteria co-
culture experiments (Figure 34). 
 
  
Figure 34. LDH release from 16HBE cells after co-cultured with H. parainfluenzae, 
NTHi and P. aeruginosa for 8 hours and 24 hours. 16HBE cells were co-cultured with 
107 cfu/mL H. parainfluenzae (n=6), 107 cfu/mL NTHi (n=6), 107 cfu/mL P. aeruginosa 
(n=6) for 8 hours and 24 hours, control was same volume of PBS. 100 μL of cell culture 
supernatant was run on each LDH assay. Data is presented in min to max box and whisker 
plots. The box shows +/- IQR. The line inside the box is median. Y axis shows LDH release 
compared to the total LDH which was calculated based on the LDH assay results. P-values 




3.4.6 16HBE cells inflammatory responses were dose-dependent 
From the previous patient’s serum ESR, WCC and sputum MPO results, we found that 
higher bacterial load was related to higher inflammatory responses. So, we proposed 
that H. parainfluenzae’s inflammatory effect on 16HBE cells was bacterial load-
dependent. H. parainfluenzae (n=6), NTHi (n=6) and P. aeruginosa (n=6) at 104 
cfu/mL, 105 cfu/mL, 106 cfu/mL, 107 cfu/mL and 108 cfu/mL were cultured with 
16HBE cells for 8 hours. 
For H. parainfluenzae, at 104 cfu/mL, 105 cfu/mL and 106 cfu/mL, there was no 
significant CXCL8 production compared to the control group. At 107 cfu/mL and 108 
cfu/mL, the CXCL8 production significantly increased compared to the control group 
(p=0.03 and p=0.004 respectively). Using 1-way ANOVA test shows there was a 
significant overall increase in CXCL8 production (p=0.0001). The median CXCL8 
value for 104 cfu/mL H. parainfluenzae group was 272.5 pg/mL, for 105 cfu/mL group 
was 275 pg/mL, for 106 cfu/mL group was 325 pg/mL, for 107 cfu/mL group was 417 
pg/mL and 108 cfu/mL group were 944.6 pg/mL (Figure 35a). 
Similar to H. parainfluenzae, NTHi induced significant CXCL8 production at 107 
cfu/mL and 108 cfu/mL (p=0.02 and p=0.035 respectively). 1-way ANOVA test shows 
there was a significant overall increase in CXCL8 production (p=0.0002). The median 
CXCL8 value for 104 cfu/mL NTHi group was 334.2 pg/mL, for 105 cfu/mL group 
was 311.2 pg/mL, for 106 cfu/mL group was 366 pg/mL, for 107 cfu/mL group was 
516.7 pg/mL and 108 cfu/mL group were 881 pg/mL (Figure 35b). 
P. aeruginosa was different from the two Haemophilus species, from 105 cfu/mL, P. 
aeruginosa already stimulated significant more CXCL8 production (p=0.02) 
compared to the control group. Similar to H. parainfluenzae and NTHi, higher 
bacterial load of P. aeruginosa can trigger higher CXCL8 production. 1-way ANOVA 
test shows there was a significant overall increase in CXCL8 production (p=0.0001). 
The median CXCL8 value for 104 cfu/mL P. aeruginosa group was 288.6 pg/mL, for 
105 cfu/mL group was 497.1 pg/mL, for 106 cfu/mL group was 588.2 pg/mL, for 107 





Figure 35. CXCL8 production of 16HBE cells after co-cultured with H. 
parainfluenzae, NTHi and P. aeruginosa for 8 hours. 16HBE cells were co-cultured with 
104 cfu/mL, 105 cfu/mL, 106 cfu/mL, 107 cfu/mL and 108 cfu/mL H. parainfluenzae (n=6), 
H. parainfluenzae (n=6), NTHi (n=6) and P. aeruginosa (n=6) for 8 hours. Control was 
same volume of PBS. 100 μL of cell culture supernatant was run on each ELISA. Data is 
presented in min to max box and whisker plots. The box shows +/- IQR. The line inside 
the box is median. Y axis shows actual value of CXCL8. P-values were calculated by paired 





3.4.7 H. parainfluenzae can cause a similar range of inflammatory responses on 
16HBE cell line as P. aeruginosa  
From previous experiments, we have found that after 8 hours and at 107 cfu/mL, H. 
parainfluenzae, NTHi and P. aeruginosa can stimulate significant CXCL8 production, 
and we wanted to detect whether H. parainfluenzae would also stimulate a broad 
inflammatory response from 16HBE cells. 105 cytokines were measured after 16HBE 
cells had been co-cultured with 104 cfu/mL of H. parainfluenzae (n=6), 107 cfu/mL of 
H. parainfluenzae (n=6), 107 cfu/mL of NTHi (n=6) or 107 cfu/mL of P. aeruginosa 
(n=6) for 8 hours using a cytokine antibody microarray (Figure 36 and Figure 37). 
These bacteria were all isolated from our bronchiectasis patients’ sputum samples. The 
cytokine production levels were expressed as spots in the results of the microarray. 
The average expression levels of spot density stimulated by the four bacterial groups 
for 42 of these cytokines are shown in figure 37. There was a visible difference in the 
cytokine profile between 16HBE cells co-cultured with H. parainfluenzae at a 
concentration of 104 cfu/mL and those cultured at 107 cfu/mL. We then detected and 
semi-quantified 18 cytokines with higher production levels in the 107 cfu/mL groups 
compared to the 104 cfu/mL group: Angiopoietin 1 (ANG1), basic fibroblast growth 
factor (FGF-2), Hepatocyte growth factor (HGF), Leukemia inhibitory factor (LIF), 
angiogenin, CD40 ligand, Chemokine ligand 20 (CCL20), IL6, TNFα, CXCL1, 
Granulocyte-macrophage colony-stimulating factor (GM-csf), CXCL8, LCN2, 
Urokinase receptor (uPAR), Interleukin 24 (IL24) and ICAM-1. There was no 
difference between cells co-cultured at 107 cfu/mL of H. parainfluenzae, NTHi or P. 
aeruginosa, which suggests that H. parainfluenzae induced similar cell inflammatory 
responses as NTHi and P. aeruginosa. The same experiment has been performed twice, 






Figure 36. Cytokine array results. 16HBE cells were co-cultured with 104 cfu/mL H. 
parainfluenzae (n=6), 107 cfu/mL H. parainfluenzae (n=6), 107 cfu/mL NTHi (n=6) and 
107
 
cfu/mL P. aeruginosa (n=6) for 8 hours. 600 μL of pooled cell culture supernatant was 
run on each array. Cell culture experiment was repeated and the second array was 
performed in the same manner. a) Shows the membranes of those four groups from one 
array assay. Those membranes were exposed to X-ray for 3 minutes. b) Blue marks 
represent the cytokines that expressed in higher levels in high bacterial load cell culture 














Figure 37.  Pixel density of the cytokines measured in the cytokine array. a) Shows the 
pixel density of the blue colour marked cytokines from two separate cytokine array 
experiments. Yellow lines highlighted our interested cytokines. Pixel density were 
calculated by Image J. Heat map were generated using R. b) Average pixel density of two 





3.4.8 H. parainfluenzae induced CXCL8 production by 16 HBE cells at 8 hours in 
a similar manner as NTHi and P. aeruginosa  
CXCL8 was measured and quantified by ELISA after previous cytokine array. 12 
different clinical strains of H. parainfluenzae, NTHi and P. aeruginosa were co-
cultured with 16HBE cells for 8 hours. A low bacterial load (104 cfu/mL) of H. 
parainfluenzae did not induce a significant CXCL8 production compared to the control 
group. A high bacterial load (107 cfu/mL) of H. parainfluenzae (n=12) induced a 
significant higher CXCL8 production when co-cultured with 16HBE cells compared 
to the 104 cfu/mL group and the control group. The median CXCL8 value for the 107 
cfu/mL H. parainfluenzae group was 1711 pg/mL, and for the 104 cfu/mL H. 
parainfluenzae group it was 766.4 pg/mL, p=0.0016. P-value was calculated by paired 
t-test. NTHi (n=12) and P. aeruginosa (n=12) at 107 cfu/mL induced significantly 
more CXCL8 production compared to the control group (p=0.002 and p=0.0004 
respectively). There was no significant difference between the 107 cfu/mL H. 
parainfluenzae (1711 pg/mL), 107 cfu/mL NTHi (1267 pg/mL) and 107 cfu/mL P. 































































































Figure 38. CXCL8 production from 16HBE cells after co-cultured with 10
7
 cfu/ml H. 
parainfluenzae, NTHi and P. aeruginosa. 16HBE cells were co-cultured with 104 cfu/mL 
H. parainfluenzae (n=12), 107 cfu/mL H. parainfluenzae (n=12), 107 cfu/mL NTHi (n=12) 
and 107 cfu/mL P. aeruginosa (n=12) for 8 hours. Control group was cultured with same 
volume of PBS. 100 μL of cell culture supernatant was run on each ELISA. Data are 
presented in min to max box and whisker plots. The box shows +/- IQR. The line inside 
the box is median. Y axis shows actual value of CXCL8. P-value between 104 cfu/mL H. 
parainfluenzae and 107 cfu/mL H. parainfluenzae was calculated by paired t-test. The rest 




3.4.9 H. parainfluenzae induced CXCL1 production by 16 HBE cells at 8 hours in 
a similar manner as NTHi and P. aeruginosa 
Similar to CXCL8, 104 cfu/mL H. parainfluenzae did not induce significant CXCL1 
production compared to the control group. High bacterial load (107 cfu/mL) of H. 
parainfluenzae (n=12) induced significant higher CXCL1 from 16HBE cells compared 
to 104 cfu/mL H. parainfluenzae. Median CXCL1 value for 107 cfu/mL H. 
parainfluenzae group was 986.3 pg/mL, for 104 cfu/mL H. parainfluenzae group was 
176.4 pg/mL. P-value (p=0.003) was calculated by paired t-test.   
NTHi (n=12) and P. aeruginosa (n=12) at 107 cfu/mL induced significantly more 
CXCL1 production than the control group (p=0.01 and p=0.001 respectively). There 
was no significant difference between 107 cfu/mL H. parainfluenzae (986.3 pg/mL), 
NTHi (813.2 pg/mL) and P. aeruginosa (1092 pg/mL). P-value was calculated by 
unpaired t-test. (Figure 39) 
 
  
Figure 39. CXCL1 production from 16HBE cells after co-cultured with 10
7
 cfu/ml H. 
parainfluenzae, NTHi and P. aeruginosa. 16HBE cells were co-cultured with 104 cfu/mL 
H. parainfluenzae (n=12), 107 cfu/mL H. parainfluenzae (n=12), 107 cfu/mL NTHi (n=12) 
and 107 cfu/mL P. aeruginosa (n=12) for 8 hours. Control group was cultured with same 
volume of PBS. 100 μL of cell culture supernatant was run on each ELISA. Data are 
presented in min to max box and whisker plots. The box shows +/- IQR. The line inside 
the box is median. Y axis shows actual value of CXCL1. P-value between 104 cfu/mL H. 
parainfluenzae and 107 cfu/mL H. parainfluenzae was calculated by paired t-test. The rest 

























































































3.4.10 H. parainfluenzae induced LCN2 production by 16 HBE cells at 8 hours in 
a similar manner as NTHi and P. aeruginosa 
104 cfu/mL H. parainfluenzae did not induce significant LCN2 production compared 
to the control group. High bacterial load (107 cfu/mL) of H. parainfluenzae (n=12) 
induced significant more LCN2 when co-cultured with 16HBE cells compared to 104 
cfu/mL. Median LCN2 value for 107 cfu/mL H. parainfluenzae group was 76.7 pg/mL, 
for 104 cfu/mL H. parainfluenzae group was 65.6 pg/mL. P-value (p=0.01) was 
calculated by paired t-test.  
 P. aeruginosa (n=12) at 107 cfu/mL can induce significant LCN2 production 
compared to the control group (p=0.017). There was no significant difference between 
107 cfu/mL H. parainfluenzae (76.7 pg/mL), NTHi (151.7 pg/mL) and P. aeruginosa 
(371.1 pg/mL). P-value was calculated by unpaired t-test. (Figure 40)  
 
  
Figure 40. LCN2 production from 16HBE cells after co-cultured with 10
7
 cfu/ml H. 
parainfluenzae, NTHi and P. aeruginosa. 16HBE cells were co-cultured with 104 cfu/mL 
H. parainfluenzae (n=12), 107 cfu/mL H. parainfluenzae (n=12), 107 cfu/mL NTHi (n=12) 
and 107 cfu/mL P. aeruginosa (n=12) for 8 hours. Control group was co-cultured with same 
volume of PBS. 100 μL of cell culture supernatant was run on each ELISA. Data are 
presented in min to max box and whisker plots. The box shows +/- IQR. The line inside 
the box is median. Y axis shows actual value of LCN2. P-value between 104 cfu/mL H. 
parainfluenzae and 107 cfu/mL H. parainfluenzae was calculated by paired t-test. The rest 






















































































3.4.11 H. parainfluenzae induced ICAM-1 production from 16 HBE cells at 8 
hours in a similar manner as NTHi and P. aeruginosa 
104 cfu/mL H. parainfluenzae did not induce significant ICAM-1 production to 
compared to the control group. 107 cfu/mL H. parainfluenzae (n=12) induced 
significant more ICAM-1 when co-cultured with 16HBE cells compared to 104 cfu/mL. 
Median ICAM-1 value for 107 cfu/mL H. parainfluenzae group was 64.7 pg/mL, for 
104 cfu/mL H. parainfluenzae group was 42.3 pg/mL. P-value (p=0.002) was 
calculated by paired t-test.  
NTHi (n=12) and P. aeruginosa (n=12) in 107 cfu/mL induced significantly more 
ICAM-1 production than the control group (p=0.02 and p=0.006 respectively). There 
was no significant difference between 107 cfu/mL H. parainfluenzae (64.7 pg/mL), 
NTHi (54.1 pg/mL) and P. aeruginosa (56.3 pg/mL). P-value was calculated by 
unpaired t-test. (Figure 41) 
 
  
Figure 41. ICAM-1 production from 16HBE cells after co-cultured with 10
7
 cfu/ml H. 
parainfluenzae, NTHi and P. aeruginosa. 16HBE cells were co-cultured with 104 cfu/mL 
H. parainfluenzae (n=12), 107 cfu/mL H. parainfluenzae (n=12), 107 cfu/mL NTHi (n=12) 
and 107 cfu/mL P. aeruginosa (n=12) for 8 hours. Control group was cultured with same 
volume of PBS. 100 μL of cell culture supernatant was run on each ELISA. Data are 
presented in min to max box and whisker plots. The box shows +/- IQR. The line inside 
the box is median. Y axis shows actual value of ICAM-1. P-value between 104 cfu/mL H. 
parainfluenzae and 107 cfu/mL H. parainfluenzae was calculated by paired t-test. The rest 



















































































3.4.12 16HBE cell did not produce significant level of IL1β  
Cytokine array results showed there was no production of IL1β from16HBE cells in 
both bacteria groups: H. parainfluenzae at 107 cfu/mL, NTHi at 107 cfu/mL and P. 
aeruginosa at107 cfu/mL. We confirmed this result using the ELISA test. 
There was no detectable production of IL1β when 16HBE cells were cultured with 
PBS or with 105 cfu/mL to 107 cfu/mL of H. parainfluenzae (n=6). When cells co-
cultured with 108 cfu/mL H. parainfluenzae, there was increased production of IL1β, 
but iss not statistically significant compared to the control group. 
When 16HBE cells were cultured with a different bacterial load of NTHi (n=6), there 
was no IL1β detected by ELISA (Figure 42a).   
Similar to H. parainfluenzae, when 16HBE cells co-cultured with P. aeruginosa (n=6), 
there was no detectable IL1β production at control, 105 cfu/mL, 106 cfu/mL and 107 
cfu/mL groups. There was very low and not significant production of IL1β at 108 







Figure 42. IL1β production from 16HBE cells after co-cultured with 107 cfu/ml H. 
parainfluenzae, NTHi and P. aeruginosa.16HBE cells were co-cultured with 105 cfu/mL, 
106 cfu/mL, 107 cfu/mL and 108 cfu/mL H. parainfluenzae (n=6), H. parainfluenzae (n=6), 
NTHi (n=6) and P. aeruginosa (n=6) for 8 hours. Control group was cultured with same 
volume of PBS. 100 μL of cell culture supernatant was run on each ELISA. Data are 
presented in min to max box and whisker plots. The box shows +/- IQR. The line inside 
the box is median. Y axis shows actual value of IL1β . P-values were calculated by 








































































































































3.4.13 Different subtypes of H. parainfluenzae induced similar inflammatory 
effects on 16HBE cells 
In bronchiectasis patients, various H. parainfluenzae subtypes were isolated from 
patients’ sputum samples. We wanted to elucidate whether different subtypes of H. 
parainfluenzae would have different inflammatory effects on 16HBE cells.  
There was no significant difference in CXCL1 and CXCL8 production between 
different H. parainfluenzae subtypes. P-value was calculated using 1-way ANOVA. 
However, only one strain of type IV H. parainfluenzae and two strains of type VII H. 
parainfluenzae were identified; a higher availability of strains may change the P-value. 
The median CXCL8 fold change compared to the control group for subtype I was 1.42, 
for subtype II, 1.5; for subtype III, 1.9; subtype IV, 1.14; subtype V, 1.34, and for 
subtype VII, 1.1. The median CXCL1 fold change for subtype I was 1.374; for subtype 
II, 1.429; for subtype III, 1.633; for subtype IV, 1.077; for subtype V, 2.848, and for 
subtype VII, 2.524. 
  
Figure 43. CXCL8 and CXCL1 production from 16HBE cells after co-cultured with 
10
7
 cfu/ml of different subtypes of H. parainfluenzae. 16HBE cells were co-cultured with 
107 cfu/mL type I H. parainfluenzae (n=5), type II H. parainfluenzae (n=5), type III H. 
parainfluenzae (n=5), type IV H. parainfluenzae (n=1), type V H. parainfluenzae (n=5) 
and type VII H. parainfluenzae (n=1) for 8 hours. 100 μL of cell culture supernatant was 
run on each ELISA. Data are presented in min to max box and whisker plots. The box 
shows +/- IRQ. The line inside the box is median. Y axis shows fold change of CXCL8 




3.4.14 Heat-killed H. parainfluenzae triggered significant inflammatory responses 
on 16HBE cells 
LPS is the main virulence factor of Haemophilus species. To confirm this, we co-
cultured 16HBE cells with 6 different clinical strains of heat-killed H. parainfluenzae, 
NTHi and P. aeruginosa for 8 hours. 
Heat-treated H. parainfluenzae and NTHi induced significant CXCL8 production 
(p=0.053 and p=0.08 respectively). Compared to non-heat-treated H. parainfluenzae, 
NTHi and P. aeruginosa; the heat-treated bacteria shows a stronger ability at inducing 
CXCL8 production in 16HBE cells, although it is not statistically significant (p=0.053, 
p=0.08 and p=0.37 respectively) (Figure 44). 




















































































































Figure 44. CXCL8 production from 16HBE cells after co-cultured with heat treated 
H. parainfluenzae, NTHi and P. aeruginosa. 16HBE cells were co-cultured with 107 
cfu/mL non heat-treated H. parainfluenzae (n=6), heat-treated H. parainfluenzae (n=6), 
non-heat-treated NTHi (n=6), heat-treated NTHi (n=6), non-heat-treated P. aeruginosa and 
heat-treated P. aeruginosa for 8 hours. 100 μL of cell culture supernatant was run on each 
ELISA. Data are presented in min to max box and whisker plots. The box shows +/- IQR. 
The line inside the box is median. Y axis shows actual CXCL8 level. P-value was 




3.4.15 H. parainfluenzae viability after co-cultured with 16HBE cells 
Besides the inflammatory responses from 16HBE cells induced by H. parainfluenzae. 
We also looked into the bacterial viability of H. parainfluenzae after co-cultured with 
16HBE cells. 107 cfu/mL H. parainfluenzae (n=3) and NTHi(n=3) were co-cultured 
with 16HBE cells for 10 minutes, 20 minutes, 50 minutes, 90 minutes, 150 minutes 
and 300 minutes and 480 minutes. There was no significant difference in the outer 
cellular bacterial load between these two Haemophilus species. After 90 minutes co-
cultured with 16HBE cells, the number of H. parainfluenzae and NTHi both decreased. 
After 480 minutes (8 hours), both bacterial loads dropped to 0 (Figure 45 a). As 
background control, 107 cfu/mL H. parainfluenzae (n=3) or NTHi (n=3) were cultured 
in cell media without 16HBE cells for 8 hours. After 8 hours, bacterial loads of NTHi 
and H. parainfluenzae did not significantly change compared to the original bacterial 





































a) With 16HBE cells  
b) Without 16HBE cells  
Figure 45. H. parainfluenzae viability after co-cultured with 16HBE cells. a) 
16HBE cells were co-cultured with 107 cfu/mL H. parainfluenzae (n=3) or NTHi (n=3)for 
10 minutes, 20 minutes, 50 minutes, 90 minutes, 150 minutes and 300 minutes and 480 
minutes. b) 107 cfu/mL H. parainfluenzae (n=3) or NTHi (n=3) were cultured in cell media 
without 16HBE cells for 8 hours. Cell culture supernatant was collected and diluted, 100 
µL diluted supernatant was plated on CBA plates. Bacterial load was calculated according 
to colony numbers on the plates after 24 hours incubation. Y axis shows bacterial load for 




3.4.16 NHBE cells’ CXCL8 production induced by H. parainfluenzae was 
culture time-dependent 
Besides 16HBE cells, we also looked into how primary human bronchial epithelial 
cells reacted to H. parainfluenzae. 6 different clinical strains of H. parainfluenzae, 
NTHi and P. aeruginosa were co-cultured with NHBE cells. 
NHBE cells were co-cultured with 107 cfu/mL H. parainfluenzae, NTHi or P. 
aeruginosa for 2 hours, 4 hours, 6 hours and 8 hours. 1-way ANOVA test shows a 
significant overall increase of CXCL8 with time increasing (H. parainfluenzae p=0.04, 
NTHi p=0.01 and P. aeruginosa p=0.016 respectively). CXCL8 production at 8 hours 
was significantly higher than at 2 hours for H. parainfluenzae, NTHi and P. aeruginosa 
groups (p=0.004, p=0.035 and p=0.014 respectively). The median CXCL8 fold change 
for H. parainfluenzae at 2 hours was 0.9, at 4 hours was 0.99, at 6 hours was 1.0 and 
at 8 hours was 1.2; for NTHi at 2 hours was 0.9, at 4 hours was 0.89, at 6 hours was 
1.18 and at 8 hours was 1.12; for P. aeruginosa at 2 hours was 0.9, at 4 hours was 1.5, 






   
Figure 46. CXCL8 production from NHBE cells after co-cultured with H. 
parainfluenzae, NTHi and P. aeruginosa for 2 hours, 4 hours, 6 hours and 8 hours. 
NHBE cells were co-cultured with a) 107 cfu/mL H. parainfluenzae, b) 107 cfu/mL NTHi 
and c) 107 cfu/mL P. aeruginosa (n=6) for 2 hours, 4 hours, 6 hours and 8 hours, control 
group was cultured with same volume of PBS. 100 μL of cell culture supernatant was run 
on each ELISA. Data are presented in min to max box and whisker plots. The box shows 
+/- IQR. The line inside the box is median. Y axis shows fold change of CXCL8 compared 
to the control group. P-values between individual time points were calculated by paired t-




3.4.17 NHBE CXCL1 production induced by H. parainfluenzae was culture time 
related 
We also measured CXCL1 production. Similarly, after NHBE cells co-cultured with 
H. parainfluenzae, NTHi or P. aeruginosa for a different time, 1-way ANOVA test 
shows a significant overall increase of CXCL1 production with time increasing 
(p=0.0018, p=0.007 and p=0.003 respectively). Different from CXCL8, CXCL1 
production was more significant at 6 hours rather than at 8 hours when compared to 2 
hours (p=0.006, p=0.0004 and p=0.005 respectively). The median CXCL1 fold change 
for H. parainfluenzae at 2 hours was 1.1, at 4 hours was 0.94, at 6 hours was 1.5 and 
at 8 hours was 1.3; for NTHi at 2 hours was 1.1, at 4 hours was 0.93, at 6 hours was 
1.35 and at 8 hours was 1.28; for P. aeruginosa at 2 hours was 1.01, at 4 hours was 
1.20, at 6 hours was 1.93 and at 8 hours was 1.40 (Figure 47). 
  Figure 47. CXCL1 production from NHBE cells after co-cultured with H. 
parainfluenzae, NTHi and P. aeruginosa for 2 hours, 4 hours, 6 hours and 8 hours. 
NHBE cells were co-cultured with 107 cfu/mL H. parainfluenzae, NTHi and P. aeruginosa 
(n=6) for 2 hours, 4 hours, 6 hours and 8 hours, control group was cultured with same 
volume of PBS. 100 μL of cell culture supernatant was run on each ELISA. Data are 
presented in min to max box and whisker plots. The box shows +/- IQR. The line inside 
the box is median. Y axis shows change fold of CXCL1 compare to control group. P-values 
between individual time points were calculated by paired t-test. P-value for overall 

















































3.4.18 H. parainfluenzae induced significant inflammatory responses from 
NHBE in a similar manner as NTHi and P. aeruginosa 
H. parainfluenzae (n=6) induced significant more CXCL8, CXCL1 and ICAM-1 when 
co-cultured with NHBE cells at 107 cfu/mL compared to 104 cfu/mL (CXCL8 p=0.009, 
CXCL1 p=0.04 and ICAM p=0.04 respectively). 107 cfu/mL H. parainfluenzae also 
induced significantly higher CXCL8, CXCL1 and ICAM-1 production compared to 
the control group (CXCL8 p=0.02, CXCL1 p=0.033 and ICAM p=0.02 respectively). 
The median CXCL8 value for 107 cfu/mL H. parainfluenzae group was 249.1 pg/mL, 
for 104 cfu/mL H. parainfluenzae group was 155.4 pg/mL, for the control group was 
134.5 pg/mL. The median CXCL1 value for 107 cfu/mL group was 1898 pg/mL, for 
104 cfu/mL group was 1663pg/mL, for the control group was 1527 pg/mL. The median 
ICAM-1 value for 107 cfu/mL group was 1077 pg/mL, for 104 cfu/mL group was 681.1 
pg/mL, for the control group was 528.4 pg/mL (Figure 48a). 
P. aeruginosa (n=6) also induced significantly higher CXCL8, CXCL1 and ICAM-1 
when co-cultured with NHBE cells in 107 cfu/mL compared to the control group 
(CXCL8 p=0.017, CXCL1 p=0.027 and ICAM-1 p=0.025 respectively) (Figure 47b). 
NTHi (n=6) induced significant higher CXCL8 and ICAM-1 when co-cultured with 
NHBE cells in 107 cfu/mL compared to the control group (CXCL8 p=0.04, ICAM-1 
p=0.036). However, we did not observe a similar statistically significant induction for 






Figure 48. CXCL8, CXCL1 and ICAM-1 production from NHBE cells after co-
cultured with 10
7
 cfu/mL H. parainfluenzae, NTHi and P. aeruginosa. NHBE cells were 
co-cultured with 104 cfu/mL H. parainfluenzae (n=6), 107 cfu/mL H. parainfluenzae (n=6), 
107 cfu/mL NTHi (n=6) and 107 cfu/mL P. aeruginosa (n=6) for 8 hours. Control group 
was cultured with same volume of PBS. 100 μL of cell culture supernatant was run on each 
ELISA. Data is presented in min to max box and whisker plots. The box shows +/- IQR. 
The line inside the box is median. Y axis shows actual value of CXCL8, CXCL1 and 
ICAM-1. P-value was calculated by unpaired t-test between individual groups and 1 way 
ANOVA between 107 cfu/mL H. parainfluenzae, 107 cfu/mL NTHi and 107 cfu/mL P. 




3.4.19 Patients’ primary human nasal epithelial cells 
We have observed that H. parainfluenzae induced significant cell inflammatory 
responses from the 16HBE cell line and NHBE cells. We wanted to see if it would 
have a similar effect on bronchiectasis patient primary cells, so patient primary nasal 
primary cells were collected from patients in the Royal Infirmary and cultured in the 
laboratory, and eventually co-cultured with H. parainfluenzae, NTHi and P. 
aeruginosa.  
Ten patients were recruited from the bronchiectasis clinic, they were all more than 18 
years old, have been clinically stable for at least 21 days, they did not have severe 
asthma, rhinitis (require nasal steroid), and not on anti-coagulants. They were not 





3.4.19.1 Patients’ primary human nasal epithelial cells culture 
After cells were collected and cultured in cell media, cells usually started to attach to 
the plates and had initial growth within two days. Figure 49 shows the image of cells 
after cultured for four days and seven days.  
There was a difference in the growth speed between different samples. Five strains of 
cells out of ten patients’ samples survived until passage 2. Bacteria culture experiments 
were done at passage 2. After passage 3, cells started to became swollen and grew at 
slow speed or even stopped growing.     
  
Figure 49. Patients’ primary human nasal epithelial cells under microscope at 10×10 
magnification. Patients’ primary human nasal epithelial cells were cultured for 4 days 




3.4.19.2 Patients’ primary human nasal epithelial cells’ CXCL8 and CXCL1 
production induced by H. parainfluenzae was culture time-dependent  
Five patients’ nasal epithelial cell strains were co-cultured with 3 different clinical H. 
parainfluenzae strains at 107 cfu/mL for 2 hours, 4 hours, 6 hours and 8 hours. 1-way 
ANOVA test shows a significant overall increase of CXCL8 and CXCL1 levels with 
time (p=0.019 and p=0.02 respectively). CXCL8 and CXCL1 production at 8 hours 
was significantly higher than at 2 hours (p=0.014 and p=0.014 respectively). The 
median CXCL8 fold change at 2 hours was 1.02, at 4 hours 1.01, at 6 hours 1.2 and at 
8 hours 1.35; fold changes for CXCL1 were: at 2 hours 1.02, at 4 hours 1.01, at 6 hours 





Figure 50. CXCL8 and CXCL1 production from patients’ nasal epithelial cells after 
co-cultured with H. parainfluenzae for 2 hours, 4 hours, 6 hours and 8 hours. Five 
strains of patients’ primary human nasal epithelial cells were co-cultured with 107 cfu/mL 
H. parainfluenzae (n=3) for 2 hours, 4 hours, 6 hours and 8 hours, control was cultured 
with same volume of PBS. 100 μL of cell culture supernatant was run on each ELISA. a) 
and b) show the CXCL8 and CXCL1 values pooled results from all cells. Data are 
presented in min to max box and whisker plots. The box shows +/- IQR. The line inside 
the box is median. Y axis shows fold change of CXCL8 and CXCL1compared to the 
control group. P-values between individual time points were calculated by paired t-test. P-




3.4.19.3 Patients’ primary human nasal epithelial cells CXCL8 and CXCL1 
production induced by NTHi was culture time-dependent  
Five strains of patients’ nasal epithelial cells were co-cultured with 107 cfu/mL NTHi 
(n=3) for 2 hours, 4 hours, 6 hours and 8 hours. 1-way ANOVA test shows a significant 
overall increase of CXCL8 and CXCL1 levels with time increasing (p=0.04 and 
p=0.03 respectively). CXCL8 and CXCL1 productions at 8 hours were significantly 
higher than at 2 hours (p=0.02 and p=0.0006 respectively). At 6 hours, NTHi also can 
stimulate significant CXCL1 production compared to 2 hours (p=0.03). The median 
CXCL8 fold change at 2 hours was 1.01, at 4 hours was 1.05, at 6 hours was 1.22 and 
at 8 hours was 1.57; for CXCL1 at 2 hours was 0.86, at 4 hours was 1.09, at 6 hours 




Figure 51. CXCL8 and CXCL1 production from patients’ nasal epithelial cells after 
co-cultured with NTHi for 2 hours, 4 hours, 6 hours and 8 hours. Five strains of 
patients’ primary human nasal epithelial cells were co-cultured with 107 cfu/mL NTHi 
(n=3) for 2 hours, 4 hours, 6 hours and 8 hours, control group was cultured with same 
volume of PBS. 100 μL of cell culture supernatant was run on each ELISA. a) and b) show 
the CXCL8 and CXCL1 values from pooled results from all cells. Data are presented in 
min to max box and whisker plots. The box shows +/- IQR. The line inside the box is 
median. Y axis shows fold change of CXCL8 and CXCL1 compared to control group. P-
values between individual time points were calculated by paired t-test. P-value for overall 




3.4.19.4 Patients’ primary human nasal epithelial cells CXCL8 and CXCL1 
production induced by P. aeruginosa was culture time-dependent 
 Five strains of patients’ nasal epithelial cells were co-cultured with 107 cfu/mL P. 
aeruginosa (n=3) for 2 hours, 4 hours, 6 hours and 8 hours. 1-way ANOVA test shows 
a significant overall increase of CXCL8 and CXCL1 level with time increasing 
(p=0.02 and p=0.004 respectively). CXCL8 and CXCL1 productions at 8 hours were 
significantly higher than at 2 hours (p=0.01 and p=0.0009 respectively). P. aeruginosa 
also can trigger significantly more CXCL8 production at 4 hours and 6 hours compared 
to 2 hours (p=0.02, p=0.003). The median CXCL8 fold change for at 2 hours was 1.26, 
at 4 hours was 1.75, at 6 hours was 3.20 and at 8 hours was 3.32; for CXCL1 at 2 hours 
was 1.25, at 4 hours was 1.30, at 6 hours was 1.86 and at 8 hours was 2.10 (Figure 52). 
  Figure 52. CXCL8 and CXCL1 production from patients’ nasal epithelial cells after 
co-cultured with P. aeruginosa for 2 hours, 4 hours, 6 hours and 8 hours. Five strains 
of patients’ primary human nasal epithelial cells were co-cultured with 107 cfu/mL P. 
aeruginosa (n=3) for 2 hours, 4 hours, 6 hours and 8 hours, control group was cultured with 
same volume of PBS. 100 μL of cell culture supernatant was run on each ELISA. a) and b) 
show the CXCL8 values from individual cells. c) shows the pooled results from all cells. 
Data is presented in min to max box and whisker plots. The box shows +/- IQR. The line 
inside the box is median. Y axis shows fold change of CXCL8 compare to control group. 
P-values between individual time points were calculated by paired t-test. P-value for overall 




3.4.19.5 H. parainfluenzae induced inflammatory responses in patients’ nasal 
epithelial cells in a similar manner as NTHi and P. aeruginosa  
H. parainfluenzae (n=3) at 107 cfu/mL induced significantly more CXCL8, CXCL1 
and ICAM-1 production when co-cultured with five different strains of patients’ nasal 
epithelial cells compare to the negative control. Similarly, to other epithelial cells 
(CXCL8 p=0.038, CXCL1 p=0.0005, ICAM-1 p=0.0001). There was significantly 
more CXCL8, CXCL1 and ICAM-1 production when cells were co-cultured with 107 
cfu/mL H. parainfluenzae compared 104 cfu/mL of H. parainfluenzae (CXCL8 p=0.04, 
CXCL1 p=0.03 and ICAM-1 p=0.0001 respectively). 104 cfu/mL H. parainfluenzae 
did not induce significant CXCL8, CXCL1 and ICAM-1 production compared to the 
control group. The median CXCL8 value for 107 cfu/mL H. parainfluenzae group was 
319.9 pg/mL, for 104 cfu/mL H. parainfluenzae group was 171.6 pg/mL, for control 
group was 187.1 pg/mL. The median CXCL1 value for 107 cfu/mL group was 1271 
pg/mL, for 104 cfu/mL group was 1048 pg/mL, for control group was 777.3 pg/mL. 
The median ICAM-1 value for 107 cfu/mL group was 315.4 pg/mL, for 104 cfu/mL 
group was 249 pg/mL, for control group was 183.1 pg/mL (Figure 53). 
P. aeruginosa (n=3) also induced significantly more CXCL8, CXCL1 and ICAM-1 
production when co-culture with patients’ primary human nasal epithelial cells (n=5) 
at 107 cfu/mL compared the negative control (CXCL8 p=0.017, CXCL1 p=0.0002 and 
ICAM-1 p=0.0001 respectively). P-value was calculated using an unpaired t-test 
(Figure 53). 
NTHi (n=3) induced significantly more CXCL1 and ICAM-1 production from patients’ 
primary human nasal epithelial cells (n=5) at 107 cfu/mL (CXCL1 p=0.004 and ICAM-
1 p=0.0002 respectively). P-value was calculated by unpaired t-test (Figure 53). 
There was no significant difference in the CXCL8, CXCL1 and ICAM-1 level when 
patients’ primary human nasal epithelial cells were co-cultured with 107 cfu/mL H. 





Figure 53. CXCL8, CXCL1 and ICAM-1 production from patients’ nasal epithelial 
cells after co-cultured with H. parainfluenzae, NTHi and P. aeruginosa for 8 hours. 
Five strains of patients’ nasal epithelial cells were co-cultured with 104 cfu/mL H. 
parainfluenzae (n=3), 107 cfu/mL H. parainfluenzae (n=3), 107 cfu/mL NTHi (n=3) and 
107 cfu/mL P. aeruginosa (n=3) for 8 hours. Control group was cultured with same volume 
of PBS. 100 μL of cell culture supernatant was run on each ELISA. a), b) and c) show the 
pooled results from all cells.  Data are presented in Tukey box and whisker plots. The box 
shows +/- IQR. The line inside the box is median. Y axis shows actual value of CXCL8 
and CXCL1. P-value was calculated using unpaired t-test between individual groups and 1 
way ANOVA between 107 cfu/mL H. parainfluenzae, 107 cfu/mL NTHi and 107 cfu/mL 





3.4.20 Conclusion for aim 4 
 According to the microarray results, H. parainfluenzae at 107cfu/mL 
stimulated wide range of inflammatory responses in 16 HBE cell after 8 hours 
of culture. 
 There was a dose-response from 104 cfu/mL to 108 cfu/mL for H. 
parainfluenzae, with significant increased CXCL8, CXCL1, LCN2, ICAM-1 
level at 107cfu/mL, no difference in IL1β production consistent to the 
microarray results 
 The inflammatory response was time-dependent. At 8 hours, H. parainfluenzae 
was similar to NTHi and P. aeruginosa at stimulating CXCL8 production, with 
a low cell death rate. 
 Heat-treated H. parainfluenzae stimulated higher CXCL8 production than non-
heat-treated H. parainfluenzae. 
 H. parainfluenzae subtypes stimulated similar inflammatory responses, 
although numbers were low in type IV and VII. 
 Similar dose-responses from 104 cfu/mL to 108 cfu/mL of H. parainfluenzae 
on NHBE cells and primary human nasal epithelial cells were observed.  
 Primary human nasal epithelial cells were challenging to grow, we had a 50% 
success rate. 
 Overall, we showed H. parainfluenzae in high bacterial loads can stimulate 





3.5 Results for aim 5. Assessing the impact of coinfection of H. parainfluenzae 
with P. aeruginosa and H. parainfluenzae with NTHi 
This part of the study was attempted to discover how microbiome or bacterial 
interaction impact epithelial cells inflammatory response.  
To understand multi pathogen colonisation in bronchiectasis, we analysed sputum 
microbiology results from 208 bronchiectasis patients. Those patients were all ≥ 18 
years old and had stable bronchiectasis. 
We then looked into how H. parainfluenzae and P. aeruginosa together would change 
16HBE cell inflammatory responses compared to single bacteria interaction with 




3.5.1 In bronchiectasis, 20% of patients have more than one pathogen 
colonisation  
In 208 bronchiectasis patients, 169 of them had single dominant pathogen isolated 
from sputum samples. There were 39 patients had more than one predominant 
pathogen (34 double pathogens, five triple pathogens). In those 39 patients, 
Haemophilus species and S. pneumoniae was the most prevalent combination (n=16), 
followed by Haemophilus species with Moraxella catarrhalis (n=11). P. aeruginosa 
was found to co-exist with S. pneumonia (n=4) and Moraxella catarrhalis (n=1). 
Interestingly, as the two most common pathogen, Haemophilus species had not been 
found co-exist with P. aeruginosa. P. aeruginosa, is well known for being able to 
interact with other bacteria in multiple strategies, so we decided to look into bacterial 
interaction between H. parainfluenzae with P. aeruginosa. 
The other co-exist dominant pathogens were: Serratia marcens with Escherichia coli, 
Acinetobacter with Stenotrophomonas maltophilia (S. maltophilia), yeast with S. 
pneumoniae, S. maltophilia with Klebsiella oxytoca, P. aeruginosa with Eschericia 
coli and Mould with Serratia marcescens. (Figure 54) 
  
Figure 54. Co-pathogen in bronchiectasis patients. a) 169 (81.2%) patients had single 
pathogen from their sputum samples. 39 (18.8%) patients had more than one pathogen. b) 
among these 39 patients, 16 (41%) patients had Haemophilus species with S. pneumoniae, 
11(28%) patients had Haemophilus species; 4 (2.3%) patients had P. aeruginosa and S. 
pneumonia. 1 (2.5%) patients had P. aeruginosa and M. catarrhalis. There was 7 (4.1%) 




3.5.2 H. parainfluenzae and P. aeruginosa co-cultured with 16HBE cells for 8 
hours 
16HBE cells were cultured with either H. parainfluenzae (n=12) at concentrations of 
1×105 cfu/mL and 2×105 cfu/mL or P. aeruginosa (n=12) at 1×105 cfu/mL and 2×105 
cfu/mL, as well as with both H. parainfluenzae (n=12) at 1×105 cfu/mL and P. 
aeruginosa (n=12) at 1×105 cfu/mL for 8 hours. CXCL8, CXCL1 and LCN2 
production was measured after 8 hours. In the case of CXCL8 production, there was a 
significant decrease when P. aeruginosa was co-cultured with H. parainfluenzae in 
16HBE cells compared to when P. aeruginosa was cultured on its own at 1×105 
cfu/mL or 2×105 cfu/mL (p=0.0007 and p=0.0005 respectively). The median CXCL8 
value of the 1×105 cfu/mL H. parainfluenzae group was 1206 pg/mL, the 2×105 
cfu/mL H. parainfluenzae group 1110 pg/mL, 1×105 cfu/mL P. aeruginosa group 
1450 pg/mL, 2×105 cfu/mL P. aeruginosa group 1399 pg/mL, and the mixed H. 
parainfluenzae and P. aeruginosa at 1×105 cfu/mL group 1150 pg/mL (Figure 55). 
 
 
Figure 55. CXCL8 production from 16HBE cells after co-cultured with H. 
parainfluenzae and P. aeruginosa together for 8 hours. 16HBE cells were cultured with 
1×105 cfu/mL and 2×105 cfu/mL H. parainfluenzae (n=12), 1×105 cfu/mL and 2×105 
cfu/mL P. aeruginosa (n=12), and 1×105 cfu/mL H. parainfluenzae (n=12) together with 
1×105 cfu/mL P. aeruginosa (n=12) for 8 hours. Control group was cultured with same 
volume of PBS. After 8 hours, media was then collected. Media CXCL8 level was 
measured by ELISA. Data are presented in box and whisker plots. The box shows +/- IQR. 
The line inside the box is median. P-value was calculated by paired t-test. Y axis shows the 




Similar results were found in CXCL1 and LCN2 level. There was a significant 
decrease when 1×105 cfu/mL P. aeruginosa co-culture with 16HBE cells together with 
1×105 cfu/mL H. parainfluenzae compared to 105 cfu/mL P. aeruginosa and 2×105 
cfu/mL P. aeruginosa co-cultured with 16HBE cells on its own (CXCL1 p=0.003, 
p=0.0003, LCN2 p=0.04 and p=0.003 respectively). The median CXCL1 value 1×105 
cfu/mL H. parainfluenzae group was 242.6 pg/mL, 2×105 cfu/mL H. parainfluenzae 
group was 235.3 pg/mL, 1×105 cfu/mL P. aeruginosa group was 313.9 pg/mL, 2×105 
cfu/mL P. aeruginosa group was 334.7 pg/mL, for 1×105 cfu/mL H. parainfluenzae 
together with 1×105 cfu/mL P. aeruginosa group was 263.9 pg/mL (Figure 56a). The 
median LCN2 value 1×105 cfu/mL H. parainfluenzae group was 53.8 pg/mL, 2×105 
cfu/mL H. parainfluenzae group was 33.9 pg/mL, 105 cfu/mL P. aeruginosa group 
was 87.1 pg/mL, 2×105 cfu/mL P. aeruginosa group was 159.4 pg/mL, for 105 cfu/mL 
H. parainfluenzae together with 1×105 cfu/mL P. aeruginosa group was 40.88 pg/mL 
(Figure 56b). 
Figure 56. CXCL1 and LCN2 production from 16HBE cells after co-cultured with H. 
parainfluenzae and P. aeruginosa together for 8 hours. 16HBE cells were cultured with 
105 cfu/mL and 2×105 cfu/mL H. parainfluenzae (n=12), 1×105 cfu/mL and 2×105 cfu/mL 
P. aeruginosa (n=12), and 1×105 cfu/mL H. parainfluenzae (n=12) together with 1×105 
cfu/mL P. aeruginosa (n=12) for 8 hours. Control group was cultured with same volume 
of PBS. After 8 hours, media was then collected. Media CXCL1and LCN2 levels were 
measured by ELISA. Data are presented in box and whisker plots. The box shows +/- IQR. 
The line inside the box is median. P-value was calculated by paired t-test. Y axis shows the 




3.5.3 H. parainfluenzae and P. aeruginosa co-cultured with 16HBE cells together 
for 8 hours in a higher bacterial load 
16HBE cells were cultured with 1×106 cfu/mL and 2×106 cfu/mL H. parainfluenzae 
(n=12), 1×106 cfu/mL and 2×106 P. aeruginosa (n=12), and 1×106 cfu/mL H. 
parainfluenzae (n=12) together with 1×106 cfu/mL P. aeruginosa (n=12) for 8 hours. 
In the combination group, there was no significant decrease of CXCL8 production 
compared to 1×106 cfu/mL and 2×106 cfu/mL P. aeruginosa group (p=0.58 and p=0.06 
respectively). The median CXCL8 value 1×106 cfu/mL H. parainfluenzae group was 
1567 pg/mL, 2×106 cfu/mL H. parainfluenzae group was 1701 pg/mL, 1×106 cfu/mL 
P. aeruginosa group was 2051 pg/mL, 2×106 cfu/mL P. aeruginosa group was 2428 
pg/mL, for 1×106 cfu/mL H. parainfluenzae together with 1×106 cfu/mL P. aeruginosa 
group was 2230 pg/mL. (Figure 57) 
  
Figure 57. CXCL8 production from 16HBE cells after co-cultured with H. 
parainfluenzae and P. aeruginosa together for 8 hours. 16HBE cells were cultured with 
106 cfu/mL and 2×106 cfu/mL H. parainfluenzae (n=12), 1×106 cfu/mL and 2×106 cfu/mL 
P. aeruginosa (n=12), and 1×106 cfu/mL H. parainfluenzae (n=12) together with 1×106 
cfu/mL P. aeruginosa (n=12) for 8 hours. Control group was same volume of PBS. After 
8 hours, media was then collected. Media CXCL8 level was measured by ELISA. Data is 
presented in box and whisker plots. The box shows +/- IQR. The line inside the box is 




3.5.4 H. parainfluenzae and NTHi co-cultured with 16HBE cells together for 8 
hours at different bacterial loads 
16HBE cells were cultured with NTHi at different bacterial load (from 103 cfu/mL to 
108 cfu/mL). Those cells were also cultured with 1×105 cfu/mL H. parainfluenzae or 
the same volume of PBS. After 8 hours, CXCL8 production was measured, there was 
no difference between the cells cultured with only NTHi or with both NTHi and H. 




Figure 58. CXCL8 production from 16HBE cells after co-cultured with H. 
parainfluenzae and NTHi together for 8 hours.16HBE cells were cultured with NTHi in 
different bacterial load (from 103 cfu/mL to 108 cfu/mL). Those cells were also cultured 
with 1×105 cfu/mL H. parainfluenzae (+) or same volume of PBS (-).  After 8 hours, media 
was then collected. Media CXCL8 level was measured by ELISA. Data are presented in 
min to max box and whisker plots. The box shows +/- IQR. The line inside the box is 
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3.5.5 Heat-treated H. parainfluenzae and P. aeruginosa co-cultured with 16HBE 
cells together 
To investigate the mechanism behind the decreased inflammatory responses in the H. 
parainfluenzae and P. aeruginosa combined group, we co-cultured 16HBE cells with 
heat-treated H. parainfluenzae (n=6) and P. aeruginosa (n=6). 80 ºC water bath for 
one-hour kills bacteria. However, their LPS are heat-stable endotoxins. The results 
showed that there was no significant difference in CXCL8 and CXCL1 production 
between heat-treated H. parainfluenzae with heat-treated P. aeruginosa combined 
group and heat-treated P. aeruginosa group. This result suggested that the decreasing 




Figure 59. CXCL8 and CXCL1 production from 16HBE cells after co-cultured with 
heated treated H. parainfluenzae and P. aeruginosa together for 8 hours.16HBE cells 
were cultured with heat treated 1×105 cfu/mL H. parainfluenzae (n=6), 1×105 cfu/mL P. 
aeruginosa (n=6), and 105 cfu/mL H. parainfluenzae (n=6) together with 105 cfu/mL P. 
aeruginosa (n=6) for 8 hours. Control group was cultured with same volume of PBS. After 
8 hours, media was then collected. Media CXCL8 level was measured by ELISA. Data are 
presented in box and whisker plots. The box shows +/- IQR. The line inside the box is 
median. P-value was calculated by paired t-test. Y axis shows the actual value of CXCL8 




3.5.6 H. parainfluenzae and non-PCN P. aeruginosa co-cultured with 16HBE cells 
together for 8 hours 
PCN is an important virulence factor of P. aeruginosa; it interferes with multiple 
cellular functions in P. aeruginosa. We proposed that PCN may play a role in the 
decreasing effect found in the combined group. 16HBE cells were co-cultured with 
1×105 cfu/mL 6 different strains of H. parainfluenzae, 1×105 cfu/mL 6 different strains 
of non-PCN P. aeruginosa, as well as 1×105 cfu/mL H. parainfluenzae together with 
1×105 cfu/mL non-PCN P. aeruginosa for 8 hours. CXCL8 and CXCL1 were 
measured.  
In the combination group, there was still a significant decrease of CXCL8 (p=0.02) 
and CXCL1 (p=0.02) production compares to non-PCN P. aeruginosa alone group. 
The median CXCL8 and CXCL1 value for non-PCN P. aeruginosa group were 1636 
pg/mL and 567 pg/mL, for H. parainfluenzae and non-PCN P. aeruginosa group was 




Figure 60. CXCL8 and CXCL1 production from 16HBE cells after co-cultured with 
H. parainfluenzae and non-PCN P. aeruginosa together for 8 hours.16HBE cells were 
cultured with 1×105 cfu/mL H. parainfluenzae (n=6), 1×105 cfu/mL non PCN P. 
aeruginosa (n=6), and 105 cfu/mL H. parainfluenzae (n=6) together with 105 cfu/mL non 
PCN P. aeruginosa (n=6) for 8 hours. Control group was cultured with same volume of 
PBS. After 8 hours, media was then collected. Media CXCL1and CXCL8 levels were 
measured by ELISA. Data are presented in min to max box and whisker plots. The box 
shows +/- IRQ. The line inside the box is median. P-value was calculated by paired t-test. 




3.5.7 H. parainfluenzae co-cultured with 16HBE cells with media that had 
cultured cells and P. aeruginosa 
From previous results, we proposed that bacterial interaction between P. aeruginosa 
and H. parainfluenzae may lead to a decrease of CXCL8 and CXCL1 production. 
Bacterial interaction can be direct interaction or indirect interaction. P. aeruginosa are 
already known for being able to produce outer membrane proteins, outer membrane 
vesicles and toxins, P. aeruginosa are also very well researched about its quorum 
sensing pathway (Soukarieh F et al). Hence, we decided to look into the indirect 
interaction between H. parainfluenzae and P. aeruginosa.   
With this purpose, we tried to mimic an indirect interaction situation between H. 
parainfluenzae and P. aeruginosa. We co-cultured 1×105 cfu/mL H. parainfluenzae 
and 16HBE cells in the media that has cultured 16HBE cells and 1×105 cfu/mL P. 
aeruginosa (P. aeruginosa media). In this way, H. parainfluenzae and cells were 
exposed to proteins or chemicals or DNA that produced by P. aeruginosa instead of 
directly in contact with P. aeruginosa. After 8 hours co-culture, the supernatant was 
collected, and CXCL8 and CXCL1 levels were measured. Results for this group is 
column C in figure 61. 
H. parainfluenzae and 16HBE cells were also cultured in media that has cultured only 
16HBE cells (cell media) as a comparison. Results for this group is shown as column 
A in figure 61. 
Control group was 16HBE cells cultured with 1×105 cfu/mL H. parainfluenzae in fresh 
media; this group is column E in figure 61. For background control, we cultured cells 
with those different media without the presence of H. parainfluenzae, those groups are 
column D (with P. aeruginosa media), column B (with cell media) and column F (with 
fresh media) in figure 61.  
From CXCL8 and CXCL1 results, 16HBE cells and H. parainfluenzae that were 
cultured in P. aeruginosa media (column C) significantly reduced the CXCL8, and 
CXCL1 production compared to the 16HBE cells and H. parainfluenzae that were 
cultured in cell media group (column A) (CXCL8 p=0.0017 and CXCL1 p=0.027 




A was 2739 pg/mL. The median CXCL1 value for column C was 910.5 pg/mL, for 
column A was 1210 pg/mL (Figure 61). 
Figure 61. CXCL8 and CXCL1 production from 16HBE cells after cultured with H. 
parainfluenzae in P. aeruginosa media for 8 hours. 16HBE cells were cultured with 105 
cfu/mL H. parainfluenzae (n=6) in different media for 8 hours. After 8 hours, media was 
then collected. Media CXCL1 and CXCL8 levels were measured by ELISA. Data are 
presented in box and whisker plots. The box shows +/- IQR. The line inside the box is 
median. P-value was calculated by paired t-test. Y axis shows the actual value of CXCL8 




3.5.8 P. aeruginosa co-cultured with 16HBE cells with media that had cultured 
cells and H. parainfluenzae 
We also co-cultured 1×105 cfu/mL P. aeruginosa and 16HBE cells in media that had 
cultured 16HBE cells and H. parainfluenzae (H. parainfluenzae media), show as 
column B in Figure 56.   
P. aeruginosa and 16HBE cells were also cultured in media that has cultured only 
16HBE cells (cell media) as a comparison, show as column A in Figure 62. 
Control group was 16HBE cells cultured with 1×105 cfu/mL P. aeruginosa in fresh 
media, show as column C in Figure 62. 
From CXCL8 and CXCL1 results, there was no significant difference between 16HBE 
cells and P. aeruginosa that were cultured in H. parainfluenzae media compare to the 
group that was cultured in cell media(CXCL8 p=0.4, CXCL1 p=0.7).     
 
 
Figure 62. CXCL8 and CXCL1 production from 16HBE cells after cultured with P. 
aeruginosa in H. parainfluenzae media for 8 hours. 16HBE cells were cultured with 
1×105 cfu/mL P. aeruginosa (n=6) in different media for 8 hours. After 8 hours, media was 
then collected. Media CXCL1and CXCL8 levels were measured by ELISA. Data are 
presented in box and whisker plots. The box shows +/- IQR. The line inside the box is 
median. P-value was calculated by paired t-test. Y axis shows the actual value of CXCL8 




3.5.9 H. parainfluenzae cultured with media that had cultured 16HBE cells and 
P. aeruginosa on chocolate blood agar plate 
Previously results showed that the media that had cultured P. aeruginosa and 16HBE 
cells can significantly reduce 16HBE cells inflammatory responses to H. 
parainfluenzae. Since bacterial load is an important factor to determine the 
inflammatory response, we proposed that this media may reduce H. parainfluenzae 
growth then reduce 16HBE cells inflammatory responses.  As a positive control, H. 
parainfluenzae (n=5) were plated with 100 µL 15 µg/mL polymyxin B, which has been 
tested to inhibit the growth of H. parainfluenzae. The result shows that the media had 
cultured P. aeruginosa and 16HBE cells did not reduce H. parainfluenzae growth. 
(Figure 63) 
 
   
Figure 63. H. parainfluenzae cultured on CBA agar with P. aeruginosa media. a) H. 
parainfluenzae cultured with 15 µg/mL polymyxin B on CBA plate overnight (n=5) 
showing zone of inhibition. b) H. parainfluenzae cultured with the media that had cultured 





3.5.10 H. parainfluenzae and 16HBE cells cultured with media that had cultured 
16HBE cells and P. aeruginosa  
Although P. aeruginosa and 16HBE cells did not significantly reduce H. 
parainfluenzae growth on CBA plates from the last experiment, it could be that this 
process requires the presence of 16HBE cells. So 16HBE cells were again co-cultured 
with H. parainfluenzae (n=5) in the media that had cultured 16HBE cells and P. 
aeruginosa (n=5). After 8 hours, the supernatant was collected and diluted in one time 
and 100 times, then 100 µL of the diluted supernatant was plated on CBA plates. 
Colony number was calculated the next day (Figure 64).  
Surprisingly we found that H. parainfluenzae that was co-cultured with media that had 
cultured P. aeruginosa and 16HBE cells showed a significantly higher bacterial load 
compared to H. parainfluenzae that was co-cultured with media that had only cultured 
16HBE cells (Figure 58). Instead of a suppressing effect, there was a promoting effect 
from P. aeruginosa to H. parainfluenzae bacterial growth. The median bacterial load 
for H. parainfluenzae that cultured in cell media was 1.75×104 cfu/mL, for H. 
parainfluenzae that cultured in P. aeruginosa media was 1.18×105 cfu/mL. 
Figure 64. Bacterial load of H. parainfluenzae after co-cultured with 16HBE cells in 
P. aeruginosa media. H. parainfluenzae (n=5) was co-cultured with 16HBE cells for 8 
hours with media that had cultured 16HBE cells and P. aeruginosa (P. aeruginosa media) 
or media that had cultured only 16HBE cells (cell media). After 8 hours, supernatant was 
collected and diluted 1 time, 10 times and 100 times. 100 µL of diluted solution was plated 
on CBA plate, plates were incubated overnight, and colony number was calculated next 
day. Y axis shows the bacterial load that was calculated from colony number. P-value was 




3.5.11 H. parainfluenzae and 16HBE cells cultured with broth that had cultured 
P. aeruginosa 
The media that had cultured P. aeruginosa and 16HBE cells can promote the growth 
of H. parainfluenzae, to figure out whether 16HBE cells is essential for this phenotype, 
H. parainfluenzae (n=5) was co-cultured with 16HBE cells with the broth that had 
only cultured P. aeruginosa (n=5).  
After 8 hours, there was still a significant increase in the bacterial load of the H. 
parainfluenzae that were cultured with P. aeruginosa broth (p=0.048). This result 
suggests that P. aeruginosa can promote the growth of H. parainfluenzae.  The median 
bacterial load for H. parainfluenzae that were cultured without P. aeruginosa broth 
was 8.75×105 cfu/mL, for H. parainfluenzae that were cultured with P. aeruginosa 
broth was 7.58×106 cfu/mL (Figure 65). 
 
  
Figure 65. Bacterial load of H. parainfluenzae after co-cultured with 16HBE cells in 
P. aeruginosa broth. H. parainfluenzae (n=5) was co-cultured with 16HBE cells for 8 
hours with 800 µL DMEM media and 200 µL filtered BHI broth that had cultured P. 
aeruginosa (P. aeruginosa broth). As comparison, H. parainfluenzae (n=5) was co-
cultured with 16HBE cells for 8 hours with 800 µL DMEM media and 200 µL BHI broth. 
After 8 hours, supernatant was collected and diluted in 1 time, 10 times and 100 times. 100 
µL of diluted solution was plated on CBA plate, plates were incubated overnight, and 
colony number was calculated next day. Y axis shows the bacterial load that was calculated 




3.5.12 H. parainfluenzae cultured with broth that cultured P. aeruginosa  
Finally, H. parainfluenzae (n=5) was cultured with broth that had cultured P. 
aeruginosa (n=5). Bacterial load (OD value) was measured at different time points (2 
hours, 4 hours, 6 hours, 8 hours and 24 hours). (Figure 66) 
The broth that had cultured P. aeruginosa significantly increased H. parainfluenzae 
bacterial load at 6 hours, 8 hours and 24 hours compared to the H. parainfluenzae that 
were cultured only in broth (p=0.02, p=0.009 and p=0.02 respectively).  
The median OD value for the H. parainfluenzae that were grown in the filtered broth 
which had previously cultured P. aeruginosa was 0.107 at 2 hours, 0.191 at 4 hours, 
0.253 at 6 hours, 0.408 at 8 hours, 0.749 at 24 hours. The median OD value for H. 
parainfluenzae that were grown in the normal broth was 0.102 at 2 hours, 0.146 at 4 
hours, 0.177 at 6 hours, 0.240 at 8 hours and 0.531 at 24 hours. (Figure 66)  
 
  
Figure 66. Bacterial load of H. parainfluenzae after co-cultured with P. aeruginosa 
broth. H. parainfluenzae (n=5) were incubated with 4 mL BHI broth and 1 mL filtered 
BHI broth that cultured P. aeruginosa. In control group, H. parainfluenzae were cultured 
with 5 mL BHI broth. After 2hours, 4 hours, 6 hours, 8 hours and 24 hours, OD value was 
measured at each time points. Y axis shows the OD value. P-values were calculated by 
paired t-test.   






















3.5.13 Conclusion for aim 5 
 Poly-microbial (H. parainfluenzae and P. aeruginosa) infection reduced 
16HBE cell inflammatory responses (CXCL8, CXCL1, LCN2 production) 
compared to single bacterial infection at 105 cfu/mL  
 P. aeruginosa media at 8 hours can reduce the inflammatory responses caused 
by H. parainfluenzae on 16HBE cells, but H. parainfluenzae media could not 
affect the inflammatory response caused by P. aeruginosa on 16HBE cells.  
 P. aeruginosa media can promote the growth of H. parainfluenzae rather than 
inhibit its growth. 
 Further research is planned to determine what components of the P. aeruginosa 





















Chapter 4: Discussion 
 
4.1 Discussion for hypothesis 1 
4.1.1 H. parainfluenzae are common in bronchiectasis 
H. parainfluenzae are often treated as a commensal bacterium in lower airway diseases. 
One of the main reasons is that in the lower airways H. parainfluenzae are not as 
prevalent as H. influenzae. For example, in CF, before 2000, the number of H. 
parainfluenzae detected in human lower airways was about a third of the number of H. 
influenzae. However, the number of H. parainfluenzae had significantly increased by 
2009. By 2012, H. parainfluenzae was almost three times that of H. influenzae. This 
significant increase could be due to the development of better techniques for H. 
parainfluenzae culture and identification, as well as increased awareness of H. 
parainfluenzae. (Ebbing and Robertson, 2015) 
In this study, the number of patients that presented H. parainfluenzae was almost equal 
to those with H. influenzae. There was no H. parainfluenzae reported from the NHS 
microbiology laboratory. There could be a couple of reasons: 1) the technique to isolate 
and identify bacteria from sputum samples. Haemophilus species are fastidious 
bacteria to culture; In the NHS laboratory, usually, a loop ( ≈10 µL) of liquefied 
sputum sample was used for bacterial culture. In my microbiology method, liquefied 
sputum was diluted 100 times and 10000 times first, then extract 100 µL of each diluted 
sputum for bacterial culture. In the NHS microbiology method, a loop of liquefied 
sputum was tiny volume and may lead to a selective representation of bacteria in 
sputum. Furthermore, In the NHS microbiology method, the liquefied samples were 
not diluted, which may results in less Haemophilus species growth than the sputum 
actually contains, since Haemophilus species can be overwhelmed by other species 
when the growing condition is crowded 2) in the clinical practice, H. parainfluenzae 
are often considered as a commensal bacteria, so even if the NHS microbiology 
laboratory could identify H. parainfluenzae from a sputum sample, it may not be 
reported. This could be another key reason that no H. parainfluenzae was reported 




No capsulated H. influenzae have been recovered from this patient's cohort. NTHi have 
been reported more frequently from lower airways diseases than capsulated H. 
influenzae because of the use of Hib vaccination. My study confirmed this in 
bronchiectasis as well. For the identification of NTHi from capsulated H. influenzae, 
gene bexA had been commonly used. The polysaccharide capsule of typeable H. 
influenzae strains is encoded by the cap locus, which is composed of three distinct 
regions: regions I to III. The genes contained within regions I and III, designated 
bexDCBA and hcsAB, respectively, are highly conserved across all capsular types and 
are required for transport of capsule constituents across the outer membrane (Satola et 
al, 2003). The use of bexA gene to identify NTHi sometimes failed to identify capsule-
deficient variants, so the use of gene bexB was proposed, there was no reported bexB 
partial deletions analogous to those observed in bexA. The combined use of bexA and 
bexB gene significantly increased the accuracy of identification. (Gregg S et al. 2011) 
 
In our laboratory compared to NHS microbiology laboratory, we found fewer patients 
had MNF, instead more pathogens were identified. In our method, we serially diluted 
sputum samples and plated them at different dilutions, this contributes to the growth 
of the bacteria that grow in a low speed or in low bacterial load. Also, our method 
includes multiple molecular strategies (PCR and qPCR), which allows more specific 
identification of bacteria to minimize the chance of misidentification of pathogen. 
In this patient cohort 5.6% (n=8) patients had more than one pathogen, this number is 
much smaller than the 208 patients cohort which was 19%. This could be due that fact 
that this group of patients was selected to only have H. influenzae as their main 
pathogen according to their latest NHS reports.  
Figure 66. The three cap locus in H. influenzae. The cap locus is divided into three 





The identification of H. parainfluenzae from H. influenzae was done by XV text in 
this study, which is the golden standard test for H. parainfluenzae identification. The 
experiment may have been enhanced if molecular identification methods were also 
used.  
Haemophilus species are delicate bacteria when culture in the laboratory practice 
especially for storage. The PCR and qPCR tests were performed on the Haemophilus 
species that were recovered from -80
。
C, there was around 15% to 25% of bacteria 
could not grow successfully. This could be avoided if PCR and qPCR tests were 
performed as soon as bacteria were isolated from patients’ sputum samples. However, 
the patients’ samples were collected at different times through this study, it was not 
practical to run PCR or qPCR tests on a small number of samples, so, we decided to 
freeze and store the bacterial isolates until there was sufficient number of samples for 
PCR tests. 
In this study, we only collected sputum sample once from each patient, so, the results 
cannot clarify if these patients are chronically colonised by H. parainfluenzae. For 
future study, it would be important to investigate if bronchiectasis patients would be 





4.1.2 H. parainfluenzae from the lower airways and upper airways are genetically 
different but related. They also trigger different inflammatory responses 
H. parainfluenzae are very common upper airways bacteria in healthy people and 
bronchiectasis patients (Kosikowska et al., 2016). H. parainfluenzae can colonise our 
upper airways and behave as commensal bacteria, it seems to suggest that H. 
parainfluenzae are not pathogenic (Bottone and Zhang, 1995).  
In this study, H. parainfluenzae from same patient’s lower airways and upper airways 
had different but related genomic profiles. The different but related genetic profile may 
suggest that the H. parainfluenzae from upper airways and lower airways were related, 
and some mutations may have happened or selected when H. parainfluenzae travelled 
from upper airways to lower airways due to the different environment. Furthermore, 
upper airways’ H. parainfluenzae stimulated significantly higher inflammatory 
responses than the lower airways ones. The low inflammatory response from lower 
airways may contribute to the survival and colonisation of H. parainfluenzae in the 
lower airways.   
This part of the project suggests that H. parainfluenzae from lower airways are 
different from those in the upper airways, so the fact that H. parainfluenzae do not 
trigger a host immune response in the upper airways does not mean that H. 
parainfluenzae are not pathogenic in bronchiectasis lower airways. 
Limitations  
In this part of the project, the sample size was small because of the difficulty of 
growing H. parainfluenzae from frozen stock. A more significant sample number 
could help to strengthen this result. Also, whole genome sequencing could be used to 






4.1.3 H. parainfluenzae patients and NTHi patients have similar clinical 
symptoms 
Pathogen infection usually adds to airways inflammation in bronchiectasis. To explore 
the pathogenicity of H. parainfluenzae, H. influenzae, a commonly accepted pathogen 
in bronchiectasis, was used as a comparison. In this study, serum WCC, ESR, CRP 
and ICAM-1 were measured. WCC is a basic clinical test marker for infection and 
inflammation, in bronchiectasis, patients usually have high number of neutrophils 
(Belda et al, 2000). ESR and CRP are both general inflammation markers. It has been 
found that bronchiectasis patients have higher serum WCC, ESR and CRP compared 
to healthy people (Ergan Arsava and Coplu, 2011), and in patients that are colonised 
with pathogens compared to the patients that had MNF, there was also higher serum 
inflammation (Chalmers, J. D. et al. 2012). ICAM-1 mediates the interaction between 
the neutrophils and bronchial epithelial cells, it can be produced from epithelium and 
has been demonstrated to be upregulated in bronchiectasis (Chan SC et al, 2008). For 
sputum inflammation, MPO was measured, it is the most abundant pro-inflammatory 
enzyme stored in the neutrophilic granulocytes, it can reflect the activation of 
neutrophils. In bronchiectasis, there is higher MPO levels in colonised patients 
compared to the non-colonised patients (Pulli et al, 2013). Besides the inflammatory 
markers, we also compared the patients for their BSI scores. It takes into consideration 
of multiple clinical factors, is a useful predictor of morbidity and mortality, it can also 
give predictions of hospital admission, exacerbation and life quality (Chalmers et al, 
2014). The use of these markers as well as patient’s lung function tests can give a 
complete comparison for the clinical relevance of NTHi and H. parainfluenzae in 
bronchiectasis.  
From this study, patients that had H. parainfluenzae did not show a significant 
difference in their serum and sputum inflammation markers from those patients that 
had H. influenzae. This suggests that H. parainfluenzae may have similar clinical 
relevance as H. influenzae in bronchiectasis.  
H. parainfluenzae patients had significantly lower bacterial load than H. influenzae 
patients (Figure 24). This may suggest that H. parainfluenzae are less efficient than H. 




than half of them had bacterial loads of more than 106 cfu/mL. In bronchiectasis, when 
patients’ sputum bacterial load is 106 cfu/mL or more, they usually have significantly 
increased serum and sputum inflammation, also more frequent out-patient 
exacerbations (Chalmers, J. D. et al. 2012).  
Patients that had higher bacterial load of H. parainfluenzae had significantly higher 
serum ESR, ICAM-1 and sputum MPO in comparison to the patients that had lower 
bacterial load of H. parainfluenzae. The high bacterial load is thus necessary for H. 
parainfluenzae to be pathogenic in bronchiectasis. 
Limitations  
In this study, blood and sputum samples were collected from patients only for a single 
time, but patient's clinical symptoms can be influenced by a lot of other factors, 
especially patients also with COPD, asthma or some other clinical conditions. Multiple 
time points may be better for this case. However, since sputum microbiology test was 
only performed once for each patient as previously mentioned, the inflammatory data 
from other time points may relate to different microbiology results, so in this study, 
only one time point (the same time as sputum microbiology test was done) was chosen. 
This study would be continued by comparing a larger cohort of patients with 
bronchiectasis and chronically colonised with H. parainfluenzae or NTHi.  
Also, we compared the patients that had both serum sample and sputum sample. Due 
to the fact that all patients were at stable stage, their sputum sample volume was limited, 
so not all the patients gave sufficient volume of sputum sample for bacteria 
identification and also MPO measurement. The sample size was smaller in this part of 
study compared to the number of patients that we got microbiology results.  
There are other ways to assess the severity of bronchiectasis, for example the FACED 
score, which compare to BSI score, is an easier to use tool but incorporate less 
dichotomic variables. Study had shown these two scores gave similar results and both 
can be used for routine clinical work (Minov J et al, 2015). There is also the St. 
George’s Respiratory questionnaire, the Leicester Cough questionnaire, the 




all found to be useful clinical end points and can be included in future study (Cartlidge 
MK et al, 2018). 
4.1.4 H. parainfluenzae triggers similar inflammatory responses from epithelial 
cells as H. influenzae 
4.1.4.1 Cell culture 
In this study, three different epithelial cells were used. 16HBE is a widely used cell 
line as a model for the airway’s epithelium barrier function. They can express 
cytokines and form tight junction. In this study, cytokine production was the main 
target. NHBE are normal human primary bronchial cells; they were isolated from the 
epithelial lining of airways above the bifurcation of the lungs. Compared to 16HBE 
cells, NHBE cells, as primary cells, can represent more normal epithelial cells’ 
behaviour. However, NHBE cells are taken from healthy people, and in bronchiectasis, 
patients have damaged airways and a deficient immune system, so patients’ nasal 
epithelial cells were also isolated and tested. We in total recruited 10 stable 
bronchiectasis patients and collected their nasal brush for cell cultural. Five nasal 
samples successfully grown in the laboratory, four samples could not grow due to 
contamination, one sample stopped growing after one passage.  
 
Limitations 
In this study, we have included three different cells, especially the patients’ nasal 
epithelial cells. However, we did not use patients’ bronchial epithelial cells. This could 
be achieved by culturing bronchial tissue obtained from patients (Yaghi A1, Zaman A 
and Dolovich M, 2010). This is an invasive procedure for the patients, also more time 
consuming and complex. It could be included for future study since we have confirmed 




H. parainfluenzae can cause inflammatory responses from nasal epithelial cells, it 
would be important to also prove that H. parainfluenzae can trigger similar 
inflammatory responses from patients’ lower airways epithelial cells.  
The effect from patient’s macrophage and neutrophils on H. parainfluenzae is 
important as well. From this study, we found that patients had H. parainfluenzae had 
smaller bacterial load compared to NTHi. It is interesting to see if phagocytosis to H. 
parainfluenzae from patients’ neutrophils would be more efficient to NTHi, which 
could be the reason for the smaller number of H. parainfluenzae in bronchiectasis 
patients.  
Animal tissue model had been involved in this study. We isolated a 1mm×1mm size 
bronchial tissue from healthy porcine model. Then we co-cultured this bronchial tissue 
with H. parainfluenzae, NTHi and P. aeruginosa for different hours. The cultural 
media was collected and cytokine production was measured. We did not observe 
significant cytokine production and there was insufficient number of tissues, so this 
part of study was stopped without further input. There is also no bronchiectasis animal 
model available yet. On animal model we can mimic long term bacterial colonisation, 
which can help to understand the long-term effect of H. parainfluenzae on epithelium. 
Research about bronchiectasis animal model would be very appreciated. 
4.1.4.2 Cytokines production were time-dependent   
To figure out the optimum time point to investigate cell inflammatory response to H. 
parainfluenzae, bacteria were co-cultured with 16HBE cells for 1 hour, 2 hours, 4 
hours,6 hours, 8 hours and 24 hours. For H. parainfluenzae and NTHi, after 8 hours 
CXCL8 production reached to peak, no significant difference was observed between 
8 hours and 24 hours. And from the LDH assay, we found that after 16HBE cells co-
cultured with H. parainfluenzae after 24 hours, there was significant cell injury or 
death. According to these, 8 hours was the best time point for the purpose of this study 
when there was sufficient cytokine production from cells and the cells were still at a 





For different cells and cytokines, there were differences in the hour when the cytokine 
production reached to the peak. For NHBE cells, CXCL1 production triggered by all 
three bacteria was in peak at 6 hours rather than 8 hours. For the further study, 8 hours 
was still used for compare the CXCL1 production triggered by different bacterial load 
of H. parainfluenzae. This may lead to less significant change between low bacterial 
load group and high bacterial load group.  
4.1.4.3 Cytokines produced by epithelial cells 
Epithelial cells play a crucial role in host defence against infection. Airways 
epithelium can recognise microorganisms by toll-like receptors (TLR). TLR2 and 
TLR4 can bind to bacterial LPS and then activate downstream pathways (Miller, Ernst 
and Bader, 2005). Through those pathways, epithelial cells can produce inflammatory 
mediators, chemotactic mediators and antimicrobial substances. In this study, mainly 
inflammatory and chemotactic mediators were measured. These mediators can initiate 
an inflammatory reaction and recruit phagocytosis. CXCL8, CXCL1 and ICAM-1 all 
can contribute to neutrophil migration(Mukaida, 2015; Filippo et al., 2018; Yang et 
al., 2005), CXCL1 also give positive feedback to MAPK/ERK pathway (Physiology, 
2014), NFκB production(Papa et al., 2004) and interleukin 17 production (Zhao et al., 
2014), which can promote cytokine production. LCN2 can directly inhibit bacterial 
growth by interrupting their iron pathway (Lois et al., 2015; Kumar et al., 2015). From 
cytokine array results, H. parainfluenzae can also stimulate strong production of 
cytokines like GM-CSF, which is important for macrophage differentiation and 
activation (Shibata et al., 2001; Berclaz et al., 2007)(Shibata et al., 2001; Berclaz et 
al., 2007); IL6, can contribute to CRP production, a key marker for inflammation in 
the airways (Hashizume, Hayakawa and Suzuki, 2009; Tanaka, Narazaki and 
Kishimoto, 2014); TNFα, can add to CRP levels and neutrophil migration (Eonard et 
al., 1999). All these may indicate that H. parainfluenzae can lead to a strong 




4.1.4.4 Inflammatory response caused by H. parainfluenzae is similar to H. 
influenzae  
The main finding was that H. parainfluenzae could induce a similar epithelial immune 
response as H. influenzae. H. influenzae and H. parainfluenzae are both gram-negative 
bacteria; LOS is their main virulence factor. It seems evident that they can cause a 
similar response from the cell. However, LPS differs from bacteria to bacteria. Such 
as H. parainfluenzae and Prevotella melaninogenica (both gram-negative) stimulate a 
significantly different inflammatory response from macrophages, it is mainly because 
of their different LPS structure. H. parainfluenzae have a short acyl chain LPS while 
P. melaninogenica has a long acyl chain LPS (Goleva et al., 2013). Between H. 
influenzae and H. parainfluenzae, their LOS is similar (Young and Hood, 2013), but, 
not identical. Compared to H. influenzae, H. parainfluenzae have a reduced capacity 
for synthesis of LOS outer core structure, which may lead to a lack of phase variation 
of H. parainfluenzae LOS molecule (Young and Hood, 2013). At the same time, H. 
parainfluenzae LOS contains O-antigen, which has not been found in H. influenzae. 
Figure 68. The cytokines that were up regulated by H. parainfluenzae on 16HBE cells. 
H. parainfluenzae can activate the production of CCL20, CCL2, IL6, TNF α, CXCL1, GM-
CSF, CXCL8, LCN2, Upar, Angiogenin, IL24 and ICAM-1. Those cytokines are related 




O-antigen facilitates H. parainfluenzae survival from the human serum killing 
effect(Young et al., 2013)(Vitiazeva et al., 2011).  
H. parainfluenzae have also been reported to have capsule structures, while all the H. 
influenzae found from this cohort were all NTHi, which do not have a capsule. The 
capsule is another critical virulence factor. It can protect bacteria from been recognised 
and engulfed by immune cells, and also help bacteria to attach to different surfaces 
(Moxon and Kroll, 1990).  
Knowing the differences between these two Haemophilus species, it was essential to 
specifically investigate the pathogenicity of H. parainfluenzae in vitro. From the cell 
infection experiments, H. parainfluenzae at high bacterial loads can stimulate 
significant epithelial cell cytokine production and cell injury or death. This suggests 
that H. parainfluenzae can be a potential pathogen in bronchiectasis, although further 
research needed.     
4.1.4.5 Epithelial cells response to P. aeruginosa 
In the cell culture experiment, it has been noticed that after 24 hours, P. aeruginosa 
can trigger significantly higher CXCL8 production than the two Haemophilus species. 
P. aeruginosa not only have LPS as a virulence factor, but also produce toxins such as 
PCN(Lau et al., 2004). The bacterial load of P. aeruginosa were significantly higher 
than H. parainfluenzae and NTHi after 8 hours and 24 hours growth, and these could 
also be the reason for the high CXCL8 level at 24 hours. 
Limitations for 4.1.4.3, 4.1.4.4 and 4.1.4.5 
For these parts we found that H. parainfluenzae can trigger significant inflammatory 
responses from epithelial cells by measuring cytokine productions. There are other 
measurements can be used to investigate the virulence of H. parainfluenzae on 
epithelial cells. For example, H. influenzae have been shown to be able to enter 
epithelial cells using electron and confocal microscopic analysis (Sajjan et al, 2008), 
which is not shown for H. parainfluenzae. It would be also important to see if H. 




In those epithelial cell co-culture experiments, we co-cultured epithelial cells with 
multiple strains of H. parainfluenzae, NTHi and P. aeruginosa. The addition of LPS 
positive control would have strengthened these results, and further experiments to 
block LPS while co-culture with epithelial cells would complement the heat-kill 
bacteria experiment to support the theory that LPS is the main virulence factor of H. 
parainfluenzae. Previous experiment has attempted to use polymyxin B to block 
bacterial LPS, however it was also harmful to 16HBE cells, so a better LPS blocking 






4.1.5 Future work for hypothesis 1  
Our data explored the pathogenicity of H. parainfluenzae in stable bronchiectasis 
patients. It is crucial to also investigate H. parainfluenzae in bronchiectasis 
exacerbation. That H. parainfluenzae are common in stable patients does not mean it 
would still be in exacerbation patients. If H. parainfluenzae can lead to bronchiectasis 
exacerbation. How frequent it would be in bronchiectasis patients? Would those 
patients still have similar serum and sputum inflammation as patients that have H. 
influenzae exacerbation? To explain the mechanism, the research could focus on: 1) 
Epithelial cells are the first line of defence in our immune system. In this study, we 
investigated the inflammatory response from epithelial cells. For future work, we can 
isolate neutrophils and macrophages from patients’ blood and bronchoalveolar lavage 
samples to figure out if those immune cells will also give a significant response to H. 
parainfluenzae. 2) Besides causing an inflammatory response, another important 
factor for the pathogenicity of H. parainfluenzae are whether they can persist in the 
airways. Our previous results show that patients had H. parainfluenzae had a lower 
bacterial load; it could be related to a more efficient killing function from the immune 
system to H. parainfluenzae. For this, phagocytosis effect of neutrophils to H. 





4.2 Discussion for hypothesis 2 - H. parainfluenzae and P. aeruginosa together 
reduced the inflammatory response 
From this study, when H. parainfluenzae was co-cultured with P. aeruginosa, there 
was an inhibitory effect on 16HBE cells inflammatory response. This inhibitory effect 
only appeared when bacteria were in low bacterial load (105 cfu/mL).  
The human airways are colonised by millions of different bacteria. In bronchiectasis, 
it has been suggested that the sudden rise of bacterial load of one or a few bacteria 
could lead to an imbalance of the microbiome (Woo et al., 2019), which contributes 
to exacerbations. This theory can be further supported by these results. When bacteria 
were all in a small dosage, they stimulated less inflammation from cells. Bacteria may 
form competitive or cooperative relationship, which results in a “peaceful” 
environment. However, when bacterial load increases, the relationship on longer exist, 
which may interrupt the balance and lead to an “un-peaceful” environment. (B.Rogers, 
2018) 
 P. aeruginosa have already been known to inhibit the growth and biofilm formation 
of Staphylococcus aureus (Kim et al., 2014); it may have the same inhibitory effect on 
H. parainfluenzae, after which the decreased number of bacteria may lead to a milder 
inflammatory response from 16HBE cells. Although, from the aspect of bacteria, 
persistence in the host is more relevant than triggering host immune response. This 
decrease in inflammatory response could also be a result of cooperation between the 
two bacteria to escape from being recognised and cleared by the host immune system. 
(Apollo Stacy, 2015) 
After finding out that H. parainfluenzae and P. aeruginosa together reduced the 
inflammatory response from 16HBE cells, we then found that the media that had 
cultured P. aeruginosa could reduce the CXCL8 and CXCL1 production caused by H. 
parainfluenzae. In comparison, media that had cultured H. parainfluenzae could not 
do the same to P. aeruginosa. This shows that something produced by P. aeruginosa 
could work on H. parainfluenzae or the cells, which lead to a decrease of cytokine 
production. For this study, we looked into the interaction between P. aeruginosa media 




Although this part of the study is a preliminary attempt to explore bacterial interaction, 
there are still a lot of questions that remain unanswered, or I would rather say a lot of 
possibilities for future work.  
Our results suggested a cooperative relationship between P. aeruginosa and H. 
parainfluenzae. P. aeruginosa turned out to be able to promote the growth of H. 
parainfluenzae rather than inhibit it; this leads to a huge question: How does this 
interaction results in the lower inflammatory response? 
4.3 Future work 
As previously mentioned, the reduction effect led by P. aeruginosa media could be 
because of interaction with bacteria, or with cells. From this study, this question 
remains unsolved. Although we found that P. aeruginosa can positively influence H. 
parainfluenzae growth, there is not enough evidence to prove that this was the reason 
for the change in the inflammatory response.  
If the change of H. parainfluenzae growth was a key factor in this process, it is crucial 
to figure out what produced by P. aeruginosa that can interact with H. parainfluenzae. 
In bacterial interaction, there is a metabolic cross-feeding model, in which one species 
consumes the by-products of another. This may, therefore, facilitate H. parainfluenzae 
growth and change the proportion of the metabolic pathway of H. parainfluenzae or 
its by-products, eventually resulting in changes in its virulence.  
If the change of H. parainfluenzae growth was not a key factor in this process, then it 
could be that something produced by P. aeruginosa can inhibit the inflammatory 
response. It has been observed that some mRNA released from P. aeruginosa outer 
membrane vesicles can negatively influence the production of CXCL8 from cells 
(Bomberger et al., 2009). So far, from current results, figuring out what is in the P. 
aeruginosa media should be the next step to explore. Both metabolic or proteomic 






4.4 Final discussion  
H. parainfluenzae as a successful commensal species, its potential role as a pathogen 
has long been neglected. Most studies about Haemophilus species were only focused 
on H. influenzae. H. parainfluenzae infection was considered too rare to merit any 
research and case reports, not only in bronchiectasis but also in other respiratory 
diseases. 
In otitis media, H. influenzae have been found in 38% of 8198 patients (Broides et al., 
2009). There is no clear data about the frequency of H. parainfluenzae in otitis media, 
however, a lot of research include H. parainfluenzae as a potential pathogen in otitis 
media, although there is no clear data to support this (Cardines et al., 2009).  
In pneumonia, type b H. influenzae have been found to be the main Haemophilus 
species, they have caused 1304 cases of pneumonia per 100,000 children under five 
globally in 2000, with figures of 1724 for Africa and 283 for Europe (Watt et al., 2009). 
H. parainfluenzae are not commonly reported in pneumonia. Multiple group had 
reported isolation or growth of H. parainfluenzae in pneumonia, but the method used 
to classify H. parainfluenzae were not clear (Numazaki et al., 2004) (Pillai et al., 2000). 
There was case report about H. parainfluenzae causing pneumonia, but the prevalence 
of H. parainfluenzae is still unknown. 
In COPD, H. influenzae have been considered as pathogen and contribute to 20-30% 
of COPD exacerbations and also frequent involved in stable COPD (Sethi and Murphy, 
2008). H. parainfluenzae have been found to be frequently isolated from both stable 
and exacerbated COPD, but it has been thought not pathogenic (Taylor et al, 1992).  
In this study, we established the prevalence of H. parainfluenzae in bronchiectasis, 
and also, we confirmed that H. parainfluenzae plays similar role as NTHi in stable 
bronchiectasis in patients’ clinical symptoms and in vitro experiments. This will help 
our understanding about H. parainfluenzae in bronchiectasis, and further more may 
draw more attentions to H. parainfluenzae in different airway diseases. 
A better understanding of H. parainfluenzae is also needed the paediatric 
bronchiectasis, in which Haemophilus species is more commonly detected (around 




from paediatric bronchiectasis patients (Pijnenburg et al., 2004), but information about 
H. parainfluenzae in this area is very limited. It is unknow the frequency of H. 
parainfluenzae in children with bronchiectasis.   
Bacterial infection drives the airway inflammation and remodelling, and bacterial 
clearance can reduce markers of inflammation and improve clinical outcome in 
bronchiectasis (Murray et al., 2010). Therefore, the identification of H. parainfluenzae 
and the awareness of H. parainfluenzae can be a potential pathogen would benefit the 
patients with more efficient treatment. Currently in NHS laboratory, H. parainfluenzae 
are often dismissed as mixed normal flora. With more studies about the pathogenic 
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